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Summary 
Energy homeostasis is controlled in the hypothalamus. Hypothalamic tanycytes 
are a type of glial cell that lie in the wall of the third ventricle, between 
ventricular CSF and the key nuclei controlling feeding, and are potentially linked 
to this regulation. Tanycytes have been found to express sweet taste receptors; 
similar receptors exist for amino acids and could be present in tanycytes. 
Therefore, the aims of this work were to understand the tanycyte amino acid 
signalling process, determine the impact of diet on tanycyte function, and link 
tanycytes to energy homeostasis. 
Using ratiometric Ca2+ imaging, I showed that tanycytes responded to amino 
acids; the responses also involved ATP release via pannexin 1 and CalHM1 
from tanycyte cell bodies and down their processes towards the parenchyma. 
As IMP increased the amplitude of tanycyte responses to some amino acids, 
one of the receptors is Tas1r1/Tas1r3. The Tas1r1 subunit was expressed in 
mouse tanycytes, and Tas1r1-null mice showed sex-specific altered responses 
to arginine and lysine. mGluR4 antagonist MAP4 reduced the responses to 
alanine, and mGluR4 was shown to be present in mouse tanycytes. 
Tas1r1/Tas1r3 and mGluR4 are therefore two of the receptors responsible for 
tanycyte amino acid signalling. 
Fasting and essential amino acid deprivation increased tanycyte sensitivity to 
alanine. Essential amino acid-deprived diet also reduced the intake of an 
alanine-enriched drink. While amino acid-imbalanced diets did not have strong 
effects on mouse metabolism over 24 hours, increasing dietary alanine content 
reduced feeding and increased metabolism in the light phase. 
These results demonstrate for the first time that tanycytes can detect amino 
acids, and that they do so via two different pathways, similarly to taste receptor 
cells in the tongue. Tanycytes can send ATP signals to inform the 
hypothalamus about nutrient availability. The data also show that tanycyte 
amino acid sensitivity is diet-dependent. High alanine food has a satiating 
effect, which could be partially mediated by tanycytes, although a direct link 
cannot be confirmed at this stage.  
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1. Introduction 
The impact of food choices on health and wellbeing has been known for 
millennia: as famously said by Hippocrates, “Let food be thy medicine and 
medicine be thy food”. Unfortunately, most people in the Western cultures seem 
to not follow this rule; the World Health Organization has recognized obesity as 
a disease since 1948 (James and Rigby 2010), and it has gradually developed 
into an epidemic (Mitchell et al. 2011). 70 years later, scientists and medical 
professionals have not yet found a full explanation of what underlying 
processes in the body and the brain control feeding, the storage of energy and 
its expenditure through metabolism. These processes are collectively called 
energy homeostasis and are now known to be primarily controlled in the 
hypothalamus, with influences from the periphery as well as other sites of the 
brain (Sainsbury et al. 2002). 
While it seems obvious from the modern neuroscience point of view, the 
involvement of the brain in the regulation of energy homeostasis was not 
apparent until the early 20th century. Previously, it was believed that the 
stomach was in full control of hunger, although alternative theories about a 
“hunger centre in the blood” had been proposed (Mayer 1953). However, in 
1901 Fröhlich observed excessive weight gain in a patient who suffered from a 
tumour in the pituitary region, linking the central nervous system with metabolic 
functions for the first time (Bruch 1939). This and several other cases prompted 
further studies in the field, and in 1940 Hetherington and Ranson discovered 
that lesions in the medial hypothalamus consistently caused obesity in male 
and female rats (Hetherington and Ranson 1940). Similar research continued, 
including Anand and Brobeck revealing in 1951 that bilateral destruction of the 
lateral hypothalamic nucleus induced anorexia (Anand and Brobeck 1951). A 
decade later, Kennedy concluded that the hypothalamus regulated food intake 
and activity in response to changes in body fat, as well as caloric intake and 
blood glucose level (Kennedy 1961). Current knowledge extends his 
observations, connecting hormonal signals from the periphery and blood 
nutrient levels with specific cell populations in the hypothalamus and the 
brainstem, which then lead to adjustments in feeding and energy expenditure. 
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Hypothalamic tanycytes, a type of non-neuronal cell lining the third ventricle, are 
potentially linked to the regulation of energy homeostasis. Tanycytes have 
recently been found to respond to changes in glucose concentration in the 
ventricular cerebrospinal fluid, suggesting that they may monitor the nutritive 
status of the brain (Frayling et al. 2011). Moreover, our laboratory has shown 
that tanycytes sense glucose through the same sweet taste receptors 
(Tas1r2/Tas1r3) that are used in the taste buds of the tongue to detect sugar 
and sweeteners (Benford et al. 2017). Receptors for another taste modality – 
umami (the savoury flavour of L-glutamate for humans and most non-aromatic 
L-amino acids for rodents) – are closely related to the sweet taste receptors 
(Zhao et al. 2003), proposing the idea that the umami taste receptor may be 
involved in tanycyte amino acid sensing. This dissertation explores the potential 
contribution of tanycytes as hypothalamic amino acid sensors in the control of 
feeding and energy expenditure. 
1.1. Regulation of energy homeostasis 
While the discoveries relating brain injury to changes in food consumption were 
unexpected at the time, it is now widely accepted that the hypothalamus 
integrates metabolic information from the digestive tract and sensory organs, as 
well as locally produced signals. The combined effects of central and peripheral 
signals are then used to determine feeding-associated behaviours and adjust 
long-term energy expenditure. The presently established aspects of the control 
of energy homeostasis are described here in detail. 
1.1.1. Peripheral signals 
Initially, the information about the metabolic status of an organism comes from 
its digestive system and adipose tissue (Figure 1.1).  
When the stomach empties, the epithelial cells in the stomach lining produce 
ghrelin, a hormone that acts on neurons to stimulate hunger (Asakawa et al. 
2001). The expression of ghrelin in the stomach is increased by fasting but 
reduced in obese mice by anorexigenic hormones leptin and interleukin-1β 
(Asakawa et al. 2001). Ghrelin is transported into the brain over the median 
eminence (ME), a circumventricular organ within the hypothalamus containing 
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fenestrated capillaries, which gives the area around the third ventricle improved 
access to circulating hormones (Schaeffer et al. 2013). Ghrelin increases 
neuronal production of neuropeptide Y (NPY), which in turn increases food 
intake and decreases energy expenditure (Asakawa et al. 2001).  
Leptin is produced by the adipose tissue and acts to reduce food intake. Leptin 
regulates energy homeostasis by inactivating orexigenic NPY/agouti-related 
peptide (AgRP) neurons while activating anorexigenic proopiomelanocortin 
(POMC)/cocaine- and amphetamine- related transcript (CART) neurons in the 
hypothalamus (Schwartz et al. 1996, Cheung et al. 1997). This is achieved by 
Stomach
Ghrelin
Adipose tissue
Leptin
Asprosin
Pancreas
Insulin
Glucagon
Amylin
PPSmall intestine
CCK
Motilin ColonGLP-1
GLP-2
OXM
PYY
H B
Figure 1.1. Peripheral signals involved in the regulation of energy homeostasis. Adipose 
tissue cells produce leptin and asprosin, both detected in the hypothalamus. Stomach 
secretes orexigenic ghrelin, while the pancreas produces a range of anorexigenic hormones 
and peptides, all of which also affect neuronal activity in the hypothalamus. Peptides from the 
small and large intestine project to the hypothalamus and brainstem, as well as other parts of 
the digestive system. Grey triangles next to peptide names indicate their effect on food intake: 
triangle pointing ‘up’ represents an increase in feeding, ‘down’ represents a decrease. B, 
brainstem; H, hypothalamus; CCK, cholecystokinin; PP, pancreatic polypeptide; GLP-1, 
glucagon-like peptide-1; GLP-2, glucagon-like peptide-2; OXM, oxyntomodulin; PYY, peptide 
tyrosine tyrosine. 
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the binding of leptin to leptin receptors (LepR). Leptin also regulates the brain 
reward system by inhibiting dopaminergic neurons in the ventral tegmental area 
(VTA) to reduce the motivation for feeding (Hommel et al. 2006). 
Unfortunately, a constantly high level of circulating leptin, as seen in many 
obese individuals, can lead to a dramatic reduction in leptin detection, which is 
referred to as leptin resistance and is a common cause for metabolic syndrome 
(Frederich et al. 1995). Two potential mechanisms for central leptin resistance 
are a decrease in leptin transport into its sites of action within the brain by 
tanycytes of the ME and the suppression of leptin signalling by an increase in 
circulating inhibitory molecules. Impaired leptin transport through the ME has 
been observed in obese mice, where leptin accumulated in the ME without 
entering the third ventricle (Balland et al. 2014), and the ratio of cerebrospinal 
fluid (CSF)/serum leptin is decreased in obesity (Caro et al. 1996). 
The peripheral effects of leptin are the promotion of energy expenditure by 
increasing sympathetic nerve signalling to brown adipose tissue (BAT) and the 
modulation of gluconeogenesis in the liver by increasing parasympathetic nerve 
activity (Bell et al. 2017). Leptin has also been shown to suppress responses to 
sweet stimuli in the tongue (Kawai et al. 2000). 
Another hormone produced by the adipose tissue has been recently discovered 
and termed asprosin (Romere et al. 2016). Asprosin secretion is induced by 
fasting and leads to hepatic glucose release and increased appetite. The latter 
effect is mediated by inhibition of hypothalamic POMC neurons, and 
neutralisation of asprosin in the blood with specific antibodies reduces food 
intake and body weight (Duerrschmid et al. 2017). 
The pancreas produces insulin in response to increased blood glucose. Insulin 
has an anorexigenic effect as hypothalamic neurons expressing insulin 
receptors co-express POMC, which is a precursor for melanocortins, known to 
decrease appetite while increasing energy use (Benoit et al. 2002). The 
administration of insulin into the hypothalamus leads to a dose-dependent 
decrease in food intake and sustained weight loss in a range of species (Woods 
et al. 1979, Schwartz et al. 1992, Chavez et al. 1995). Moreover, the loss of 
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insulin receptors in the brain results in increased body weight and susceptibility 
to diet-induced obesity (Brüning et al. 2000). 
The pancreas also produces glucagon, amylin, and pancreatic polypeptide 
(PP), all of which are anorexigenic (Suzuki et al. 2010). Glucagon secretion is 
induced by hypoglycaemia, and peripheral administration of glucagon reduces 
meal size and total food intake in rats (Geary and Smith 1982). Amylin is 
coreleased with insulin and has been demonstrated to reduce meal size and 
duration (Lutz et al. 1995). PP reduces food intake by acting on the Y4 receptor 
in the brainstem and hypothalamus, as well as via the vagus nerve (Asakawa et 
al. 2003). Circulating PP concentration changes with food ingestion (Wisén et 
al. 1992). 
A number of peptides related to the regulation of food intake are released from 
the small and large intestines.  
Motilin, a 22-amino acid peptide secreted by the small intestine, regulates 
interdigestive motility, gallbladder contractions, and the secretion of enzymes 
from the stomach and pancreas (Itoh 1997). It has also been reported to 
stimulate growth hormone secretion. Motilin is closely related to ghrelin, and 
their receptors exhibit 50% identity with each other (Asakawa et al. 2001). 
Cholecystokinin (CCK) is produced in the small intestine after food ingestion, 
reaching a peak concentration in the blood plasma within 15 minutes and 
reducing further food intake (Liddle et al. 1985). The two CCK receptor 
subtypes, CCK1 and CCK2, can be found in several areas of the brain, 
including the brainstem and hypothalamus (Honda et al. 1993), although the 
anorectic effect is mostly mediated via vagal afferents (Zarbin et al. 1981). 
Continuous CCK administration does not affect food intake (Crawley and 
Beinfeld 1983). Interestingly, CCK is also expressed in the taste buds and has 
been shown to modulate bitter taste sensitivity and transduction in mice 
(Yoshida et al. 2017). 
Glucagon-like peptide-1 (GLP-1) is synthesized and released in the distal part 
of the small intestine and the colon in response to nutrients to suppress short-
term food intake in rats (Rüttimann et al. 2009). It is also produced in the 
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nucleus of the solitary tract (NTS) of the brainstem, and acts as a 
neurotransmitter to depolarise neurons in the hypothalamus (Merchenthaler et 
al. 1999). GLP-1 is involved in glycaemic control as it stimulates insulin 
secretion and has a stimulatory effect on pancreatic β cells (Egan et al. 2003). 
Conversely, glucagon-like peptide-2 (GLP-2) has no effects on food intake, but 
chronic administration has been shown to have an intestinal trophic effect 
(Drucker et al. 1996). Another peptide in this family, oxyntomodulin (OXM), 
reduces food intake and increases energy expenditure in humans and rodents, 
although it has low affinity for the GLP-1 receptor (Cohen et al. 2003). 
Peptide tyrosine tyrosine (PYY) is a 36-amino acid lower gut hormone which 
binds to the hypothalamic Y2 receptor, leading to a reduction in food intake 
(Batterham et al. 2002). PYY concentration in blood plasma is low during fasting 
but increases 1–2 hours after food ingestion and remains elevated for several 
hours, reflecting the size and nutrient proportions of the meal (Adrian et al. 
1985). A study in mice has shown that PYY also increases energy expenditure 
independently of food intake (Boey et al. 2008). 
A common feature of the peripheral peptides described above is that they all, 
either directly (via blood plasma) or indirectly (via vagus nerve or by stimulating 
the release of other peptides), send information about changes in the nutritive 
state to the brain, particularly to the brainstem and the hypothalamus (Figure 
1.1).  
1.1.2. Hypothalamic nuclei involved in energy homeostasis 
The hypothalamus is the area of the brain that receives and integrates signals 
from the whole body, including the rest of the brain, about the homeostatic state 
of the organism. It is subdivided into three regions: periventricular, medial and 
lateral, different in their morphology and functions. The periventricular and 
medial hypothalamic zones contain nuclei involved in the regulation of 
homeostatic behaviours such as hunger, thirst, thermoregulation, circadian 
rhythms, and reproduction (Simerly 2015). A summary of hypothalamic nuclei 
and their functions is presented in Table 1, and the connections between the 
nuclei are shown in Figure 1.2. 
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The ME is a circumventricular organ located in the basal hypothalamus 
containing fenestrated capillaries and tanycytes, which are heavily involved in 
the transport of blood-born substances such as gut peptides, hormones and 
nutrients into the arcuate nucleus (ARC) (Langlet et al. 2013, Balland et al. 
2014). Thus, the ARC is considered to be outside the blood-brain barrier (BBB) 
(Ciofi 2011). The ARC contains the main neuronal populations responsible for 
regulating energy homeostasis: anorexigenic POMC/CART-producing neurons, 
and orexigenic NPY/AgRP-producing neurons (Hahn et al. 1998). The 
populations are localized in adjacent subsets and interact with each other in an 
asymmetric manner (Roseberry et al. 2004). 
ARC
VMH
PVN
LH
DMH
3V
ME
POMC/
CART
NPY/AgRP
GE GI
Orx/hcrt
VGlut2
MCH
Amylin
VGlut2
VGlut2
CRH
Oxytocin
Galanin
CART
CART
Figure 1.2. Hypothalamic circuits involved in the regulation of energy homeostasis. The 
arcuate nucleus contains POMC/CART, NPY/AgRP and VGlut2 neurons that are directly 
involved in the regulation of energy balance. These neuronal populations project into other 
hypothalamic nuclei. The ventromedial hypothalamus has glucose-excited and glucose-
inhibited neurons, as well as VGlut2 neurons. The dorsomedial hypothalamus has strong 
connections with other nuclei and integrates their signals. The lateral hypothalamus contains 
orexin/hypocretin and MCH neurons, both promoting positive energy balance, as well as 
anorexigenic amylin-producing neurons. The paraventricular nucleus neurons produce CRH 
and oxytocin to reduce food intake and galanin, which increases preference for high-fat foods. 
Dashed lines show projections between nuclei. 3V, third ventricle; AgRP, agouti-related 
peptide; ARC, arcuate nucleus; CART, cocaine- and amphetamine-regulated transcript; CRH, 
corticotropin-releasing hormone; DMH, dorsomedial hypothalamic nucleus; GE, glucose-
excited neurons; GI, glucose-inhibited neurons; LH, lateral hypothalamus; MCH, melanocortin 
concentrating hormone; ME, median eminence; NPY, neuropeptide Y; orx/hcrt, 
orexin/hypocretin neurons; POMC, proopiomelanocortin; PVN, paraventricular nucleus; 
VGlut2, vesicular glutamate transporter 2; VMH, ventromedial hypothalamic nucleus. 
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ARC POMC/CART neurons produce the precursor to an agonist to the 
melanocortin receptors 3 and 4 (MC3R, MC4R), the α-melanocyte-stimulating 
hormone (α-MSH), and the deletion of the Pomc gene results in hyperphagia 
and obesity (Yaswen et al. 1999). Intracerebroventricular (ICV) administration of 
a synthetic α-MSH analogue Melanotan II increases body temperature and 
oxygen consumption, as well as expression of uncoupling proteins in brown 
adipose tissue and muscle (Murphy et al. 2000, Cettour-Rose and Rohner-
Jeanrenaud 2002, Hamilton and Doods 2002). Inactivation of MC4R has the 
opposite effects (Marie et al. 2000, Small et al. 2001, Baran et al. 2002). MC3R 
knockout mice are obese but their food intake is reduced, suggesting that 
MC4R modulates the hypophagic action of α-MSH (Butler et al. 2000). 
Central administration of CART peptide reduces feeding in fasted rodents within 
1 hour after the injection, as well as inhibits NPY-induced food intake in satiated 
rats (Kristensen et al. 1998). CART also acts on the dopaminergic system and 
is therefore associated with food- and drug-related rewards (Vicentic and Jones 
2007). 
While the expression of POMC and CART mostly overlaps in the ARC, the 
distribution of CART mRNA is much wider than that of POMC throughout the 
hypothalamus: CART is also found in the paraventricular nucleus (PVN), 
periventricular nucleus, dorsomedial nucleus (DMH), and lateral hypothalamus 
(LH) (Li et al. 2002). This distribution pattern has been observed in both mice 
and humans (Elias et al. 2001). 
ARC POMC/CART neurons are considered to be slow in their response to 
feeding. Another anorexigenic population of cells expressing the vesicular 
glutamate transporter 2 (VGlut2) has been identified in ARC and demonstrated 
to rapidly suppress feeding (Fenselau et al. 2017). A subpopulation of these 
neurons (around 40%) also express POMC and CART, while others produce 
kisspeptin or no neuropeptides at all (Fenselau et al. 2017). ARC VGlut2 
neurons are activated by oxytocin but inhibited by direct inputs from AgRP 
neurons and fasting (Fenselau et al. 2017). VGlut2 is also expressed in various 
neuronal subpopulations throughout the hypothalamus, but precise functions of 
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glutamatergic signalling originating from each hypothalamic nucleus are yet to 
be defined (Ziegler et al. 2002). 
NPY/AgRP neurons respond to caloric deficiency, and their firing is negatively 
correlated with food ingestion, constantly increasing between meals but 
suddenly dropping as food becomes available (Mandelblat-Cerf et al. 2015). 
The orexigenic peptide NPY is widely expressed throughout the brain, with the 
main population of NPY/AgRP neurons involved in energy homeostasis located 
in the ARC (O'Donohue et al. 1985). ICV administration of NPY promotes 
feeding and fat storage while reducing signalling to BAT (Billington et al. 1991). 
Acute activation of ARC NPY/AgRP neurons also causes insulin resistance via 
peripheral actions on muscle-related genes in BAT (Steculorum et al. 2016). 
Chronic administration of NPY rapidly induces obesity (Raposinho et al. 2001).  
AgRP is more sensitive to changes in metabolic state than POMC, so it may act 
to ensure a rapid response to the reduced availability of food in the 
melanocortin system (Harrold et al. 1999). AgRP neurons inhibit oxytocin 
secreting neurons to stimulate food intake (Atasoy et al. 2012). They also 
project via the amygdala into the bed nucleus of stria terminalis to suppress 
territorial aggression and reduce fear (Padilla et al. 2016). Additionally, AgRP 
directly inhibits neurons producing the reproductive hormone kisspeptin during 
metabolic deficiency, acting as one of the links between nutrition and fertility 
(Padilla et al. 2017). Thus, AgRP neurons are considered to be a major 
coordinator of behavioural responses to the metabolic state (Padilla et al. 
2016). 
The ventromedial hypothalamic nucleus (VMH) has been long considered to be 
the satiety centre of the brain: stimulation of neurons in the VMH inhibits 
feeding, while lesions in this area are associated with hyperphagia and weight 
gain (Stellar 1954). The VMH expresses leptin receptors and has direct 
connections with the PVN, LH, and DMH (Elmquist et al. 1998, Elmquist et al. 
1999). Some neurons in the VMH, as well as ARC and LH, are known to be 
either glucose-excited (GE) or glucose-inhibited (GI) (Wang et al. 2004). The 
GE neurons increase, and the GI neurons decrease their action potential 
frequency as the level of extracellular glucose increases.  
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VMH GE neurons are inhibited by leptin and modulated by insulin depending on 
the concentration of extracellular glucose, while ARC GE neurons exhibit no 
leptin sensitivity and a variable response to insulin (Spanswick et al. 1997, 
Wang et al. 2004). ARC GE neurons, located in the lateral ARC, are activated 
via an ATP-sensitive K+ channel (KATP)-dependent pathway (Wang et al. 2004). 
NPY hyperpolarizes GE neurons and prevents them from firing; α-MSH 
increases their action potential frequency, and functional evidence suggests 
that ARC GE neurons are, in fact, a subpopulation of the POMC neurons 
(Ibrahim et al. 2003, Wang et al. 2004).  
ARC GI neurons are located in the medial part of the ARC and most of them are 
NPY neurons (Fioramonti et al. 2007). While the exact pathway of ARC GI 
activation has not yet been clarified, a model has been proposed for VMH GI 
neurons: a decrease in glucose concentration induces VMH GI neuron activity 
by an increase in the AMP:ATP ratio within the cells, which activates AMP-
activated protein kinase (AMPK) to increase nitric oxide (NO) production; 
moreover, the binding of NO to its receptor, soluble guanylyl cyclase, leads to 
cyclic GMP production, further increasing AMPK activation to a level that 
reduces Cl- channel conductance, resulting in the depolarisation of the neuron 
(Murphy et al. 2009). In addition, activation of oestrogen receptors (ER) blunts 
the responses to low glucose in VMH GI neurons by inhibiting AMPK (Santiago 
et al. 2016). The AMPK/Cl- channel-dependent activation pathway does not 
apply to LH GI neurons, which have been suggested to use tandem-pore (also 
known as two-pore) K+ channels instead (Burdakov et al. 2006), although 
another group have shown that mice lacking this channel still exhibited glucose 
inhibition of LH neurons (Guyon et al. 2009). 
The DMH is extensively interconnected with other hypothalamic nuclei and the 
brainstem (Horst and Luiten 1986, Thompson et al. 1996). Lesions in this region 
result in hypophagia and weight loss (Dalton et al. 1981). The DMH contains 
insulin and leptin receptors (Corp et al. 1986, Elmquist et al. 1998). Neurons in 
the DMH also participate in the regulation of stress-related cardiovascular 
parameters: heart rate, blood pressure and respiratory rate (Stotz-Potter et al. 
1996). 
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The LH was originally known as the feeding centre of the brain, as stimulation of 
this nucleus increases food intake, while its destruction reduces feeding and 
causes weight loss (Anand and Brobeck 1951, Delgado and Anand 1952). 
Orexin/Hypocretin (orx/hcrt) neurons of the LH are associated with energy 
homeostasis (Sakurai et al. 1998, Thannickal et al. 2000). Orx neurons produce 
conserved neuropeptides called orexins: orxA and orxB (also termed hcrt1 and 
hcrt2) (De Lecea et al. 1998). Central administration of orx stimulates food 
consumption, and their production is reduced with feeding (Sakurai et al. 1998). 
Orx receptors are similar to the Y2 receptors (Sakurai et al. 1998). 
Orx/hcrt neuron activity correlates with wakefulness and is reduced during sleep 
(Estabrooke et al. 2001). Humans and animals with low numbers of orx/hcrt 
neurons exhibit abnormal sleeping patterns such as narcolepsy (Thannickal et 
al. 2000). These neurons have also been described to modulate 
thermogenesis, cardiovascular and gastrointestinal functions (Berthoud et al. 
2005). Interestingly, while hunger and hypoglycaemia activate orx/hcrt neurons 
to induce foraging, food consumption rapidly decreases orx/hcrt activity; orx/hcrt 
neurons are therefore associated with locomotion and food seeking behaviour 
rather than feeding (González et al. 2016). 
Another population of LH neurons is known as the melanin-concentrating 
hormone (MCH)-producing neurons. MCH neurons are activated by glucose, 
and MCH induces sleep and suppresses metabolism, which implies that these 
neurons promote energy conservation after a period of high energy intake 
(Burdakov et al. 2005). Mice lacking MCH are hypophagic and exhibit a lean 
phenotype (Shimada et al. 1998). 
Conversely, while orx/hcrt and MCH neurons are associated with increased 
feeding and energy preservation, some neurons in the LH express the 
pancreatic peptide amylin, which reduces food intake and positively modulates 
the effects of leptin in the hypothalamus (Li et al. 2015). 
The periventricular nucleus contains neurons expressing NPY (Pelletier et al. 
1984), somatostatin (Kiss et al. 1988), and kisspeptin, which regulates female 
reproduction by acting on gonadotropin-releasing hormone (GnRH)-secreting 
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neurons (Adachi et al. 2007). While not directly involved in energy homeostasis, 
the periventricular nucleus has close connections with ARC and ME (Kiss et al. 
1988). 
Table 1. Hypothalamic nuclei and their functions. 
Region Nucleus Functions 
Periventricular Periventricular Growth and sex hormone regulation 
 Suprachiasmatic Circadian rhythm generation 
 Paraventricular  Integration of signals related to 
energy homeostasis 
 Arcuate Production of POMC, CART, NPY 
and AgRP 
Medial Medial preoptic  Thermoregulation (Tan et al. 2016) 
 Anterior hypothalamic  Initiation of sexual behaviour 
(Mathews and Edwards 1977) 
 Dorsomedial Regulation of insulin production; 
cardiovascular stress responses 
 Ventromedial Inhibition of feeding; glucosensing 
 Premammillary  Control of reproduction (Malpaux et 
al. 1998) 
 Mammillary bodies Locomotion, memory (Vann and 
Aggleton 2004) 
 Posterior hypothalamic Blood pressure control (Buccafusco 
and Brezenoff 1979) 
Lateral Lateral preoptic Stress response (Duarte et al. 2017) 
 Lateral hypothalamic Stimulation of food intake and 
wakefulness 
 Supraoptic Oxytocin production 
The paraventricular nucleus is located at the top of the third ventricle (3V). 
Neurons in the PVN synthesize corticotropin-releasing hormone (CRH), central 
administration of which reduces food intake and body weight (Dallman 1993). 
Overproduction of CRH causes anorexia associated with the activation of the 
hypothalamic-pituitary-adrenal axis (Coste et al. 2001). Oxytocin, which also 
has anorexigenic effects, is produced in some neurons of the PVN, as well as in 
the supraoptic nucleus (SON) (Rosen et al. 2008). Oxytocin receptor (OXTR) 
antagonists can stimulate food intake, and OXTR-null mice show increases in 
meal size during the dark cycle (Blouet et al. 2009, Yamashita et al. 2013).  
In contrast, the PVN is also associated with high-fat intake as it contains 
neurons synthesizing the peptide galanin, which potentiates food consumption 
with preference for high-fat foods (Akabayashi et al. 1994). Galanin also lowers 
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insulin secretion during fat absorption, and its expression is enhanced in 
diabetic rats but suppressed by insulin administration (Akabayashi et al. 1994). 
1.1.3. Integration of metabolic state-related signals 
The above described neuronal populations respond to hormones, 
neuropeptides, nutrients, and inputs from other neurons within and outside the 
hypothalamus (Figure 1.3). 
ARC POMC/CART and NPY/AgRP neurons express receptors for leptin, 
insulin, ghrelin, melanocortins, NPY, and other neuropeptides and 
neurotransmitters; these signals can modulate electrical activity in the cells to 
influence the production of peptides (Cheung et al. 1997).  
Leptin stimulates the melanocortin system – intraperitoneal administration of 
leptin increases the level of POMC mRNA in the hypothalamus, while fasting or 
absence of leptin reduces POMC expression (Schwartz et al. 1997, Mizuno et 
al. 1998). Moreover, inhibition of MC4R impairs the anorexigenic effects of 
leptin (Seeley et al. 1997). The expression of another anorexigenic molecule in 
ARC POMC/CART neurons, CART, is also leptin-dependent (Kristensen et al. 
1998).  
Additional mechanisms for leptin effects are the inhibition of NPY/AgRP 
neurons, and increased CRH production in the PVN (Schwartz et al. 1996). 
NPY signalling is further inhibited by negative feedback from insulin (Elias et al. 
1999). 
Oestrogen is another modulator of ARC neuronal activity. POMC/CART 
neurons contain the oestrogen receptor-α (ERα), the expression of which is 
decreased by fasting in male but not female mice (Iwasa et al. 2017). Mice 
lacking ERα in POMC/CART neurons exhibit hypometabolism, hyperphagia and 
abnormal weight gain, particularly in females (Xu et al. 2011).  
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ARC POMC/CART and NPY/AgRP neurons project into the PVN, which is rich 
in MC4 receptors (Mountjoy et al. 1994), as well as anterior hypothalamus, 
medial preoptic area, LH, DMH, VMH, and posterior hypothalamus (Wang et al. 
2015). Both the orexigenic and anorexigenic populations of ARC neurons also 
activate the sympathetic nervous system in order to influence protein 
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Figure 1.3. Hypothalamic integration of food-related signals. Orexigenic ghrelin and 
anorexigenic leptin, insulin and oestrogen access the arcuate nucleus via the median eminence 
and have opposing effects on POMC/CART and AgRP/NPY neurons. Depending on peripheral 
inputs, these neuronal populations can inhibit each other as well as modulate firing and 
neuropeptide production in other nuclei. Insulin also inhibits galanin production, while 
hypoglycaemia activates orx/hcrt neurons. Glucose activates glucose-excited and inhibits 
glucose-inhibited neurons in the VMH; in addition, increases in glucose levels induce MCH 
production in lateral hypothalamus. Glucose, L-leucine and gut peptides also activate NTS 
POMC neurons. PVN oxytocin neurons are activated by POMC-produced α-MSH and inhibited 
by NPY, AgRP and orexins; oxytocin activates NTS neurons and inhibits the reward pathway to 
reduce feeding. Orexins feed back to the arcuate nucleus to inhibit POMC/CART activity and 
increase the production of AgRP and NPY while activating reward-related dopaminergic 
neurons. Abbreviations as in Figure 1.2, with the addition of NAc, nucleus accumbens; VTA, 
ventral tegmental area; DVC, dorsal vagal complex; NTS, nucleus of the solitary tract; CCK, 
cholecystokinin; GLP-1, glucagon-like peptide 1; OXM, oxyntomodulin; PYY, peptide tyrosine 
tyrosine. 
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uncoupling in BAT, thus regulating metabolism by adjusting thermogenesis 
(Kooijman et al. 2014).  
Some LH VGlut2 expressing neurons have been shown to receive inhibitory 
inputs from the bed nucleus of the stria terminalis in the amygdala, and 
optogenetic stimulation of these projections produces feeding even in well-fed 
mice (Jennings et al. 2013).  
The PVN contains axons projecting from the NPY/AgRP and POMC/CART 
neurons of the ARC, and from the orexin neurons of the LH (Elmquist et al. 
1998, Elmquist et al. 1999). These inputs determine local release of oxytocin in 
the PVN, which projects to the dopaminergic neurons of the VTA, POMC 
neurons of the NTS, and the spinal cord (Sawchenko and Swanson 1982, 
Shahrokh et al. 2010). Oxytocin receptors are also expressed in other areas of 
the brain associated with energy homeostasis – VMH, area postrema (AP), the 
striatum – as well as relevant peripheral tissues, including the gastrointestinal 
tract and adipocytes (Gimpl and Fahrenholz 2001). The anorexigenic effects of 
oxytocin have been suggested to be partially due to inhibition of feeding reward 
circuitry in the nucleus accumbens (NAc) of the striatum as oxytocin 
administration reduces drug reward behaviour (Carson et al. 2010).  
Circadian rhythms form a key regulatory mechanism for feeding behaviour and 
energy expenditure. The central clock is located in the suprachiasmatic nucleus 
(SCN), and surgical or genetic manipulations of this nucleus disrupt glucose 
metabolism (la Fleur et al. 2001), increase food intake and body weight, and 
decrease energy expenditure (Turek et al. 2005). Peripherally produced 
hormones leptin and ghrelin have been shown to follow SCN-driven diurnal 
rhythms (Kalsbeek et al. 2001, Bodosi et al. 2004). 
1.1.4. Hypothalamic plasticity 
In addition to the intricate mechanisms that rapidly respond to hunger and food 
consumption, the hypothalamus exhibits a high level of plasticity to provide 
long-term adaptation to variations in energy availability. The acute responses, 
i.e. neuronal firing and production of neuropeptides that result in short-term 
behavioural changes, act to ensure that the bodyweight remains as close as 
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possible to a set-point around which it constantly fluctuates (Cone 1999). 
However, chronic exposure to similar conditions, such as a constantly high-fat 
diet or long periods of fasting, can alter the hypothalamic neural circuits in order 
to adjust the set-point to the current food environment. 
Hypothalamic plasticity occurs on three different levels: changes in synaptic 
weights; alteration of neuronal properties; and generation of new neurons. The 
changes in synaptic organisation and cell excitability are quite rapid and can 
occur within a day (Sternson et al. 2005, Schneeberger et al. 2013), while 
neurogenesis can take between several days and weeks (Kokoeva et al. 2005, 
Lee et al. 2014). 
Leptin and ghrelin are two of the known regulators of POMC and NPY synaptic 
plasticity: leptin deficient (ob/ob) mice exhibit a lower total number of synapses 
and a marked increase in the inhibitory tone onto POMC neurons, and an 
increase in the excitatory tone onto NPY neurons, which can all be reversed to 
wild-type levels by leptin treatment; furthermore, chronic administration of 
ghrelin decreases the number of excitatory inputs and reduces the number of 
inhibitory inputs on POMC neurons without affecting NPY neurons (Pinto et al. 
2004). Another study has shown that fasting, which is associated with a high 
level of ghrelin, also reduces the strength of excitatory inputs on ARC POMC 
neurons from the VMH, and the effect is not rescued by leptin (Sternson et al. 
2005). An overnight fast is enough to form new excitatory synapses on orx/hcrt 
neurons (Horvath and Gao 2005).  
Oestrogen, like leptin, robustly increases the number of excitatory inputs on 
POMC neurons independently of leptin receptor signalling (Gao et al. 2007). A 
high-fat diet has been found to increase hypothalamic expression of polysialic 
acid, which modulates distances between cells thus promoting cellular 
reorganisation, and to increase the frequency of miniature excitatory 
postsynaptic currents in POMC neurons (Benani et al. 2012). In seasonal 
mammals, plasticity is observed in GnRH neurons, while annual changes in 
thyroid hormone availability regulate genes involved in synapse formation 
(Jansen et al. 2003, Zhang et al. 2008). 
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The activation of POMC neurons depends on mitochondrial fusion, while the 
development of these cells requires mitochondrial fission – processes during 
which mitochondria fuse or divide to adapt their number and morphology to the 
environmental conditions (Schneeberger et al. 2013). Faults in these processes 
are associated with type 2 diabetes and obesity (Schneeberger et al. 2013, 
Toda et al. 2016). The deletion of the mitochondrial fission regulator dynamin-
related protein 1 (DRP1) in mature POMC neurons results in higher leptin and 
glucose sensitivity (Santoro et al. 2017). Additionally, fasting increases DRP1 
expression to reduce POMC excitability, thus silencing the anorexigenic circuit 
in ARC and promoting feeding (Santoro et al. 2017). 
The hypothalamus has been recently discovered to form one of the adult 
neurogenic niches (Pencea et al. 2001). Hypothalamic neurogenesis has been 
demonstrated to function as a compensatory mechanism for chronic AgRP 
neurodegeneration, allowing mice to maintain normal levels of food intake 
despite the disruption in the ARC orexigenic circuit (Pierce and Xu 2010). In 
contrast, ciliary neurotrophic factor (CNTF), used as a drug to treat obesity, 
induces cell proliferation in the hypothalamus to produce leptin-sensitive 
neurons which in turn promote long-term weight loss (Kokoeva et al. 2005). 
Moreover, the generation of new neurons in this area is diet-responsive: high-
fat diet (HFD) disrupts hypothalamic neurogenesis in the parenchyma of the 
mediobasal hypothalamus (MBH), which results in weight gain and obesity (Li et 
al. 2012); conversely, both HFD and low-protein diet can increase neural 
progenitor cell proliferation in the ME of female rats (Lee et al. 2014). 
The cell types that have been found to proliferate into new neurons in the 
hypothalamus are NG2 glia, also known as oligodendrocyte precursor cells 
(Robins et al. 2013), and tanycytes (Haan et al. 2013, Robins et al. 2013). 
Hypothalamic tanycytes can differentiate into both glial cells and neurons (Xu et 
al. 2005). 
The complexity of the adaptive mechanisms in the hypothalamus required to 
maintain bodyweight reflects the importance of these processes for animal 
survival. From an evolutionary perspective, most animals have always gone 
through long periods of scarce food availability; the processes of tuning down 
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the anorexigenic mechanism and increasing the activation of orexigenic circuits 
therefore function to maintain motivation and drive to feed throughout these 
periods, while hypothalamic changes in the opposite direction are required 
when food is abundant to avoid the negative effects of overeating such as 
inflammation and obesity (Zeltser et al. 2012). 
1.1.5. Other neuronal mechanisms of food intake control 
The dorsal vagal complex (DVC) in the hindbrain is linked to the control of meal 
size. Chronic administration of oxytocin activates neurons in this area, as well 
as the hypothalamus and amygdala, which can lead to weight loss in obese 
rodents due to reduced meal sizes, increased latency of the first meal and 
increased energy expenditure (Arletti et al. 1990, Takayanagi et al. 2008).  
Nucleus of the solitary tract is an important centre of convergence and 
integration of signals related to energy availability and metabolic state (Blouet 
and Schwartz 2012). The NTS receives direct input from the gastrointestinal 
tract and can negatively control food intake (Blevins et al. 2000). Just like the 
ARC, VMH and PVN in the hypothalamus, the NTS is in close proximity to a 
circumventricular organ, the area postrema, allowing a range of circulating 
factors to reach the neurons in this nucleus (Borison 1974). NTS neurons have 
a role in glucose sensing and the response to hypoglycaemia (Ritter et al. 
2000), and can detect L-leucine (Blouet and Schwartz 2012). 
POMC is also expressed in some neurons in the brainstem, mostly in the AP 
and the NTS (Padilla et al. 2011). A study in Pomc-Cre mice has revealed that 
brainstem POMC neurons are involved in acute suppression of feeding, while 
hypothalamic POMC neurons regulate long-term feeding behaviour, as the 
onset of the effects of ARC POMC neurons is slow (Zhan et al. 2013). 
The VTA is a part of the mesolimbic reward pathway with dopaminergic neurons 
projecting into the NAc (Kelley and Berridge 2002). Neurons in the VTA detect 
leptin, GLP-1 and ghrelin (Naleid et al. 2005, Hommel et al. 2006, Dickson et al. 
2012), and are activated by orexins (Korotkova et al. 2003), forming a close link 
between homeostatic and hedonic regulation of feeding. 
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Some neurons in the striatum, including those in NAc, express the orphan G-
protein coupled receptor GPR88 (Van Waes et al. 2011). Gpr88-KO mice 
exhibit increased lean mass and fat loss on HFD, as well as decreased food 
intake and energy expenditure on standard chow; the changes in feeding and 
metabolism in these mice are attributed to Cart upregulation in ARC and 
downregulation in DMH and LH (Lau et al. 2017).  
New mechanisms and factors involved in the regulation of energy homeostasis 
are constantly emerging; the central and peripheral factors described so far in 
this thesis are only the ones that are already widely recognised, but ongoing 
research will undoubtedly continue to provide an increasingly detailed picture of 
food intake and energy expenditure control.  
1.1.6. Glia and energy homeostasis 
Originally, most research on central regulation of energy homeostasis focussed 
on neurons; in recent years, non-neuronal cells have also received substantial 
attention, revealing their roles in the control of food intake and energy 
expenditure in both health and disease. 
The major glial cell types found in the hypothalamus are astrocytes, microglia, 
NG2 glia, and the ependymal layer of 3V, formed of ependymal cells and 
tanycytes. Astrocytes are best known for their roles in synapse formation, 
maintenance, and the modulation of synaptic transmission (Chung et al. 2015). 
Microglia act as immune cells in the brain (Gehrmann et al. 1995). NG2 glia are 
precursors to oligodendrocytes – cells involved in neuron myelination (Baumann 
and Pham-Dinh 2001) – and, to some extent, new neurons (Robins et al. 2013). 
The ependymal layer of the 3V regulates the exchange of hormones, nutrients 
and other substances between the CSF and hypothalamic parenchyma (Langlet 
2014). A more diverse set of functions, most of which relate to metabolism or 
reproduction, have been attributed to hypothalamic tanycytes in recent years 
and will be discussed further in following sections. 
Obesity leads to increases in the production of pro-inflammatory markers in the 
hypothalamus (De Souza et al. 2005). Even short-term (under 1 week) intake of 
HFD is associated with hypothalamic injury, the hallmarks of which are 
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autophagy and microglial accumulation, or microgliosis, in the ARC (Thaler et 
al. 2012). A distinction has been made between obesity caused by hormonal 
imbalance and HFD: increased microglial activation in ARC is observed only 
under HFD conditions but not in leptin deficient animals, meaning that diet, but 
not obesity alone, induces hypothalamic inflammation (Gao et al. 2014). 
Peripheral signals such as leptin and GLP-1 can regulate the level of microglial 
activation as microglia have recently been shown to express the leptin receptor, 
and mice with a specific deletion of leptin receptor from microglia and 
macrophages have increased food intake and bodyweight (Gao et al. 2014, 
Gao et al. 2017). 
While the microglia-driven inflammation is commonly recognised as only a 
consequence of high-fat feeding, new evidence shows that microglia are 
actually critical regulators of susceptibility to diet-induced obesity (DIO), as 
microglial activation is required for both the onset of hypothalamic inflammatory 
processes and the control of energy balance in response to HFD (Valdearcos et 
al. 2017). The level of inflammation in the hypothalamus after chronic HFD 
intake correlates with the number of microglial cells present in ARC and ME; 
and depletion of microglia in the area restores leptin signalling, which is 
otherwise impaired by prolonged exposure to saturated fatty acids (Valdearcos 
et al. 2014). 
Interestingly, ARC astrogliosis also occurs rapidly in response to HFD, but the 
number of astrocytes returns to baseline level over several weeks (Thaler et al. 
2012). However, if increased fat intake persists, astrocytes begin to accumulate 
again (Thaler et al. 2012). 
Astrogliosis has been shown to have a protective effect against HFD: astrocytic 
nuclear factor kappa B (NFκB) prevents HFD-induced hyperphagia, while a 
disruption the NFκB transcription pathway increases caloric intake in the short 
term (Buckman et al. 2013).  
While microgliosis is mostly induced by DIO, astrogliosis is also observed in a 
genetic model of obesity, the MC4 receptor deficient mouse (Buckman et al. 
2013). Astrogliosis also differs from microgliosis in its spatial organisation as 
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GFAP immunoreactivity shows pronounced astrogliosis in response to HFD in 
most hypothalamic nuclei, with the highest increases in ARC and DMH but only 
small changes in VMH, LH and anterior hypothalamic nucleus (Buckman et al. 
2013).  
Besides neuroinflammation, astrocytes are involved in the plasticity of neuronal 
populations that control energy homeostasis, as increased glial ensheathment 
of POMC neuron cell bodies is associated with loss of synapses (Horvath et al. 
2010). Some astrocytes also express receptors for leptin, insulin, and 
melanocortins, and astrocyte-specific leptin signalling has been shown to affect 
neural plasticity in ARC (Kim et al. 2014). Experiments involving chemogenetic 
astrocyte activation showed that astrocytes could potentiate anorexia induced 
by direct leptin administration and reduce hyperphagia caused by a ghrelin 
injection via an adenosine-dependent pathway (Yang et al. 2015); however, a 
later study challenged these findings showing that astrocyte activation 
stimulates both ARC NPY/AgRP and POMC/CART neurons, but the strong 
inhibitory signal from NPY/AgRP to POMC/CART neurons suppresses 
POMC/CART activity, producing an overall orexigenic effect (Chen et al. 2016). 
The conflicting results may be attributed to drug dosage, as the former study 
used a high dose of clozapine-N-oxide which was later suggested to have non-
specific effects (Chen et al. 2016).  
Astrocytes are responsible for most of brain fatty acid metabolism into ketone 
bodies, used by neurons as an energy source in low glucose conditions 
(Blázquez et al. 1999). VMH astrocyte ketone body production can override 
neuronal glucose and fatty acid sensing and reduce feeding following ingestion 
of a high-fat meal (Le Foll et al. 2014). 
Another type of glial cell, originally known as oligodendrocyte precursor cells, 
termed NG2 glia, have a role in the regulation of energy expenditure, as mice 
lacking the NG2 gene in these cells exhibit a lean phenotype, possibly due to 
the hypothalamic hypomyelination resulting from a lower number of 
oligodendrocytes (Chang et al. 2012). More recent evidence suggests that a 
small proportion of NG2 glia can also give rise to hypothalamic neurons, which 
could further explain the involvement of these cells in metabolic control (Robins 
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et al. 2013). Moreover, NG2 glia can respond to glutamate and ATP with 
increases in intracellular Ca2+, which is potentially involved in glial scarring after 
injury (Butt et al. 2005). 
1.2. Hypothalamic tanycytes 
The term “tanycytes” – Greek for “elongated cells” – was first introduced by 
Ernst Horstmann in 1954, when he established in a histological study that the 
shark brain ependyma consisted of multiple cell types (Horstmann 1954). 
Hypothalamic tanycytes are non-neuronal, radial glia-like cells that line the walls 
and the floor of the third ventricle (Bolborea and Dale 2013). They lie next to 
ependymal cells and are sometimes considered to be a type of ependymal cell, 
although there are two major differences: instead of cilia, tanycytes have 
microvilli on their apical surface, and their long processes can exceed 200 μm 
into the brain parenchyma. 
Based on location, there are four subtypes of tanycytes: α1, α2, β1, β2, while 
some researchers have also described γ tanycytes (Wittmann et al. 2017). α 
tanycytes are located in the dorsal region of 3V, with α1 tanycytes interspersed 
by ependymal cells, and project into the ARC (Brawer 1972, Bruni et al. 1985) 
and the VMH (Rodríguez et al. 2005). β1 tanycytes occupy the ventral part of 
the wall of 3V, while β2 tanycytes line the floor or the ventricle. The processes 
of β tanycytes project into the external region of the ME. Tanycytes with cell 
bodies located within the ME or the pituitary stalk are referred to as γ tanycytes 
(Wittmann et al. 2017). 
1.2.1. Morphology and physiology 
Tanycyte cell bodies are elliptical, about 15 μm long, with a basal prolongation 
of up to 200 μm, and microvilli on the apical surface contacting the CSF of the 
3V. Interestingly, most tanycyte nuclei are also ovoid in shape, while the nuclei 
of ependymal cells are round (Jarvis and Andrew 1988). There is substantial 
evidence of gap junctions between adjacent tanycytes, with the number of 
junctions ranging from one single channel to aggregates of over 2000 junctions 
(Jarvis and Andrew 1988). 
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Tanycyte resting potential is around -80 mV, and they do not exhibit 
spontaneous action potentials, spontaneous postsynaptic potentials, or any 
other changes in membrane potentials over time. Their input resistance is very 
low (≪ 1 MΩ) compared to other glial cells in the area (2–20 MΩ) (Jarvis and 
Andrew 1988). This is likely to be a consequence of extensive electrical 
coupling via gap junctions. 
Tanycytes express a range of cell markers, including the glial marker GFAP 
(Gould et al. 1990). The expression of these markers is location-dependent and 
some can be limited to β tanycytes (e.g. FGF-1, FGF-2, CNTFR); others can be 
expressed in both α and β tanycytes (e.g. nestin, GPR50, Rax, DIO2), or α 
tanycytes and ependymal cells (e.g. GLAST, CNTF, Cx43); three markers are 
known to be expressed in all tanycytes and ependymal cells: Sox2, vimentin 
and GLUT1 (Goodman and Hajihosseini 2015). Such distribution of marker 
expression indicates that tanycytes are a highly heterogeneous cell population. 
1.2.2. Functions 
Initial research on hypothalamic tanycytes in the 1980s provided evidence for 
the involvement of these cells in mechanical support of the third ventricle, 
phagocytosis, regulation of extracellular space constituents and transport 
between cerebrospinal fluid and the portal vasculature (Bruni et al. 1985, Jarvis 
and Andrew 1988). Tanycytes have also long been known for their high ATPase 
activity, which was linked to their transport functions (Firth and Bock 1976). 
More recent interest in tanycytes has revealed that they also serve a range of 
different purposes, such as regulation of the secretory activity of 
neuroendocrine neurons, including β tanycytes being involved in the control of 
blood-hypothalamus barrier permeability (Mullier et al. 2010) and the GnRH 
regulatory system (Ojeda et al. 2008). Tanycytes of the ME are indirectly 
responsive to oestrogen (the mechanism requires NO release from endothelial 
cells), which induces an acute and reversible retraction of tanycyte processes to 
increase neurovascular contacts between GnRH neurons and ME capillaries 
(De Seranno et al. 2010). Tanycytes also participate in thyroid hormone 
metabolism as they express type 2 deiodinase, allowing them to take up 
thyroxine (T4) from CSF and convert it to triiodothyronine (T3) before 
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transporting it to neurons via a specific thyroid hormone transporter MCT8 
(Kalló et al. 2012).  
Another recently discovered tanycyte function is their role as adult neuronal 
stem cells as tanycytes can self-renew and give rise to neurons (Sousa-Ferreira 
et al. 2014). α tanycytes express fibroblast growth factors (FGF) 10 and 18, and 
FGF-2 signalling induces cell proliferation (Robins et al. 2013). FGF-10-
expressing β tanycytes have been shown to generate parenchymal neurons, 
primarily in ARC and VMH, but also in DMH and LH, and glial cells, suggesting 
a major role for tanycyte neurogenesis in the control of energy homeostasis 
(Haan et al. 2013). Moreover, HFD or a low-protein diet (LPD) can reduce 
neurogenesis in ARC, but HFD also selectively enhances neurogenesis in ME 
in females (Lee et al. 2012, Lee et al. 2014). 
Tanycytes also have chemosensitive properties, including glucosensing and 
fatty acid metabolism and transport, which may have some influence on their 
stem cell activity (Dale 2011, Hofmann et al. 2017). Tanycyte glucose sensitivity 
was originally proposed to occur via glucose transporter 2 (GLUT2) and KATP 
channels (García et al. 2003), but was later also found to be sweet taste 
receptor-dependent (Benford et al. 2017); both pathways are suspected to 
influence feeding (Benford et al. 2017, Barahona et al. 2018). Tanycyte fatty 
acid metabolism is altered in obesity (Hofmann et al. 2017). 
1.2.3. Potential role in food intake control 
In addition to the aforementioned functions, tanycytes might be a key player in 
energy homeostasis. Their position in the walls and the floor of the third 
ventricle means that they have privileged access to the CSF. Tanycyte 
processes extend into the hypothalamic nuclei that regulate food intake and 
energy expenditure; the projections come into close contact with neurons within 
those nuclei, which suggests that communication is possible between tanycytes 
and hypothalamic neurons (Bolborea and Dale 2013). Paired with their 
chemosensitivity and ability to signal via Ca2+ and ATP (Benford et al. 2017), 
the potential tanycyte-to-neuron communication could be established as a new 
mechanism of monitoring nutrient availability in the hypothalamus (Bolborea 
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and Dale 2013). Emerging evidence shows that tanycyte expression of the 
glucose transporter GLUT2 and glucokinase have a role in food intake 
regulation of fasted rats, and the mechanism involves tanycyte lactate signalling 
to POMC neurons (Uranga et al. 2017, Barahona et al. 2018). However, GLUT2 
is also involved in cell metabolism, thus its deletion in tanycytes could affect 
food intake by reducing tanycyte viability rather than directly inhibiting glucose-
related tanycyte signalling to ARC neurons. 
ME tanycytes form a gateway for ghrelin (Collden et al. 2015) and leptin into 
MBH, and diet-induced obesity impairs tanycyte leptin transport (Balland et al. 
2014). Conversely, fasting increases the permeability of the tanycyte layer to 
blood-borne molecules (Langlet et al. 2013). Some rat tanycytes express the 
Pomc gene, which is responsible for neuropeptides that regulate energy 
homeostasis, and was until recently thought to be expressed exclusively by 
neurons (Wittmann et al. 2017). Mouse tanycytes produce CNTF, the 
administration of which reduces food intake in obese rodents and counteracts 
positive energy balance (Severi et al. 2013). The receptor for interleukin-6, a 
pro-inflammatory cytokine known to negatively influence food intake and energy 
balance, similar in its actions and detection pathway to leptin, has recently been 
localised to tanycytes (Anesten et al. 2017). 
Tanycytes are also increasingly known as diet-responsive neural stem cells. 
Lineage tracing studies have demonstrated that tanycytes can generate new 
neurons and glia, meaning that the neuronal networks of the hypothalamus are 
highly plastic and can be remodelled by diet (Haan et al. 2013). 
1.3. Amino acid sensing in the brain 
Protein is the most effective type of macronutrient for satisfying hunger and 
providing a long period of satiety (Mellinkoff et al. 1956). This is partly because 
of the slower digestion of protein-rich foods, as well as the fact that such foods 
keep blood glucose levels relatively constant, therefore reducing potential food 
cravings that could otherwise occur soon after a meal. As well as their satiating 
effect, high-protein diets are known to reduce body fat (Weigle et al. 2005); 
however, increasing dietary protein content to 50% and beyond can have 
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adverse consequences such as nephromegaly and impaired calcium 
homeostasis (Barzel and Massey 1998, Hammond and Janes 1998). Diets 
containing 70% or more protein are not palatable, causing taste aversion and 
food rejection (Tews et al. 1992). 
It is becoming increasingly evident that amino acids derived from dietary protein 
mediate their satiating effect via the brain. Direct ICV injections of selected 
essential amino acids into the hypothalamus, thus bypassing the digestive 
system, suppressed appetite in rats (Panksepp and Booth 1971, Cota et al. 
2006). Better understanding of brain amino acid detection and the related 
satiating effects could therefore be an essential step in further unravelling the 
mechanisms behind the regulation of energy metabolism. 
1.3.1. Amino acid transport into the brain 
After a meal, the concentrations of dietary amino acids increase in both blood 
plasma (Frame 1958) and CSF (Glaeser et al. 1983). Interestingly, these rises 
are not necessarily reflective of the amino acid contents of the food, as some 
amino acids exhibit larger fluctuations in the blood than others (Frame 1958). 
Moreover, brain uptake of dietary amino acids from the blood also varies 
(Glaeser et al. 1983). 
Amino acids from blood plasma can cross the blood-brain barrier in the region 
of the median eminence, which has increased permeability, to enter the 
hypothalamus (Sclafani et al. 2014). There are several different transporter 
systems that take the blood plasma amino acids across the blood-brain barrier: 
System L for neutral amino acids with large side chains; System y+ for sodium-
independent uptake of cationic amino acids; System x– for anionic amino acids; 
System N for sodium-dependent uptake of L-glutamine (Gln), L-histidine (His) 
and L-asparagine (Asn); Systems A and ASC for small neutral amino acids; 
System Bo+ for neutral and basic amino acids; and System X– for L-glutamate 
(Glu) and L-aspartate (Asp) (Oldendorf and Szabo 1976, Smith 2000). Amino 
acid transporters are upregulated in hypothalamic cells during amino acid 
starvation (Hellsten et al. 2017). 
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The baseline levels of amino acids in rat CSF vary from 1–5 μM for isoleucine 
(Ile), proline (Pro), tryptophan (Trp), cysteine (Cys) and Asp to up to 500 μM for 
glycine (Gly) (Okame et al. 2015). Some amino acids make particularly effective 
signals of food intake – for example, the concentrations of L-tyrosine (Tyr), L-
methionine (Met), Pro, and L-alanine (Ala) markedly increase in the brain within 
2 hours of meal consumption (Glaeser et al. 1983). Others, such as L-valine 
(Val), L-leucine (Leu), L-lysine (Lys) and His, only increase if the ingested food 
is high in protein, thus representing the nutritive quality of the meal (Glaeser et 
al. 1983): for example, a high protein meal can induce a twofold increase in 
plasma Leu and a 24% increase in CSF Leu (Blouet et al. 2009). Microdialysis 
experiments in freely moving rats have shown an increase in Ala, Ile, Leu, Met, 
threonine (Thr), Tyr and Val concentrations in the lateral hypothalamic area 
within 20–40 minutes of dietary amino acid gavage (Choi et al. 1999). CSF 
concentrations of all these amino acids plus Asn and Gly in the medial preoptic 
area reflect dietary protein content (Choi et al. 2000).  
1.3.2. Brain amino acid detection mechanisms 
There are several neuronal mechanisms of direct amino acid sensing that have 
already been described in the brain. Extensive work by the Gietzen laboratory 
has shown that the mechanisms for brain amino acid sensing are so specific 
that injecting one essential amino acid reverses the negative effect of a diet 
lacking that particular amino acid (Gietzen and Magrum 2001). 
Some neurons (around 90% of NPY/AgRP and 45% of POMC) in the 
mediobasal hypothalamus express the mammalian target of rapamycin 
(mTOR), which is indirectly activated by amino acids and has been described 
as an ATP sensor (Dennis et al. 2001, Cota et al. 2006). Hypothalamic 
expression of SLC38A9, an amino acid transporter associated with mTOR 
activation, increases after exposure to high-fat diet (Hellsten et al. 2017). The 
umami taste receptor Tas1r1/Tas1r3 has been shown to facilitate amino acid 
detection in the mTOR pathway (Wauson et al. 2012). The local metabolism of 
ICV administered Leu, a potent activator of mTOR, reduces the levels of NPY in 
ARC, produces anorexia and causes weight loss without affecting oxygen 
consumption, respiratory rate, core temperature or activity (Cota et al. 2006, 
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Blouet et al. 2009). Val, similar in structure but unable to activate mTOR, does 
not have such an effect (Cota et al. 2006). 
In contrast to central administration, chronic oral Leu supplementation has no 
anorectic effect, despite being sensed by neurons (Zampieri et al. 2013). 
Moreover, additional, mTOR-independent Leu activation of MBH neurons has 
recently been demonstrated, casting doubt on the widely accepted 
hypothalamic mTOR significance (Heeley et al. 2018). 
Nevertheless, mTOR signalling is also known to be used for amino acid sensing 
in the caudomedial part of the NTS, which integrates signals from the 
gastrointestinal tract and has influence on food intake (Blouet and Schwartz 
2012). Evidence of immunoreactivity of the mTOR downstream target pS6 has 
been found in NTS POMC and CCK neurons; inhibition of another mTOR 
downstream molecule, a nutrient sensing enzyme S6K1, rapidly increases meal 
size and latency (Blouet and Schwartz 2012). 
The anterior piriform cortex (APC) has been suggested as the site of recognition 
of amino acid imbalanced diets (Leung and Rogers 1971). Hao and colleagues 
have found evidence that the accumulation of uncharged tRNA is the main 
signal of essential amino acid deficiency in the APC (Hao et al. 2005).  
Orx/hcrt neurons of the LH, involved in feeding and sleep behaviours and 
speculated to link hypothalamic and cortical networks, are sensitive to non-
essential amino acids and respond to a dietary mix of amino acids using a 
mechanism that involves KATP and System A amino acid transporters (Karnani 
et al. 2011).  
1.4. Amino acid receptors 
The amino acid detection mechanisms described in the previous section mostly 
involve complex cascades of events in order to activate the cells. In addition to 
these systems, there are receptors for direct detection of amino acids, which 
are expressed in mammals throughout the organism. 
Most known amino acid sensitive receptors are a part of the class C G protein-
coupled receptor (GPCR) family. A summary of GPCR amino acid detection 
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pathways is shown in Figure 1.4. One of these receptors, G protein-coupled 
receptor class C group 6 member A (GPRC6A), when expressed in Xenopus 
oocytes, responds to L-amino acids arginine, lysine, alanine, serine, ornithine, 
and citrulline (Wellendorph et al. 2005). It is also sensitive to Ca2+, other 
cations, and osteocalcin (Christiansen et al. 2007), and it may be involved in 
some effects of steroid hormones (Pi et al. 2010). Human tissue analysis 
showed GPRC6A mRNA expression in a wide range of tissues, which was 
particularly strong in the brain, skeletal muscle, leukocytes and testes, medium 
in liver, heart, kidney and spleen, but not detectable in the tongue, small 
intestine, or colon (Wellendorph and Bräuner-Osborne 2004). Some GPRC6A-
null mice exhibit insulin resistance, hyperglycaemia, and decreased bone 
mineral density (Pi et al. 2008). However, GPRC6A is not associated with high 
protein diet-induced weight loss (KinseyJones et al. 2015). 
Another receptor in this family, the calcium-sensing receptor (CaSR), is 
sensitive to extracellular Ca2+, other divalent and trivalent cations and pH, and 
is potentiated by L-amino acids, with preference for aromatic over polar amino 
acids as allosteric modulators (Conigrave et al. 2000). CaSR is expressed in 
gastric, intestinal and pancreatic tissues (Brown 1999). 
Two amino acids are major neurotransmitters: L-glutamate is excitatory and γ-
aminobutyric acid (GABA) is inhibitory; specialised receptors for them are 
expressed in neurons and astrocytes throughout the brain. The GABA receptors 
GABAA and GABAB, as well as the ionotropic glutamate receptors (iGluRs) 
known as the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptor, the N-methyl-D-aspartate (NMDA) receptor, and the kainate (KA) 
receptor, detect these amino acids as signalling molecules (Sivilotti and Nistri 
1991, Dingledine et al. 1999); on the other hand, some metabotropic glutamate 
receptors (mGluRs) also function as taste receptors for L-glutamate and several 
other amino acids (Chaudhari et al. 1996). 
Amino acids have distinct flavours, which allows animals to detect them in food. 
Most D-amino acids are sweet; some L-amino acids, such as L-tryptophan and 
L-phenylalanine, are bitter; the flavours of most non-aromatic L-amino acids are 
 40 
species-specific (Toda et al. 2013). The following section focuses on amino 
acids known to have an umami flavour. 
1.4.1. Umami taste receptors 
Umami is a savoury taste produced in humans by L-glutamate (often present in 
food as the flavour enhancing additive monosodium glutamate) and L-
aspartate, best described as the meaty taste of broth. In rodents, most non-
aromatic amino acids are considered to be umami tastants. The umami taste 
has been long defined by its potentiation by purine nucleotides such as inosine 
5’-monophosphate (IMP) and sensitivity to the mGluR agonist L-AP4 (Kurihara 
and Kashiwayanagi 1998). As a likely candidate for an umami taste receptor 
based on these properties, Nelson et al suggested Tas1r1/Tas1r3, a taste 
receptor expressed in the tongue, very similar to the sweet taste receptor 
Tas1r2/Tas1r3 (Nelson et al. 2002). 
Both sweet and umami Tas1 taste receptors are also class C GPCRs. They are 
both heterodimeric, sharing the Tas1r3 subunit. The Tas1r1 and Tas1r2 
subunits have not been found to form homodimers or function by themselves; 
Tas1r3 has been shown to function as a human and mouse receptor for the 
taste of calcium and a mouse receptor for magnesium (Tordoff et al. 2012). The 
sweet taste receptor Tas1r2/Tas1r3 is responsive to various sweet stimuli: 
glucose, fructose, sucrose, maltose, various sweet proteins and synthetic 
sweeteners such as acesulfame K, aspartame, saccharin and others (Li et al. 
2002). The umami taste receptor Tas1r1/Tas1r3 is known to function as a 
broadly tuned amino acid receptor, highly selective for most L-amino acids 
(Nelson et al. 2002), although the ligand specificity is species-dependent (Toda 
et al. 2013). While the human variant of the receptor exhibits the greatest 
sensitivity to L-glutamate and L-aspartate, there is evidence of human 
embryonic kidney cells that express Tas1r1/Tas1r3 responding, albeit weakly, 
to L-alanine, L-serine, L-glutamine, L-asparagine, L-arginine and L-histidine 
(although according to the authors of the study, the responses to L-arginine and 
L-histidine may have been artefacts caused by high osmolarity of the solutions 
used in the experiment) (Toda et al. 2013). The mouse Tas1r1/Tas1r3 is 
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significantly less sensitive to acidic amino acids but has greater sensitivity to 
other non-aromatic amino acids (Toda et al. 2013). 
Tas1r1/Tas1r3 possesses a large extracellular Venus flytrap domain linked to a 
smaller cysteine-rich domain and a seven-transmembrane domain (Cascales et 
al. 2010). The binding site for the amino acids is located on the Tas1r1 subunit, 
in the hinge region of the Venus flytrap domain, while the IMP-binding site lies 
near its opening (Zhang et al. 2008). 
After the binding of an amino acid to the Tas1r1 subunit, the G protein 
gustducin stimulates phospholipase C β2 (PLC-β2), which hydrolyses 
phosphatidylinositol-4,5-bisphosphate (PIP2) into inositol-1,4,5-trisphosphate 
(IP3) and diacylglycerol. IP3 then induces Ca2+ release, which leads to the 
gating of the cation channel transient receptor potential cation channel 
subfamily M member 5 (TRPM5; Figure 1.4) (Chandrashekar et al. 2006). 
TRPM5 opens large membrane channels, which allow ATP release from the cell 
(Huang and Roper 2010). 
Other candidates for umami taste detection are brain-expressed and taste-
expressed variants of type 1 and 4 mGluRs (mGluR1 and mGluR4) (Chaudhari 
et al. 2000, Maruyama et al. 2006). The brain variants of these receptors are 
expressed in a subset of cells on both the anterior and posterior tongue in rats, 
while the taste variants are located on the posterior tongue and have a 
truncated amino-terminal domain (San Gabriel et al. 2005). The stimulation of 
mGluRs activates a cyclic adenosine monophosphate (cAMP)-dependent 
pathway, leading to an increase in intracellular Ca2+ to open membrane 
channels for ATP release. It has recently been shown that mice lacking the 
Tas1r3 subunit of the Tas1r1/Tas1r3 receptor, or its downstream target TRPM5, 
can still taste umami substances to some extent, but their sensitivity can be 
further reduced by a group I mGluR antagonist (RS)-1-aminoindan-1,5-
dicarboxylic acid (AIDA) for mGluR1, or group III mGluR antagonist (RS)-α-
cyclo- propyl-4-phosphonophenylglycine (CPPG) for mGluR4 (Yasumatsu et al. 
2012). Thus, there are at least three different receptors in the tongue for amino 
acid detection. 
 42 
While mGluRs are primarily activated by glutamate, new evidence suggests that 
different L-amino acids such as L-arginine and L-serine can induce responses 
in isolated mouse taste cells (Choudhuri et al. 2016). 
 
Figure 1.4. Amino acid-sensitive G protein-coupled receptor pathways. Calcium-sensing 
receptor (CaSR) is activated by Ca2+ and potentiated by L-amino acids. The binding of Ca2+ and 
amino acids to the receptor activates G proteins α and βγ, which leads to ERK1/2 
phosphorylation, activation of PLC-β2, and, to a lower extent, direct opening of large 
conductance membrane channels that facilitate the uptake of extracellular Ca2+ and the release 
of ATP. PLC-β2 triggers Ca2+ release from the intracellular stores via IP3 receptors; the increase 
in intracellular Ca2+ then leads to ATP production and release. GPRC6A is activated by L-amino 
acids and modulated by Ca2+, and its activation also initiates the PLC-β2 pathway. 
Tas1r1/Tas1r3, sensitive to most non-aromatic amino acids and positively modulated by IMP, 
follows the same pathways as the former two receptors, but the increase in intracellular Ca2+ 
also opens TRPM5 to allow Na+ influx. Tas1r1/Tas1r3 also activates mTOR complex 1 to inhibit 
autophagy. mGluRs signal by activating PLC-β2 or protein kinase C, or decreasing cAMP. 
CaSR, calcium-sensing receptor; Cx43, connexin 43; panx1, pannexin 1; CALHM1, calcium 
homeostasis modulator 1; ERK1/2, extracellular signal-regulated protein kinases 1&2; PLC-β2, 
phospholipase C β2; IP3, inositol-1,4,5-trisphosphate; mTORC1, mammalian target of 
rapamycin complex 1; TRPM5, transient receptor potential cation channel subfamily M member 
5; DAG, diacylglycerol; PKC, protein kinase C; cAMP, cyclic adenosine monophosphate; ER, 
endoplasmic reticulum. 
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Among the three described amino acid receptors, Tas1r1/Tas1r3 is the only one 
to show synergistic responses to amino acids and nucleoside monophosphates 
(Damak et al. 2003). IMP is a compound of both human and rodent umami 
taste. It is known to enhance the umami taste properties in a concentration-
dependent manner (in the range of 0.1–10 mM) by stabilizing the closed 
conformation of the Venus flytrap domain of the Tas1r1 subunit once an amino 
acid has attached to it (Zhang et al. 2008, Yasumatsu et al. 2012). Most studies 
show that IMP alone does not elicit a response in cells expressing 
Tas1r1/Tas1r3 (but responses to IMP were observed in Tas1r3-null cells in 
work focusing on mGluRs – see Pal Choudhuri et al., 2016), and it does not 
affect sweet taste sensing (Nelson et al. 2002). 
As most D-amino acids have a sweet flavour, they are most likely detected by 
the sweet taste receptor. The several bitter L-amino acids such as L-
phenylalanine and L-tryptophan activate bitter taste receptors of the Tas2 
receptor family, as well as the CaSR (Conigrave et al. 2000, Bassoli et al. 
2014). 
1.4.2. ATP signalling 
Glial and taste cells cannot fire action potentials to communicate among 
themselves or with neurons; instead, they use Ca2+ signalling and neuroactive 
chemicals termed gliotransmitters. Some of the currently known gliotransmitters 
are ATP and adenosine, glutamate, and D-serine (Parpura et al. 1994, Haydon 
and Carmignoto 2006). 
Glial Ca2+ signalling is dependent on GPCR activation and is used for glia-to-
glia communication via gap junctions as well as to trigger gliotransmitter release 
that can activate both surrounding glial cells and neurons (Fiacco and McCarthy 
2006). 
ATP is well established as a signalling molecule that mediates various biological 
effects via purine receptors. It can be released into the extracellular space 
either in vesicles, or via membrane channels (Bodin and Burnstock 2001). 
Neighbouring cells that express P2 receptors on the cell surface then pick up 
the signal (Ralevic and Burnstock 1998). 
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Several large, non-selective membrane channels are permeable to ATP. Taste 
receptor cells have been shown to secrete ATP mainly via gap junction 
hemichannels composed of connexins or pannexins, and via calcium 
homeostasis modulator 1 (CalHM1). 
Pannexins are a class of gap junction-like proteins, one of which – pannexin1 
(panx1) – forms hemichannels in astrocytes for ATP release (Iglesias et al. 
2009). Panx1 has been demonstrated to mediate the release of ATP from taste 
receptor cells in both isolated cell preparations (Huang et al. 2007) and intact 
taste buds in tongue slices (Dando and Roper 2009). 
Connexins are vertebrate gap junction proteins. They form gap junctions in glial 
cells, allowing direct cell-to-cell communication (Stout et al. 2002). Connexin 43 
(Cx43) has been identified in tanycytes of the 3V and is likely to contribute to 
tanycyte control of the brain-cerebrospinal fluid barrier permeability between the 
fenestrated capillaries of the ME and the 3V, as well as the release of small 
molecules from tanycytes to hypothalamic neurons (Szilvásy-Szabó et al. 
2017). Connexin hemichannels have also been suggested as part of the taste-
induced ATP signalling system in the tongue (Romanov et al. 2007). However, 
the evidence in favour of connexin hemichannels being used for ATP release 
from taste receptor cells has been challenged by several authors: firstly, many 
studies on connexin channels have used carbenoxolone (CBX), which has a 
much higher potency for pannexins (by an order of magnitude); low 
concentrations of CBX are as effective as high concentrations at blocking ATP 
release from taste cells (Huang et al. 2007). Secondly, there has been a 
suggestion that an increase of intracellular Ca2+, observed after the activation of 
taste receptors, can actually close connexin hemichannels (Li et al. 1996), 
although this view is not widely accepted. And finally, anandamide, which 
blocks connexin channels previously suspected to be involved in taste 
signalling, does not interrupt communication within the taste bud (Huang et al. 
2007). 
CalHM1 is a non-selective pore-forming ion channel that can be activated either 
by lowering extracellular calcium, or in a voltage-dependent manner (Ma et al. 
2012). There is evidence of CalHM1 expression in taste buds, as well as the 
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loss of CalHM1 reducing taste-evoked ATP release from type II taste cells in the 
tongue, which are normally sensitive to sweet, umami and bitter tastes (Taruno 
et al. 2013). 
1.4.3. P2 receptors 
The ATP signal from taste or glial cells is picked up by nearby cells expressing 
P2 receptors. The P2 purine receptor family is divided into two subfamilies: 
P2X, ligand-gated ion channels, and P2Y, which are GPCRs (Fredholm et al. 
1994). 
Structurally, P2X receptors are similar to other classical ligand-gated channels, 
and they form heteromeric complexes of structurally related subunits (Ralevic 
and Burnstock 1998). P2X receptors are found on various excitable cells – 
smooth muscle cells, neurons, and glia – and they act as mediators of 
excitatory neurotransmission in central and peripheral nervous systems (Saïag 
et al. 1990, Cotrina et al. 2000, Pankratov et al. 2003). 
P2Y receptors are GPCRs (Webb et al. 1993). Five P2Y receptors have been 
fully characterised: P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11. Human P2Y4 and P2Y6 
receptors are uridine nucleotide-specific, only sensitive to UTP and UDP; rat 
P2Y4 can also be activated by ATP (Communi et al. 1996, Communi et al. 1996, 
Soto et al. 1996). P2Y receptors exhibit a slower onset of response compared 
to P2X receptors (<10 ms vs. <100 ms) (Ralevic and Burnstock 1998). 
1.5. Taste receptors in tanycytes 
Tanycytes are glucosensitive, and they have been hypothesized to sense 
glucose by utilizing a mechanism similar to that of pancreatic β cells, consisting 
of specific glucose transporters, glucokinase and KATP channels, which are all 
present in tanycytes (García et al. 2003). Direct evidence from both cultured 
tanycytes and cells in acute brain slices shows that tanycyte glucosensing 
occurs via an ATP receptor-dependent mechanism (Frayling et al. 2011, 
Orellana et al. 2012) and, in a large proportion of tanycytes, also depends on 
the sweet taste receptor (Tas1r2/Tas1r3 heterodimer) (Benford et al. 2017). 
Tas1r2/Tas1r3 is normally found in the taste cells of the tongue, surrounded by 
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cells expressing receptors for other taste modalities (Nelson et al. 2001). A 
closely related receptor, the Tas1r1/Tas1r3 heterodimer, which shares a subunit 
with the sweet taste receptor, contributes to the perception of umami taste 
(savoury taste of glutamate in humans, or most non-aromatic L-amino acids in 
rodents) (Nelson et al. 2002). This has led to the hypothesis that hypothalamic 
tanycytes use umami taste receptors to detect amino acids in the cerebrospinal 
fluid; and changes in amino acid intake can alter tanycyte gene expression and 
responses to amino acids. As amino acids are important signals of satiety, 
determination of whether tanycytes might detect amino acids would be an 
important advance in understanding the energy homeostasis-related functions 
of these cells. 
1.6. Experimental aims 
The three main aims of this thesis are to: 
1. Understand the complete signalling processes involved in tanycyte 
amino acid sensing, identify the receptors used and compare the 
findings to tanycyte sweet compound detection;  
2. Determine the effects of different diets (fasting, chow, essential amino 
acid deficient) on tanycyte taste receptor expression and function;  
3. Develop a link between tanycyte chemosensing, energy homeostasis 
and feeding behaviour in living animals.  
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2. Hypothalamic tanycytes sense amino acids via a 
Ca2+ and ATP-dependent pathway 
2.1. Introduction 
Hypothalamic tanycytes have recently emerged as chemosensitive, diet-
responsive glial cells in the wall of the 3V, potentially involved in the regulation 
of energy homeostasis. They express receptors for peripheral signals 
associated with metabolism such as leptin and ghrelin (Balland et al. 2014, 
Collden et al. 2015), as well as the sweet taste receptor (Tas1r2/Tas1r3) to 
detect glucose (Benford et al. 2017). Considering that tanycytes contact the 
ventricular cerebrospinal fluid and are positioned outside of the blood-brain 
barrier, they could be able to detect not only glucose, but also the derivatives of 
the two other types of macronutrients – amino acids from protein, and fatty 
acids from fat. The fact that tanycytes use the sweet taste receptor suggests 
that there could be other similar receptors expressed in these cells. 
The sweet taste receptor and the closely related umami taste receptor 
Tas1r1/Tas1r3 are GPCRs, which are characterised by the presence of seven 
membrane-spanning domains, an extracellular N terminus, and an intracellular 
C terminus (Rosenbaum et al. 2009). In these particular taste receptors, the 
binding of the tastant to the extracellular amino-terminal domain activates the 
heterotrimeric G proteins gustducins or Gαi2, which stimulate PLC-β2. This in 
turn hydrolyses PIP2 to produce intracellular messengers IP3 and 
diacylglycerol, which induce intracellular Ca2+ release, leading to the gating of 
the TRPM5. Mice lacking gustducin, PLC-β2, or TRPM5 have impaired 
sensitivity to sweet and umami taste, as well as bitterness (Chandrashekar et 
al. 2006). 
The other known umami taste receptors mGluR1 and mGluR4 are also GPCRs 
but respond to amino acids by activating phosphodiesterases and decreasing 
intracellular cAMP, which disinhibits nucleotide monophosphate-inhibited 
channels to elevate intracellular Ca2+. The effects of the Ca2+ increase are the 
same as for Tas1r1/Tas1r3, and eventually lead to ATP release. 
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ATP is most likely released from both taste receptor cells and tanycytes via 
large conductance membrane channels. Panx1 and CalHM1 have both been 
described as likely candidates for taste receptor cell ATP signalling (Dando and 
Roper 2009, Taruno et al. 2013). The ATP signal triggers a response in nearby 
taste nerve fibres (Yasumatsu et al. 2012), which then carry the information to 
the NTS (Whitehead and Frank 1983). 
In my Master’s thesis, I describe the initial experiments performed for this 
project that show tanycytes responding to a range of amino acids; the 
dependence of the response on both intracellular and extracellular Ca2+; the 
involvement of a range of P2 receptors in the response pathway (discovered 
using P2X and P2Y receptor antagonists separately and as a mixture), 
particularly P2Y1, P2X7, and at least one other P2X receptor (likely P2X2, as its 
expression can be seen very clearly in tanycytes throughout 3V in a previous 
study (Colldén et al. 2010)); and that the responses to Arg are blocked by CBX, 
a non-specific large conductance membrane channel inhibitor, known to block 
connexin hemichannels at high concentrations (≥100 μM) and pannexin 1 at low 
concentrations (≥10 μM). While these results pointed towards a GPCR-
dependent pathway for tanycyte amino acid sensing, they also raised more 
questions, such as how sensitive tanycytes are to different amino acids, and 
how (and where) exactly ATP is released from these cells. This chapter aims to 
answer these questions. 
The data presented in this chapter have been published as part of Lazutkaite et 
al., 2017. 
2.2. Methods 
2.2.1. Brain slices 
Male Sprague-Dawley rats (13–21 days old) were humanely killed in 
accordance with the UK Animals (Scientific Procedures) Act 1986. The brain 
was rapidly dissected and placed in ice-cold artificial cerebrospinal fluid (aCSF: 
124 mM NaCl, 26 mM NaHCO3, 1.25 mM NaH2PO4, 3 mM KCl, 2 mM CaCl2, 1 
mM MgSO4, 10 mM glucose; saturated with 95% O2/5% CO2; osmolarity 300 
mOsm) with additional 10 mM magnesium. 300 μm (for Ca2+ imaging) and 400 
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μm (for ATP biosensing) thick coronal sections were cut in the area of interest 
using a Microm HM 650 V vibrating blade microtome. Slices containing the 
hypothalamus were cut in half down the midline to the dorsal end of third 
ventricle leaving its walls intact, and through the median eminence to expose 
the tanycyte layer. These were then put into aCSF at 34–37˚C to incubate for 
30–45 minutes and later transferred to a holding chamber with room 
temperature low-glucose (1 mM glucose + 9 mM sucrose to maintain osmolarity 
at 300 mOsm) aCSF and a constant supply of 95% O2/5% CO2, where they 
were maintained throughout the experiment. 
2.2.2. Solutions and drug application 
Amino acids and drugs were applied via either the bathing medium or series of 
16 manual 300 ms puffs (pressure ~0.75 bar) from a patch pipette with a 2–3 
μm tip, applied roughly every second for Ca2+ imaging, or a single 700 ms puff 
for ATP biosensing. This series of short puffs, as established in prior work 
(Frayling et al. 2011), superfuses the desired substance over the edge of the 
slice at a steady state concentration approximately 30–40-fold lower than the 
concentration within the pipette. The positioning of the brain slice and the 
pipette in the flow chamber is shown in Figure 2.1. 
The amino acids used were L-alanine (Acros Organics, US), L-arginine (Acros 
Organics, US), L-lysine (Fisher Scientific, US), L-proline (Merck, Germany), and 
L-serine (Sigma-Aldrich, UK). The concentration of the amino acids in the puff 
pipette was 150–300 mM, depending on osmolarity, which was maintained 
around 300 mOsm to match aCSF. All amino acid solutions were made in 
purified H2O (R = 18.2 MΩ). 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES; Sigma-Aldrich, UK) buffer was added to 
165 mM L-arginine to maintain neutral pH. According to previous experiments 
using glucose biosensors placed at the edge of the brain slice during puffs of 
300 mM glucose, the final concentration of glucose reaching the slice was 30–
40 times lower than the concentration in the pipette depending on the distance 
from the tip of the pipette to the tanycytes (Frayling et al. 2011). As we were 
unable to obtain sensors for each amino acid, we used the glucose data to 
calculate approximate concentrations of amino acids, and they will be referred 
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to further in the text as: 5 mM and 10 mM L-alanine, 5 mM L-arginine, 5 mM L-
lysine, 5 mM and 10 mM L-proline, 5 mM and 10 mM L-serine. 
The concentrations of the drugs used were as follows: 200 μM 10panx (Tocris 
Bioscience, UK), 10 μM BBG (Sigma-Aldrich, UK), 10 μM and 100 μM CBX 
(Sigma-Aldrich, UK), 165 μM GAP 26 (VWR International Ltd., UK), 100 nM 
MRS2500 (Tocris Bioscience, UK), 50 μM Suramin (Sigma-Aldrich, UK), 30 μM 
PPADS (Tocris Bioscience, UK), 1 mM Probenecid (Sigma-Aldrich, UK), 50 μM 
Ruthenium Red (Sigma-Aldrich, UK), 1 µM tetrodotoxin (TTX; Tocris 
Bioscience, UK). The solutions were prepared in aCSF except for Probenecid, 
which had to be dissolved in 1 mM NaOH and then neutralised with HCl prior to 
adding it to aCSF. Only one drug treatment was performed per slice to avoid 
loss of responses due to overstimulation, bleaching of Fura-2, or loss of cell 
viability. 
Bath application of all substances except 10panx and Gap26 included 
incubation in the flow chamber for 10–30 minutes without imaging. When using 
10panx and Gap26, each slice was tested for a control response to 5 mM L-
arginine, then taken out of the flow chamber and put into an incubation chamber 
with either regular low-glucose aCSF (control) or low-glucose aCSF with 
10panx or Gap26 for 30 minutes, and put back into the flow chamber, keeping 
the orientation of the slice in the chamber and the position relative to the puff 
pipette as similar to the initial set up as possible. Responses to L-arginine were 
recorded within 5 minutes from the end of incubation to prevent washout of the 
peptides. 
2.2.3. Imaging 
Prior to imaging, the slices were incubated for 75-95 minutes in 1.25 μM Fura-2 
AM (Fura-2 dissolved in 20% Pluronic F-127 solution in DMSO and diluted 
1:800 with low-glucose aCSF; Life Technologies, UK). After incubation, the 
slices were transferred into a holding chamber with low-glucose aCSF to wash 
out excess Fura-2 AM and DMSO/Pluronic. For imaging, they were transferred 
to a flow chamber on an Olympus BX51 microscope equipped with a 60x water 
immersion objective (NA 1.0). Ratiometric imaging of Fura-2 emissions at 
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excitation wavelengths of 340 and 380 nm (provided by a Cairn Research 
Optoscan monochromator) was performed under the control of the MetaFluor 
software. Example images where 6 individual cells can be identified and 
corresponding region of interest (ROI) traces from these cells are shown in 
Figure 2.1 B,C.  
 
 
Figure 2.1. Set up for Ca2+ imaging and biosensing. (A) Schematic representation of the 
arrangement of a brain slice and puffing pipette in the imaging chamber. (B, C) Individual 
tanycytes can be seen responding to Arg under higher magnification. ROIs in the graph 
represent the cells seen in the montage. Scale bar 20 μm. (D) Schematic representation of the 
arrangement of a brain slice, puffing pipette and microelectrode biosensors in the flow chamber. 
(E) Enzymatic scheme of the ATP biosensor. The cascade of enzyme reactions produces H2O2 
when ATP is present. Glycerol is added to the bathing medium prior to ATP measurements. 
H2O2 is oxidized on the electrode surface (polarized to 500 mV). (F) The Null sensor is an exact 
copy of the ATP biosensor without the enzymes required for ATP detection. It is therefore only 
sensitive to electrical disturbances and non-specific events, allowing exclusion of any noise or 
artefacts from the ATP biosensor recording. For more information see Llaudet et al., 2005. 
DMH, dorsomedial hypothalamic nucleus; 3V, third ventricle; VMH, ventromedial hypothalamic 
nucleus; ARC, arcuate nucleus; ME, median eminence. 
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2.2.4. ATP biosensing 
For direct biosensing of ATP in brain slices, custom-made enzyme-coated 7 μm 
carbon fibre microelectrodes (Sarissa Biomedical LTD, UK) were inserted into 
the hypothalamic tissue immediately next to tanycyte cell bodies, contacting the 
bases of tanycyte processes. A “null” electrode (exact copy of the ATP 
biosensor lacking the enzyme layer, only sensitive to non-specific events and 
noise – see Figure 2.1 F) was placed next to the biosensor and used as a 
reference for any mechanical or electrical disturbances during the recordings. 
The final values of the measurements were calculated by subtracting the “null” 
values from the biosensor values at each time point. The arrangement of the 
electrodes in the brain slice is shown in Figure 2.1 D. 
The biosensor and the “null” were connected to a Sycopel Duo-Stat ME 200+ 
potentiostat. The biosensor traces were recorded via a Data Translation 
DT3016 AD board and custom software was used for storage and analysis. 
2 mM glycerol was added to all the bathing solutions used in these experiments 
to allow the enzymes within the biosensor – glycerol kinase and glycerol-3-
phosphate oxidase – produce hydrogen peroxide when ATP is present (Fig 2.1 
E,F) (Llaudet et al. 2005). 
The biosensors were calibrated with a 50 μM ATP solution in aCSF at the start 
and the end of each day, as well as in the middle of the experiments or 
whenever a new biosensor was used. 
2.2.5. Data analysis 
The emission ratios for F340/F380 were calculated using ImageJ software for 
every individual tanycyte visible in the field (selected manually). The baseline 
was calculated from 15 images prior to the start of the amino acid application 
and maximum change in the intensity in each region of interest was found for 
every trial (when substances potentially altering tanycyte responses were used, 
trials were described as follows: CONTROL amino acid application; DRUG – 
amino acid application in the presence of another substance; and WASH – 
amino acid application after washing the slice in regular aCSF for an extended 
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period of time). Average responses were then calculated for each trial in each 
slice.  
The data from the biosensor recordings were analysed using proprietary 
software. The amplitudes of the response peaks were measured manually and 
then compared to the amplitude of the biosensor calibration curve recorded 
using a known amount of ATP (50 μM) to calculate the highest amount of ATP 
detected during each response. 
Graphpad Prism 7 was used to produce graphs. All values represented in the 
graphs in this and following chapters can be found in the appendix. 
2.2.6. Statistical analysis 
Statistical analysis was performed using Graphpad Prism 7 software. For 
experiments investigating the effects of drugs, a single brain slice was 
considered an independent replicate (the total number of animals that the slices 
were obtained from is given in brackets). The Friedman non-parametric 2-way 
ANOVA was used to compare the responses across the CONTROL, DRUG and 
WASH trials. Median responses in both Ca2+ imaging and ATP biosensing 
experiments were compared between the CONTROL and DRUG trials using 
Wilcoxon’s matched pair signed ranks test. The WASH trial was used to 
evaluate the loss of cell vitality and responsiveness due to the length of the 
experiment and the number of amino acid applications. Exact probabilities 
calculated by the tests are reported in text or figures.  
All statistical tests were two-sided. Data collection and analysis were not 
performed blind to the conditions of the experiments.  
2.3. Results 
2.3.1. Tanycytes respond to L-amino acids with a Ca2+ wave 
Fura-2 AM-loaded hypothalamic tanycytes displayed an increase in intracellular 
calcium in response to a series of puffs of L-amino acids. The highest 
responses to 5 mM solutions of L-amino acids were observed when using 
essential amino acids Lys and Arg (Figure 2.2, 2.3). No response was observed 
when Arg was puffed directly onto the brain parenchyma, i.e. ARC or VMH, 
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instead of the tanycyte layer (mean ± SEM amplitude ΔF340/F380 0.032 ± 0.020, 
n = 5 slices from 4 animals; example ROI trace shown in Figure 2.3 C). Non-
essential amino acids Ala, Pro and Ser only elicited minor responses at 5 mM 
(Figure 2.4 B, 2.5 B, 2.6 B, left panels). As shown in Figures 2.4–2.6, increasing 
the concentration of non-essential amino acids to 10 mM resulted in higher 
responses to Ala and Ser. 10 mM Ala responses reached similar overall 
amplitude to the essential amino acids, but with higher variability (Figure 2.6 C). 
The response to 10 mM Pro, which is a weak agonist for the suspected tanycyte 
amino acid receptors Tas1r1/Tas1r3, mGluR1 and mGluR4, was still lower than 
the responses to all other tested amino acids (Figure 2.6 B,C). 
 
Figure 2.2. Tanycytes respond to L-lysine. (A) Montage and (B) corresponding ROI trace 
show an example response to 5 mM Lys. Yellow dots on the montage and black lines on the 
trace indicate puffing duration. White arrows show the spread of the Ca2+ wave. Scale bar 20 
μm. 
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Figure 2.3. Tanycytes respond to L-arginine. (A) Montage and (B) corresponding ROI trace 
show an example response to 5 mM Arg. Yellow dots on the montage and black lines on the 
trace indicate puffing duration. Scale bar 20 μm. (C) 5 mM Arg does not elicit a tanycyte 
response when applied directly on the brain parenchyma. 
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Figure 2.4. Tanycytes respond to L-alanine. (A) Montage showing example responses to 10 
mM Ala. (B) ROI traces showing example responses to 5 mM and 10 mM Ala. Yellow dots on 
the montages and black lines on the traces indicate puffing duration. Scale bar 20 μm. 
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Figure 2.5. Tanycytes respond to L-serine. (A) Montage showing example responses to 10 
mM Ser. (B) ROI traces showing example responses to 5 mM and 10 mM Ser. Yellow dots on 
the montages and black lines on the traces indicate puffing duration. Scale bar 20 μm. 
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Figure 2.6. Tanycytes have low sensitivity to L-proline. (A) Montage showing example 
responses to 10 mM Ser. (B) ROI traces showing example responses to 5 mM and 10 mM Ser. 
Yellow dots on the montages and black lines on the traces indicate puffing duration. Scale bar 
20 μm. (C) Full tanycyte amino acid response profile. 
To further confirm that the Ca2+ wave originated from tanycytes, the Na+ 
channel inhibitor TTX (Narahashi 1974) was used to prevent any potential 
signals generated by nearby neurons. TTX did not block tanycyte responses to 
Arg (Figure 2.7), confirming that tanycyte sensitivity to amino acids does not 
depend on spiking in neurons. 
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Figure 2.7. Tanycyte responses to L-amino acids are independent of neuronal activity. 
(A) Example ROI traces from 1 slice and (B) graph showing that tetrodotoxin (TTX), a Na+ 
channel inhibitor, did not reduce tanycyte responses to Arg. 
2.3.2. Tanycytes release ATP in response to L-amino acids 
The responses to amino acids in taste receptor cells of the tongue follow an 
ATP receptor-dependent pathway (Finger et al. 2005). In the work conducted 
during my MSc, a range of P2 receptor antagonists were used to prevent the 
spread of the tanycyte signal along the edge of 3V. Based on the findings of 
Frayling et al. and Benford et al., who showed P2Y1 expression and 
involvement in sweet taste signalling in tanycytes, the P2Y1 antagonist 
MRS2500 was first used to reduce tanycyte responses to amino acids, but had 
no effect (Figure 2.8 A,B). PPADS, Suramin, and Brilliant Blue G (BBG), which 
act on several P2X and P2Y receptors, were then tested but individually, none 
of these antagonists blocked tanycyte signals (Figure 2.8 C). However, 
combinations of any tested P2X antagonist and MRS2500 successfully reduced 
tanycyte responses to Arg (Figure 2.8 D–F; time-matched control shown for 
comparison in Figure 2.8 E). This suggested that multiple ATP receptors, one of 
which was P2Y1, were required to elicit a Ca2+ wave in response to Arg. The 
lack of effect from individual antagonists, therefore, may be explained by the 
compensation by other P2 receptors involved in mediating tanycyte amino acid 
responses. These findings were used as the basis for further experiments on 
tanycyte ATP signalling. 
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Figure 2.8. Tanycyte responses to L-amino acids require ATP detection via P2 receptors. 
(A, B) Inhibition of P2Y1 with MRS2500 was not sufficient to block tanycyte responses to Arg. 
(C) Non-specific P2 receptor antagonists PPADS, suramin and BBG failed to inhibit tanycyte 
responses. (D–F) Combinations of P2X and P2Y antagonists reversibly blocked tanycyte 
responses to Arg. (E) Time-matched control shows that the blockage was specific to the drugs 
and not dependent on the time intervals between amino acid applications. P values given for 
Friedman test comparing all three trials. 
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Direct biosensing using custom made 7 μm carbon fibre biosensors (200 μm in 
length; Sarissa Biomedical Ltd, UK) showed an increase in ATP next to 
tanycyte cell bodies immediately after a single amino acid puff. A single 700 
millisecond puff was enough to elicit ATP release in response to Ala, Arg and 
Ser (example Ala and Arg traces in Figure 2.9 B). Series of puffs resulted in 
saturation of the response, as the cells could only produce a limited amount of 
ATP in a short period of time (data not shown). Responses were observed only 
when amino acids were applied directly on the tanycyte layer, but not on brain 
parenchyma (Figure 2.9 C,D). 
Figure 2.9. Tanycytes release ATP in response to L-amino acids. (A) The arrangement for 
the biosensor recordings. Black arrows indicate the tanycyte layer. Scale bar 100 μm. VMH, 
ventromedial hypothalamic nucleus; ARC, arcuate nucleus; 3V, third ventricle. (B) Biosensor 
and “null” traces and the corrected response curve (“ATP-null”) from tanycytes responding to 10 
mM Ala and 5 mM Arg. (C) Schematic representation of the biosensor and puff pipette positions 
for applying amino acids directly on tanycyte bodies (position 1) or on the parenchyma (position 
2) (D) A comparison of ATP release detected when 10 mM Ala was applied directly on tanycyte 
bodies (position 1) and on the parenchyma (position 2). VMH, ventromedial hypothalamic 
nucleus; ARC, arcuate nucleus; 3V, third ventricle. 
The increase in ATP concentration (estimated against a calibration curve 
recorded with 50 μM ATP) after a single puff ranged between 0.3–10 μM. Any 
values higher than 10 μM were disregarded as potential artefacts, which could 
have occurred due to damage to the gel layer of the biosensor. 
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Figure 2.10. ATP travels down tanycyte processes. (A, C) The arrangement for the 
biosensor recordings with a second (inner) biosensor placed at different distances relative to the 
first (outer) biosensor. Scale bar 100 μm. VMH, ventromedial hypothalamic nucleus; ARC, 
arcuate nucleus; 3V, third ventricle. (B, D) The amount of ATP detected by the two biosensors 
and the delay between the outer and inner biosensor response peaks depended on the distance 
between the biosensors (E) ATP travelled into the brain parenchyma at a consistent rate. 
To trace the movement of the ATP signal, combined measurements with 2 
biosensors (a second biosensor in place of “null”) were performed. The second 
sensor was placed at a varying distance from the tanycyte cell bodies (Figure 
2.10). These measurements showed that the amount of ATP detected 
decreased moving the second sensor further into the hypothalamus, while the 
delay of the response peak increased. The wave of ATP travelled into the 
parenchyma at approximately 3.6 μm/s (SD = 1.48, n = 5; Figure 2.10 E). The 
speed of the ATP wave is comparable to the speed at which Ca2+ moves down 
the tanycyte processes (Benford et al. 2017). This suggests that in response to 
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amino acids, tanycytes send an ATP signal down their processes towards the 
hypothalamic nuclei that control energy homeostasis. 
2.3.3. ATP is released via large conductance channels 
To further investigate the pathway of ATP release from hypothalamic tanycytes, 
mimetic peptides for two large conductance membrane channels – Panx1 and 
Cx43, both likely candidates for tanycyte taste signal transduction, – were used 
in an attempt to block the responses to amino acids. Gap26, a mimetic peptide 
for Cx43 (Desplantez et al. 2012), did not consistently reduce tanycyte 
responses to Arg, although a trend for reduction (p = 0.065 Wilcoxon’s matched 
pair signed ranks test) could be seen (Figure 2.11 A). Blocking Panx1 with the 
mimetic peptide 10panx, on the other hand, resulted in a strong reduction in the 
responses to Arg, revealing a role for Panx1 in tanycyte amino acid detection 
(Figure 2.11 A,B). 
 
Figure 2.11. ATP is most likely released from tanycytes via pannexin 1 after L-arginine 
application. (A) Gap26, the mimetic peptide for connexin 43, did not consistently reduce 
tanycyte responses to L-arginine. The pannexin 1 mimetic peptide 10panx weakened the 
responses (Wilcoxon signed ranks test). (B) Example ROI traces from tanycytes responding to 
L-arginine before and after incubation in 10panx and (C) a time-matched control. Black lines 
indicate puffing duration. 
Another channel, CalHM1, is also a potential conduit for tanycyte ATP release. 
Ruthenium red (RuR), Gd3+ and Zn2+ are known inhibitors of CalHM1 (Ma et al. 
2012). RuR did not have an effect on tanycyte responses to Arg (Figure 2.12 
A). However, RuR was also tested against Ala in the ATP biosensing 
experiments, this time reducing the amount of ATP released after an Ala puff 
(Figure 2.12 B). The results were then replicated with Ca2+ imaging (Figure 2.12 
C,D), showing that CalHM1 is used for tanycyte ATP release in response to Ala, 
but not Arg. 
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Figure 2.12. Tanycyte ATP release in response to L-alanine requires CalHM1. (A) 
Ruthenium red (RuR), which blocks CalHM1, did not affect tanycyte responses to L-arginine. 
(B) Ruthenium red reduced biosensor-detected tanycyte ATP release in response to L-alanine. 
(E, F) The reduction in the response was also observed with Ca2+ imaging, confirming that 
tanycyte responses to L-alanine lead to ATP release trough CalHM1. P values given for 
Friedman test. 
2.4. Discussion 
Rat hypothalamic tanycytes responded to a range of amino acids following the 
expected GPCR pathway and releasing Ca2+ and ATP, with involvement of P2 
receptors and large, non-selective calcium channels. 
Based on umami taste receptor sensitivity levels for different amino acids 
described in cultured taste receptor cells (Nelson et al. 2002), the expected 
outcome of the first experiment was that tanycytes would exhibit greater 
responses to non-essential (Ala, Ser) than essential (Arg, Lys) amino acids. The 
results contradicted this hypothesis as the concentrations of non-essential 
amino acids had to be increased 2-fold to induce responses that resembled 
those to Arg and Lys. This difference between amino acid sensing in the tongue 
and in tanycytes could occur due to minor structural differences in the taste 
receptors expressed in the different areas; for example, it is known that taste- 
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and brain- variants of mGluR4 have different glutamate binding sites as taste-
mGluR4 has a truncated N-terminal, which results in lower affinity (Chaudhari et 
al. 1996). Similarly, the ligand binding sites of tanycyte Tas1r1/Tas1r3 could 
have evolved to detect essential amino acids with higher affinity in order to 
inform the hypothalamus about their availability. 
2.4.1. Tanycytes exhibit specific responses to different L-amino acids 
Distinct response patterns were observed with each tested amino acid. Arg and 
Lys elicited high responses at a low concentration (5 mM). Ala only worked at a 
higher concentration (10 mM), and the response was blocked by RuR, 
suggesting ATP release via CalHM1. Conversely, tanycyte responses to Arg 
were not reduced by RuR and seemed to depend on Panx1 with potential 
partial involvement of Cx43. Ser elicited slightly lower amplitude, slower 
responses than Arg or Lys observed in both Ca2+ imaging and ATP biosensing. 
The concentrations of Pro used in this experiment were not sufficient to activate 
tanycytes, suggesting that Pro is a weak agonist for tanycyte amino acid 
receptors.  
The range of shapes and sizes of the Ca2+ and ATP waves, the previously 
demonstrated need for multiple P2 receptors, and the involvement of Panx1 
and CalHM1 in the responses to different amino acids indicate that there must 
be more than one pathway for tanycyte amino acid detection. This could either 
be two or more separate receptors (similarly to Tas1r1/Tas1r3, mGluR1 and 
mGluR4 functioning together in the tongue), or agonist-dependent coupling 
from one receptor to different membrane channels. 
In tanycyte sweet taste sensing, inactivating P2Y1 with MRS2500 is sufficient to 
reduce tanycyte responses to glucose and artificial sweeteners mediated by 
Tas1r2/Tas1r3 (Benford et al. 2017). Tanycyte amino acid detection, on the 
other hand, involves more P2 receptors: a mix of antagonists that block a 
number of P2X receptors including P2X2 and P2X3, as well as P2Y1, is required 
to eliminate tanycyte responses to Arg (Lazutkaite et al. 2017), which could be 
an adaptation to increase sensitivity as the relative levels of amino acids in the 
third ventricle are much lower than they are in the oral cavity during a meal. 
Moreover, as P2 receptors differ in their sensitivity for ATP and other 
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nucleotides, simultaneous activation of certain subsets of P2 receptors after the 
detection of different amino acids could relay substrate-specific information to 
ARC neurons.  
Both Panx1 and CalHM1 have been shown to be involved in amino acid 
sensing in taste receptor cells of the tongue (Dando and Roper 2009, Taruno et 
al. 2013); however, there has not yet been a suggestion that they could be parts 
of separate detection mechanisms for different amino acids. Since none of the 
tested membrane channel antagonists fully abolished tanycyte responses to 
either amino acid, some overlap can be suspected between the two tanycyte 
amino acid signalling pathways. 
2.4.2. Tanycyte ATP release could be used for tanycyte-to-neuron 
signalling 
The ATP detection experiments demonstrated that ATP released by tanycyte 
cell bodies spreads not only to neighbouring cells, but also down the tanycyte 
processes and into the hypothalamic nuclei controlling food intake and 
metabolism. This is an important finding as it suggests potential nutrient-
dependent tanycyte-to-neuron signalling, which has not been described before. 
Experimental evidence from mice shows that optogenetic stimulation of 
tanycytes expressing Ca2+ permeable channelrhodopsin (CaTCh) depolarizes 
nearby NPY and POMC neurons and increases the frequency of spontaneous 
depolarizing post-synaptic potentials depending on the metabolic state of the 
subject (Dr. M. Bolborea, personal communication, September 2017). While the 
optogenetic signal is different in many aspects from the amino acid signal, the 
ATP released from tanycytes in response to dietary amino acids could 
potentially be used to inform these neurons about nutrient availability in the 3V. 
Alternatively, tanycytes could be signalling to astrocytes (or other glial cells in 
the area), which would then influence neuronal activity accordingly.  
The tanycyte signals observed in this study clearly indicate a role for tanycytes 
in central amino acid sensing, and they may possibly be responsible for the 
delivery of nutrient-related information to the neural circuits that regulate energy 
homeostasis. It could be speculated at this point that the tanycyte amino acid 
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signalling relates to satiety, as amino acids are a powerful indicator of food 
intake and, when administered centrally, can act on the hypothalamus to reduce 
hunger (Panksepp and Booth 1971).  
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3. The identification of amino acid receptors in 
tanycytes 
3.1. Introduction 
Hypothalamic tanycytes respond to L-amino acids via a GPCR-dependent 
pathway. It is now known that tanycytes express the sweet taste receptor 
Tas1r2/Tas1r3, which is a GPCR, to detect glucose and artificial sweeteners 
(Benford et al. 2017). A closely related umami taste receptor Tas1r1/Tas1r3 
shares a subunit with the sweet taste receptor and is used in taste buds of the 
tongue to detect amino acids (L-glutamate in humans and a wide range of non-
aromatic L-amino acids in rodents) (Nelson et al. 2002). However, 
Tas1r1/Tas1r3 is not the only amino acid receptor in the tongue, as research 
using mice lacking either subunit of the receptor or its downstream target 
TRPM5 showed that these animals were still able to taste amino acids, although 
the sensitivity was reduced; mGluR1 and mGluR4 have been suggested as 
additional umami taste receptors since blocking these receptors reduced the 
sensitivity of taste receptor cells to amino acids even further (Yasumatsu et al. 
2012). The different umami taste receptors on the mouse tongue exhibit distinct 
spatial organisation: mGluRs are expressed in the anterior and posterior 
tongue, while Tas1r1/Tas1r3 is located mostly in the posterior part of the tongue 
(Yasumatsu et al. 2009). 
Tas1r1/Tas1r3 responds to a range of amino acids in most mammals, but has a 
strong preference for glutamate and aspartate in humans (Nelson et al. 2002). 
The difference arises from structural differences between species in the 
extracellular Venus flytrap domain of the Tas1r1 subunit, which is responsible 
for amino acid recognition and binding (Toda et al. 2013). mGluR1 and mGluR4 
are best known as receptors for L-glutamate, as suggested in the name, but 
recent findings in taste research have revealed a more diverse range of 
agonists, including L-amino acids arginine and serine (Choudhuri et al. 2016).  
A characteristic feature of Tas1r1/Tas1r3 is that responses to amino acids via 
this receptor are enhanced in presence of nucleoside monophosphates, 
especially IMP, which is a compound of umami taste. IMP increases the 
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amplitude of the response in a concentration-dependent manner (in the range 
of 0.1–10 mM) by binding to the Tas1r1 subunit to stabilize the closed 
conformation of the receptor once an amino acid has bound to the Venus flytrap 
domain (Zhang et al. 2008, Yasumatsu et al. 2012). IMP alone does not elicit a 
response in cultured cells expressing Tas1r1/Tas1r3; neither does it have an 
amplifying effect on responses mediated by mGluRs (Yasumatsu et al. 2012) or 
the sweet taste receptor Tas1r2/Tas1r3 (Nelson et al. 2002). 
As previous work has begun to draw the parallel between tanycyte and taste 
receptor cell signalling (Benford et al. 2017), the aim of this set of experiments 
was to test if the umami taste receptors Tas1r1/Tas1r3, mGluR1 and mGluR4 
were responsible for tanycyte amino acid sensing. 
Most results presented in this chapter have been published as part of 
Lazutkaite et al., 2017. 
3.2. Methods 
3.2.1. Animals and brain slices 
For Ca2+ imaging, male Sprague-Dawley rats (13–21 days old), male and 
female C57BL/6J mice (4 to 18 weeks old), and male and female Tas1r1-null 
mice (5 to 15 weeks old, kindly provided by the Meyerhof lab, described in Voigt 
et al., 2015) were humanely killed in accordance with the UK Animals (Scientific 
Procedures) Act 1986. The following procedure was the same as described in 
2.2.1. IMP experiments were performed on rat tissue; the rest of the data were 
collected from mice. 
Brain samples for Tas1r1 expression imaging were obtained from the German 
Institute of Human Nutrition Potsdam-Rehbruecke. The frozen tissue of Tas1r1-
Cre/eR26-tauGFP mice that expressed GFP at the site of Tas1r1 (Foster et al. 
2013, Voigt et al. 2015) was cut at 35 μm using a Bright OTF 5000 cryostat and 
mounted on slides with VECTASHIELD (Vector Laboratories, US) containing 
DAPI. 
For immunohistochemistry, male C57BL/6J and Tas1R1-null mice were put in 
deep anaesthesia using Isoflurane, and cardiac perfusion with 4% 
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paraformaldehyde (PFA) was performed before dissecting the brain. The tissue 
was further immersion fixed for 24 hours in 4% PFA and transferred to 
phosphate-buffered solution (PBS). Slices were cut in the region of interest at 
100 μm using a vibrating blade microtome. 
3.2.2. Solutions 
The solutions used in these experiments were the same as described in 2.2.2, 
with the addition of 200 μM 4-CPG (Tocris Bioscience, UK), 0.5–1 mM IMP 
(Sigma-Aldrich, UK), and 200 μM MAP4 (Tocris Bioscience, UK). 4-CPG and 
MAP4 were administered via bath application through the flow chamber for 15 
minutes without imaging. IMP was applied through the flow system for 3–5 
minutes to ensure it was available at the region of interest before the amino 
acid puffs. 
4% PFA, PBS, and a blocking buffer (5% bovine serum albumin and 0.1% 
Triton in PBS) were used for immunohistochemistry. 
3.2.3. Immunohistochemistry 
Brain slices were arranged individually in a 24-well plate. They were rinsed with 
PBS 3 times (15 min. per rinse with gentle agitation) and placed in 250 μL of 
blocking buffer for 1 hour in room temperature with gentle agitation. The 
blocking buffer was then replaced with rabbit polyclonal anti-metabotropic 
glutamate receptor 4 antibody (ab53088, Abcam, UK) diluted to 1:250, 1:500, 
1:1000 and 1:2000 in blocking buffer. The slices were incubated with the 
primary antibody overnight in 4°C. Next morning, the slices were rinsed with 
PBS (3´15 min. in room temperature with gentle agitation) and incubated with 
goat anti-rabbit Alexafluor 488 secondary antibody (Invitrogen, UK) diluted to 
1:2000 in blocking buffer for 1 hour in room temperature with gentle agitation. 
The rinsing was repeated, and the slices were mounted on glass slides with 
Fluoroshield mounting medium (Sigma-Aldrich, UK), either with or without DAPI. 
3.2.4. Imaging 
Ca2+ imaging was performed as described in 2.2.3. 
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Tas1r1 and mGluR4 expression was visualised using a Leica SP5 confocal 
laser microscope. FIJI software was used for further analysis. 
3.2.5. Data and statistical analysis 
Data analysis was performed as described in 2.2.5. Statistical analysis for 4-
CPG and MAP4 experiments was performed as described in 2.2.5. The G test 
was used to evaluate the significance of the change in the proportion of high 
responses (ΔF340/F380 > 0.15) in the IMP experiment. 
In the Tas1r1-null versus wild type comparisons, a single animal was 
considered to be a replicate. On average recordings were made from 2 brain 
slices per animal for each amino acid and the results from each cell in the field 
of vision were averaged to give a single value per animal. Student’s unpaired t 
test was used to compare the responses between wild type and Tas1r1-null 
animals. For all experiments involving Tas1r1-null animals, a power calculation 
was performed after gathering the initial data to determine the appropriate 
sample sizes. Randomization was not performed, as mouse litter sizes were 
small and all littermates were used. 
3.3. Results 
3.3.1. Inosine 5’-monophosphate increases tanycyte sensitivity to L-
arginine 
Tas1r1/Tas1r3 exhibits a strong synergistic response when amino acids are 
applied in presence of IMP. To test whether such synergism was present in 
tanycyte responses to amino acids, L-arginine was applied first in regular low-
glucose aCSF, and then in low-glucose aCSF containing 0.5–1 mM IMP. The 
availability of IMP in the bathing medium resulted in an overall increase in the 
median response amplitude (Figure 3.1 A–C). Moreover, in presence of IMP, 
the number of cells exhibiting high (ΔF340/F380 > 0.15, threshold based on 
observation), rapidly rising responses increased from 14.8% to 40.9% (Figure 
3.1 D). 
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Figure 3.1. IMP enhances tanycyte responses to L-arginine. (A, B) Montage and 
corresponding graph of ROI traces demonstrate the change of the response of one slice to a 
series of 300 ms puffs of 5 mM L-arginine in normal aCSF (Control) and after the addition of 
0.5–1 mM IMP to the bathing medium (IMP). Scale bars 20 μm. (C) IMP increased tanycyte 
responses to L-arginine. P value given for Wilcoxon signed rank test. Black bars on the ROI 
traces represent the duration of amino acid puffing. (D) The proportion of cells exhibiting rapidly 
rising high responses (ΔF340/F380 > 0.15) increases from 14.1% to 40.9% with added IMP. P 
value given for G test. (E) Tanycytes exhibited a trend for increased responses to Lys with IMP 
(P = 0.063 Wilcoxon’s signed rank test), but no changes in responses to Ala or Ser. Data for 
this graph was collected during my MSc. 
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A previous experiment with IMP presented in my MSc dissertation also included 
Lys, Ala and Ser. Tanycyte responses to Lys demonstrated a trend for 
enhancement by IMP (P = 0.063, n = 5 Wilcoxon’s signed rank test), whereas 
there was little to no change in the amplitude of the responses to Ala or Ser 
(Figure 3.1 E). 
3.3.2. Tas1r1 is expressed in mouse tanycytes 
In taste buds, multiple receptors are involved in the detection of amino acids. To 
confirm the presence of Tas1r1/Tas1r3 in tanycytes, mice modified using a 
binary genetic strategy were obtained from prof. Meyerhof’s lab in Potsdam, 
Germany (Foster et al. 2013, Voigt et al. 2015). Tas1r1-Cre mice were bred with 
Rosa26-tauGFP reporter mice. In the offspring, the tauGFP reporter labelled 
cells normally expressing the Tas1r1 gene. Confocal imaging of hypothalamic 
brain slices of these mice showed GFP expression in some, but not all 
tanycytes, and a number of unidentified neuronal or glial cells (Figure 3.2). 
The fluorescence was dense in several areas: in the most anterior regions of 
the hypothalamus, the expression was scarce (Figure 3.2 A,B), but moving 
caudally towards the centre of 3V GFP was expressed in α1, α2, some β1 and 
β2 tanycytes, as well as a number of other cells on the outside of the ME, in the 
ARC, VMH, and some ependymal cells (Figure 3.2 C,D,G). In the posterior 
regions of 3V, GFP could be seen mostly in α2, β1 and β2 tanycytes and 
ependymal cells, but also unidentified cells in the ARC and VMH and a line of 
cells surrounding the ME (Figure 3.2 E,F). 
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Figure 3.2. Tanycytes express Tas1r1. (A-G) Hypothalamic tissue from Tas1r1-Cre/eRosa26-
tauGFP mice shows that the Tas1r1 subunit is expressed in some, but not all hypothalamic 
tanycytes, as well as some neurons and ependymal cells. Little GFP is seen in the anterior 
parts of 3V (A, B), but the expression is consistent through the medial (C, D) and posterior (E, 
F) parts. Scale bar 200 μm. (G) A higher magnification image shows that cells expressing 
Tas1r1 in the wall of 3V exhibit tanycyte morphology. Scale bar 50 μm (H) Schematic 
representation of the area depicted in the fluorescence imaging. Grey dashed square 
represents the area shown in panel G. Greek letters indicate tanycyte populations. Ep, 
ependymal cells; VMH, ventromedial hypothalamic nucleus; ARC, arcuate nucleus; 3V, third 
ventricle. 
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3.3.3. Tas1r1-null mice exhibit altered responses to L-amino acids 
Ca2+ signalling in tanycytes of Tas1r1-null mice was examined to test whether 
their responses to amino acids were altered. These mice had a reporter 
construct consisting of a truncated barley lectin followed by an internal ribosome 
entry site and mCherry knocked into the Tas1r1 locus (Voigt et al. 2012). 
The Tas1r1-null mice (males and females analysed together) showed no 
difference in tanycyte responses to Ala (Figure 3.3 A). There was a striking 
variation in the responses to Lys and Arg, although the variances were 
consistent between the wild type and the Tas1r1-null groups. The responses to 
Lys were partially reduced, as well as the proportion of cells responding to Lys 
(P = 0.0264 and 0.0348, respectively, Student’s t test), but there was no change 
in the responses to Arg (Figure 3.3 A).  
To better understand the variability of the phenotype in the Tas1r1-null mice, 
the effects of age on tanycyte sensitivity to amino acids were analysed, but no 
relationship was found between age and amplitude of the responses to any of 
the tested amino acids within the experimental range (Figure 3.3 B). The 
responses were then separated by sex (Figure 3.3 C,D). In neither males nor 
females were the responses to Ala altered by deletion of the Tas1r1 gene. The 
effect of Tas1r1 deletion on Lys sensitivity was lower in the separate groups: a 
trend of reduction in the responses to Lys was observed in males (P = 0.0597 
Student’s t test); while in female Tas1r1-null mice, only the number of 
responsive cells decreased (P = 0.042 Student’s t test; data not shown) without 
reducing the mean amplitude (Figure 3.3 C). The responses to Arg and the 
proportion of responding cells were strongly reduced in female Tas1r1-null mice 
(Figure 3.3 C). However, in male mice the responses to Arg were enhanced in 
the knock out compared to the wild type (Figure 3.3 D). This suggests that 
males can compensate for the loss of the Tas1r1 gene (possibly via 
upregulation of another receptor) whereas female mice cannot. Interestingly, in 
wild type mice, tanycytes in females were more sensitive to Arg than those in 
males (P = 0.0024, Student’s t test). This correlates with the differing effect of 
loss of the Tas1r1 gene in the responses to Arg in tanycytes from male and 
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female mice. No similar findings have been reported before, and the biological 
significance of this difference between the sexes remains to be determined.  
 
Figure 3.3. Tas1r1/Tas1r3 is involved in tanycyte amino acid sensing. (A) Tas1r1-null mice 
showed no change in the responses to L-alanine or L-arginine but a reduction in the responses 
to L-lysine. (B) Tanycyte responses to amino acids in wild type and Tas1r1-null mice were not 
age-dependent between 5 and 16 weeks. (C) Female mice lacking Tas1r1 exhibited strongly 
reduced responses to L-arginine. (D) In male Tas1r1-null mice, tanycytes were more sensitive 
to L-arginine. P values given for Student’s t test. 
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3.3.4. mGluR4, but not mGluR1, mediates tanycyte responses to L-alanine 
and partially to L-lysine 
Since Ala responses were unaffected by the deletion of Tas1r1, the next step 
was to investigate whether other known umami taste receptors, mGluR1 and 
mGluR4 (Maruyama et al. 2006), might be involved in tanycyte amino acid 
detection. Whereas the mGluR1 antagonist S-4-carboxyphenylglycine (4-CPG) 
(Sekiyama et al. 1996) did not have any effect on Arg, Ala or Lys responses 
(Figure 3.4 A), S-2-amino-2-methyl-4-phosphonobutanoic acid (MAP4), a 
specific mGluR4 antagonist (Johansen and Robinson 1995), greatly reduced 
tanycyte responses to Ala and partially reduced the responses to Lys (Figure 
3.4 B–D). MAP4 had no effect on the responses to Arg. 
3.3.5. Elimination of Tas1r1/Tas1r3 and mGluR4 is not sufficient to block 
all tanycyte responses to L-amino acids 
To see whether a combination of blocking mGluR4 with MAP4 and Tas1r1 gene 
deletion would have a more complete effect on amino acid responses, the effect 
of MAP4 in male Tas1r1-null mice was evaluated. The effect of MAP4 on 
tanycyte Ala sensitivity remained strong (Figure 3.4 E), but no change was 
observed in responses to either Lys or Arg. Any potential effect of MAP4 on 
responses to Lys may have been masked by the control Lys responses being 
lower in the Tas1r1-null mice. Nevertheless, if mGluR4 had been the only 
receptor mediating the responses to Lys in mice lacking the Tas1r1/Tas1r3 
receptor, a more complete reduction of the responses under MAP4 would have 
been expected. It seems unlikely therefore that male mice compensate for the 
loss of the Tas1r1 gene by upregulating mGluR4. 
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Figure 3.4. Tanycytes use mGluR4 to detect some L-amino acids. (A) mGluR1 antagonist 
4-CPG did not sufficiently block tanycyte responses to any of the tested amino acids. Some 
responses to L-alanine were reduced when 4-CPG was added (P = 0.0312 Wilcoxon’s signed 
ranks test, n = 7 slices (from 4 animals)) but the recovery was inconsistent (P = 0.0854, 
Friedman test comparing Control Ala, 4-CPG and Wash). (B, C) Example ROI traces of the 
effects of the specific mGluR4 antagonist MAP4 on L-alanine and L-lysine. (D) MAP4 blocked 
tanycyte responses to L-alanine (P = 0.0007, Friedman test, n = 9 slices (from 6 animals)); the 
responses to L-lysine were also reduced (P = 0.0099, Friedman test, n = 8 slices (from 7 
animals)). L-arginine responses were unaffected. (E) Using MAP4 on the Tas1r1-null mice did 
not eliminate all tanycyte responses to L-amino acids. The effect on L-alanine remained (P = 
0.0055, Friedman test, n = 6 slices (from 6 animals)), while any effect on L-lysine was masked 
due to lower initial response (P = 0.7402, Friedman test, n = 6 slices (from 6 animals)). There 
was still no change in the responses to L-arginine. 
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3.3.6. Mouse tanycytes express mGluR4 
The Allen Mouse Brain Atlas shows expression of mGluR4, by in situ 
hybridization, in the ependymal layer surrounding 3V in the region of the 
median eminence (Lein et al. 2007). To further confirm the presence of mGluR4 
in mouse tanycytes, immunohistochemical staining was performed on C57BL/6J 
and Tas1r1-null mouse brains.  
 
Figure 3.5. mGluR4 is expressed in hypothalamic tanycytes. (A) mGluR4 labelling is visible 
in tanycyte processes throughout the median eminence, arcuate nucleus and ventromedial 
hypothalamic nucleus. (B) The intensity of the fluorescence is similar in Tas1r1-null mouse 
tissue, with additional labelling in tanycyte cell bodies, potentially extending to ependymal cells. 
Scale bar 200 μm. Abbreviations as in Figure 3.2. 
Expression of mGluR4-like immunoreactivity could be seen in a large number of 
cells in the hypothalamus, including the cells lining 3V that exhibited tanycyte 
and ependymal cell morphology (Figure 3.5 A). The fluorescence appeared 
similar in intensity in the Tas1r1-null brain (Figure 3.5 B).  
There is no solid confirmation of the specificity for the primary antibody used in 
this experiment, although its use has been published in several papers (Wang 
et al. 2011, Betts et al. 2012, Chruścicka et al. 2014). Thus, while the 
immunohistochemical data alone would not be enough to confirm the presence 
of mGluR4 in mouse hypothalamus, it enhances the results of mGluR4 
inhibition with MAP4, supporting the role of this receptor in tanycyte amino acid 
sensing. 
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3.4. Discussion 
Tanycytes detect a range of L-amino acids, and they do so via at least two 
receptors – Tas1r1/Tas1r3 and mGluR4. According to the results from the 
previous chapter, the two receptors subsequently activate separate response 
pathways: the activation of Tas1r1/Tas1r3 leads to ATP release via Panx1, 
while mGluR4 triggers the opening of CalHM1 (Figure 3.6). While tanycyte 
glucosensing was long suspected and multiple glucose detection mechanisms 
have been demonstrated, tanycyte amino acid sensitivity has not been 
foreshadowed in literature. Therefore, the detection of amino acid concentration 
changes in the third ventricle by tanycytes is the first known non-neuronal 
mechanism of direct amino acid sensing in the brain. 
3.4.1. Tanycytes use Tas1r1/Tas1r3 to detect L-arginine and L-lysine 
This work shows that tanycytes functionally express Tas1r1/Tas1r3, and the 
loss of the Tas1r1 subunit of the receptor in mice is enough to affect tanycyte 
responses to Arg and Lys, depending on the sex of the mouse. Given that 
Figure 3.6. Proposed tanycyte amino acid signalling pathways. Experimental evidence 
suggests that Tas1r1/Tas1r3 is required for the detection of L-arginine, while L-alanine is 
detected by mGluR4, and L-lysine can activate both receptors. The activation of the receptors 
increases intracellular Ca2+, which opens membrane channels for ATP release. The ATP can 
then be picked up by nearby cells using P2 receptors, as well as travel down the tanycyte 
processes and into the parenchyma. 
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Tas1r1 expression is sparse (Figure 3.2), the fact that the effects of knocking 
out this subunit were only partial is not entirely unexpected. 
It is important to note that while a large number of tanycytes do indeed express 
Tas1r1, there are obvious gaps between cells expressing GFP in the confocal 
images (Figure 3.2). Tanycytes are often described as a heterogeneous 
population of cells, and it would not be surprising if individual tanycytes 
expressed only one of the amino acid receptors, or if there were sweet-specific, 
umami-specific and bitter-specific tanycytes. The latter organisation would 
reflect that of taste buds in the tongue, where each cell in a cluster can be 
activated by only one taste modality (Chandrashekar et al. 2006). The cell 
specificity could potentially be broken down further, with separate umami-
sensitive tanycytes expressing different umami taste receptors. This 
arrangement would enable tanycytes to send very well-defined signals to 
dedicated neural populations as different mixtures of dietary amino acids would 
activate separate subsets of tanycytes, thus maximising the amount of 
information delivered by these cells.  
3.4.2. Multiple receptors are required for tanycyte detection of L-amino 
acids 
As the group III mGluR antagonist MAP4 strongly reduced all responses to Ala 
and partially blocked those to Lys, it is evident that mouse tanycytes also use 
mGluR4 to detect at least these two amino acids. This is further supported by 
the apparent expression of mGluR4 throughout the hypothalamus, including the 
wall of the third ventricle. The fact that multiple receptors are involved in the 
detection of amino acids reflects the current knowledge in umami taste research 
and suggests that tanycyte amino acid sensing is a physiologically important 
mechanism.  
The nature and identity of the umami taste receptor has long been the subject 
of an on-going discussion between various groups investigating human and 
rodent taste receptors: while a significant body of evidence pointed towards 
Tas1r1/Tas1r3, knocking out the Tas1r3 subunit of this receptor in mice did not 
eliminate all responses to umami-tasting amino acids (Damak et al. 2003, 
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Maruyama et al. 2006). The current consensus is that additional receptors such 
as mGluR1 and mGluR4 can sense a range of amino acids in the taste receptor 
cells in the tongue, and these mechanisms can compensate for each other 
when one of the receptors is lost (Yasumatsu et al. 2012). Having different 
receptors for various amino acids (with some overlap) could also help identify 
the overall quality of the food, such that if all receptors were activated at once, 
that would mean the ingested food was nutritious and rich in a variety of amino 
acids. 
Many studies using genetically modified animals to investigate metabolic 
challenges have resulted in a rescue of phenotype by upregulation of other 
genes or activation of alternative signalling pathways (Leroux et al. 2001, 
Castro-Chavez et al. 2003, Roncon-Albuquerque et al. 2008, Castillo et al. 
2011). A possible explanation why some responses to amino acids were still 
observed in the Tas1r1-null mice when mGluR4 was blocked (see Figure 3.4 E) 
could be that due to the similarities between Tas1r1/Tas1r3 and Tas1r2/Tas1r3, 
the sweet taste receptor could adapt to function as a sensor for both glucose 
and some amino acids in rodents lacking the Tas1r1 gene. While the potential 
of such an adaptation has not been widely discussed, Tas1r1/Tas1r3 and 
Tas1r2/Tas1r3 do exhibit species-specific sensitivity profiles; for example, 
hummingbird Tas1r1/Tas1r3 has evolved to detect sugar in plant nectars 
(Baldwin et al. 2014).  
3.4.3. Physiological changes in amino acid levels in the third ventricle 
could potentially activate tanycytes in vivo 
In the experiments described in this and previous chapter, large concentrations 
(up to 10 times the baseline concentration in hypothalamic CSF based on Choi 
et al., 1999) of single amino acids were applied acutely to the tanycyte layer. 
Such approach does not accurately replicate the events occurring in 3V after 
feeding, but similar tanycyte activity can be expected in vivo, even if individual 
amino acid concentrations are relatively low, due to the following reasons.  
As mentioned before, IMP is an allosteric modulator of the Tas1r1/Tas1r3 
receptor, but has no effects on other known amino acid receptors (Yasumatsu 
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et al. 2012). In these experiments IMP enhanced tanycyte responses to Arg, 
providing further support for the functional involvement of Tas1r1/Tas1r3 in 
tanycyte amino acid sensitivity. The concentrations of the two essential amino 
acids used in this study – Arg and Lys – only increase by a small amount after 
feeding (Choi et al. 1999), but the combination of multiple amino acids ingested 
at once and the potentiation of the Tas1r1/Tas1r3 receptor by IMP could be 
sufficient to evoke tanycyte signalling. 
Conversely, the levels of alanine in both blood plasma and CSF vary greatly 
depending on food intake (Anderson et al. 1994). This, combined with the 
prevalence of alanine in cereals and other foods that make up rodent diets, 
makes alanine a likely candidate for a generic signal of protein consumption for 
tanycytes. If this is the case, the proposed tanycyte dual amino acid receptor 
model could use the amino acid information in two different ways: transient 
alanine signals would reflect feeding, while a more tonic essential amino acid 
signal would be used to monitor overall nutritive health. 
Other similar, nutritionally relevant amino acids should be investigated to check 
whether tanycyte responses exhibit a cumulative increase, or a certain few 
amino acids are used to regulate the entire tanycyte signalling mechanism. 
3.4.4. Male and female mice adapt differently to the loss of Tas1r1 
Both male and female mice were used in the Tas1r1-null experiment to 
minimise the number of unused animals culled following the “3Rs” stated in the 
Animals (Scientific Procedures) Act 1986. However, as the number of animals 
used for the study increased, differences between male and female tanycyte 
responses to amino acids started to emerge: firstly, wild type female mice 
exhibited higher responses to Arg than wild type males; secondly, the loss of 
Tas1r1 reduced the responses to Arg in females but had the opposite effect in 
males (Figure 3.3 C,D). This suggests that male and female mice possess 
different adaptive mechanisms for genetic challenges in tanycyte amino acid 
detection. 
Recent literature on energy homeostasis in male and female mice supports the 
sex differences in the adaptation to the loss of Tas1r1: further differences have 
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been observed in POMC expression in response to a high-fat diet (Plum et al. 
2006) and the effects of changes in diet on hypothalamic neurogenesis (Lee et 
al. 2014, Bless et al. 2016). Moreover, POMC-derived peptides α-MSH and 
desacetyl-α-MSH affect male and female mice differently – male mice lacking 
both peptides are as sensitive to reintroduction of desacetyl-α-MSH as α-MSH, 
while female mice only exhibit weight loss when administered α-MSH (Mountjoy 
et al. 2017). 
The oestrous cycle of female mice was not taken into account in this 
experiment, but, since oestrogen receptors are expressed widely in the 
hypothalamus and are known to influence energy homeostasis (Iwasa et al. 
2017) and tanycyte morphology (De Seranno et al. 2010), it is possible that if 
the study was repeated using animals in any one phase of the cycle, the results 
could be slightly different. The amount of circulating oestrogen affecting 
tanycyte responses to amino acids is a tempting explanation for the outliers in 
the Tas1r1-null responses to Lys and Arg (Figure 3.3 C); however, male 
Tas1r1-null responses also have a similar distribution without any known 
differences in oestrogen. 
In conclusion, hypothalamic tanycytes use a taste receptor system similar to 
that in the tongue and comprised of Tas1r1/Tas1r3, mGluR4 and potentially 
another receptor to detect changes in L-amino acid concentrations within 3V. 
The complexity of the system, as well as the rescue of Arg responses in male 
mice lacking the Tas1r1 subunit of the Tas1r1/Tas1r3 receptor, reinforce the 
prospective significance of tanycyte umami taste signalling. Moreover, tanycyte 
signalling is different in male and female mice, which should be taken into 
account in further research, especially with regards to clinical applications of 
any future findings. 
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4. Diet-related changes in feeding, metabolism and 
tanycyte sensitivity to amino acids 
4.1. Introduction 
Hypothalamic tanycytes can sense changes in nutrient concentrations in the 
CSF of the third ventricle using a range of taste receptors. The position of 
tanycytes close to the neuronal circuits in the ARC and VMH that regulate 
feeding and energy expenditure, combined with the multitude of nutrient 
detection pathways in tanycytes, indicate a key role for these cells in energy 
homeostasis. This set of experiments aimed to investigate the physiological 
significance of tanycyte amino acid signalling. 
The regulation of energy homeostasis depends closely on the qualities of 
consumed food. In addition to caloric intake-dependent release of gut peptides, 
the composition of one’s diet can affect feeding and energy expenditure via 
multiple central pathways. For example, both high-fat and low-protein diets can 
impair neurogenesis in the hypothalamus (Lee et al. 2012, Lee et al. 2014). 
HFD also leads to neuroinflammation, apoptosis of hypothalamic neurons, and 
reduction in synaptic inputs in the ARC and LH, leading to increased body mass 
and resistance to leptin and insulin (Moraes et al. 2009). POMC neurons of 
mice with HFD-induced obesity exhibit higher intracellular Ca2+, 
hyperpolarization, reduced excitability and low spontaneous activity (Paeger et 
al. 2017). Moreover, rat pups exposed to maternal HFD have increased levels 
of orexigenic peptides such as galanin, orx and MCH, and newly generated 
neurons in the 3V of these pups are more likely to be incorporated into the 
orexigenic networks (Chang et al. 2008). HFD also alters circadian rhythms, 
changing the diurnal patterns of circulating metabolic hormones leptin and 
insulin, nutrients such as glucose and free fatty acids, and hypothalamic 
peptides POMC, CART, NPY, AgRP and orx (Kohsaka et al. 2007). 
Hypothalamic tanycytes exhibit an increase in lipid droplets in animals on 
chronic HFD (Hofmann et al. 2017). 
On the other hand, HFD-fed mice supplemented with L-leucine exhibit 
decreased diet-induced obesity due to higher energy expenditure through 
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thermogenesis (Zhang et al. 2007). Leu also improves glucose metabolism and 
reduces HFD-induced insulin resistance (Zhang et al. 2007). The effects of Leu 
supplementation can be traced back to the hypothalamus, where Leu potently 
activates the mTOR pathway in hypothalamic NPY/AgRP neurons, reducing the 
production of orexigenic peptides (Cota et al. 2006). A recent study has shown 
that an additional mechanism is involved in hypothalamic Leu sensing, as 
blocking mTOR targets does not suppress Leu signalling in POMC neurons; 
interestingly, inhibiting previously suggested Leu transporters, KATP and GPCR 
pathways also failed to reduce Leu detection, suggesting that a yet unknown 
receptor is involved in its anorexigenic effects (Heeley et al. 2018). 
High-protein (HP) diets tend to reduce food intake and increase satiety, 
although the effects are short-term as partial adaptation occurs (Bensaı̈d et al. 
2003). In humans, ingestion of protein also stimulates thermogenesis and 
overall energy expenditure more effectively than carbohydrates or fat (Steiniger 
et al. 1987, Mikkelsen et al. 2000). While one study suggested that animals 
monitor their protein intake by detecting L-glutamate in food via both taste and 
gut signalling (Kondoh et al. 2009), glutamate supplementation alone did not 
result in reduced food intake and body weight (Boutry et al. 2011). 
In studies utilising HP diets to investigate their effects on food intake and 
metabolism, the composition of the protein can influence the outcome: for 
example, a 55% whey protein diet is more efficient in reducing feeding than a 
55% whole milk protein diet (Pichon et al. 2008). A difference between the 
effects of whey, soy protein and egg albumen on subsequent meal size was 
also demonstrated in human subjects (Anderson et al. 2004). Oral, 
intraperitoneal and intracerebroventricular administration of L-arginine has been 
shown to reduce food intake in male rodents (Alamshah et al. 2016). L-
phenylalanine also reduces food intake via CaSR-mediated gut peptide release 
(Alamshah et al. 2017). This suggests that the amino acid composition of the 
food, rather than total protein intake, can determine the outcome of dietary 
interventions.  
As food intake leads to an increase of amino acids in the blood plasma and 
subsequently in the CSF (Anderson et al. 1994), and hypothalamic tanycytes 
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are directly exposed to these changes, it was interesting to determine whether 
tanycyte signalling could be affected by the amino acid content of the diet, and 
if the effects would be reflected in rodent food choice and metabolism.  
4.2. Methods 
4.2.1. Animals and tissue preparation 
For Ca2+ imaging experiments, male Sprague-Dawley rats (21–28 days old) 
were fasted for 15 hours (ensuring weight loss under 15%), given one of the 
amino acid imbalanced (IMB) diets (see 4.2.2) for 22 hours, or given standard 
laboratory rodent chow (EURodent diet 14%, LabDiet, US) before being 
humanely killed in accordance with the UK Animals (Scientific Procedures) Act 
1986. The following procedure was the same as described in 2.2.1.  
For refeeding after short-term fasting experiments, 12 male Sprague-Dawley 
rats (22-24 days old on day 1 of the experiment) were singly housed in normal 
conditions with free access to normal laboratory animal chow and water. The 
chow was removed from 6 cages at 1600 on the first day of the experiment; at 
0800 the following morning 50 g of chow was placed directly inside each cage, 
and the animals were provided with drinking water supplemented with either 50 
mM Ala or 29 mM Pro. The amount of food remaining in the cage was 
measured 4, 8, and 24 hours later. The rats were then given 32 hours to 
recover with ad libitum chow and normal drinking water. The experiment was 
repeated with reversed groups: animals that had previously been fasted 
received ad libitum chow, while animals that were in the control group were now 
fasted. 
For amino acid supplement preference experiments, male and female 
C57BL6/J or Tas1r1-null mice (6–9 weeks old, housed in same sex and same 
genotype pairs) were given the arginine and lysine deficient diet (RK-; see 
4.2.2) or normal chow for 24 hours and then moved to new cages to monitor 
their food and amino acid supplement intake for 24 hours. After that they were 
given 6 days to rest in their home cages with ad libitum chow before repeating 
the experiment with reverse diets: mice that had been given RK- in the first 
round received chow in the second round, and vice versa. They were then kept 
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in their home cages for another 6 days (for experimental timeline see Figure 4.4 
A). All mice were weighed every day during the active parts of the experiment, 
and every 2 days during the rest periods. All cage and diet changes, as well as 
animal weighing, were performed in the first half of the light phase. 
For experiments using metabolic cages – the Comprehensive Laboratory 
Animal Monitoring System (CLAMS) – 16 male (experiment 1) and 16 female 
(experiment 2) mice heterozygous for the NrCAM gene (NrCAM+/-; (Sakurai et 
al. 2001), 10–14 weeks old at the start of the experiment) were used. The mice 
were individually housed for 1 week before the first two groups (n = 4 mice per 
group) were transferred to the metabolic cages to measure daily activity, food 
intake and energy expenditure. In the first CLAMS experiment, the first group 
(RK1) was provided with ground RK- diet, while the second group (RK2) 
received ground high protein chow (Teklad Global 18% Protein Rodent Diet, 
Harland Teklad, UK) for 24 hours. For the following 24 hours, both groups 
received ground alanine enhanced (A+) diet. They were then returned to their 
home cages, and the third (A1) and fourth (A2) group went into the CLAMS, 
where A1 mice were given ground alanine deficient (A-) diet, and A2 received 
ground chow for 24 hours. After that, both groups were provided with the A+ 
diet for 24 hours before returning to their home cages. One week after the start 
of the first trial, the experiments were repeated with reversed diets for the first 
24 hours in the CLAMS: RK1 received chow, RK2 received RK-, A1 received 
chow, and A2 received A-; all mice were given A+ for the following 24 hours 
(timeline of experiment shown in Figure 4.6 A and on a smaller scale in Figure 
4.8 A). At the end of the last trial, 8 more age-, sex- and weight-matched wild 
type mice from the same colony were added to the experiment and all mice 
were reassigned into new groups to be given RK-, A-, A+ or chow for 22 hours. 
They were then culled and brain samples were collected for future analysis. 
The design and timetable of the second CLAMS experiment mimicked the first 
one, except female mice and a matched control diet were used this time. 
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4.2.2. Diet 
The IMB diets – arginine and lysine deficient, alanine deficient and alanine 
enhanced – were obtained from Special Diets Services, UK. The formulation of 
the diets was based on standard laboratory mouse chow (Rat and Mouse No.1 
Maintenance Autoclavable diet, Special Diets Services, UK). RK- had no Arg in 
the formulation (0.7% in standard chow) and Lys was reduced to 0.27% (0.75% 
in chow). A- had Ala removed from the formulation (0.87% in chow). A+ had Ala 
supplemented to achieve 1.74%. All IMB diets were balanced on a 
carbohydrate source. The IMB diets and the chow diets had similar Atwater 
energy density (3.1–3.3 kcal/g). 
All diets were used in pellet form in Ca2+ imaging and 2-bottle experiments and 
in powder form in CLAMS experiments. 
Three different control diets were used in these experiments. For the Ca2+ 
imaging, refeeding and 2-bottle experiments, the EURodent 14% diet was used. 
In the first CLAMS experiment, mice received the TEKLAD Global 18% diet. A 
nutrient- and calorie-matched control diet (C2) was used in the second CLAMS 
experiment instead of standard chow. The C2 diet was formulated by grinding 
the A+ and A- diets and mixing them at a 1:1 ratio to achieve Ala level of 
approximately 0.95% while keeping the caloric content, fat, protein and 
carbohydrate proportions, fibre content, smell and texture the same as those of 
the IMB diets. 
A 50 mM Ala solution and a 25 mM Arg + 25 mM Lys solution were presented 
to the animals during the amino acid supplement preference experiment. 
Blackcurrant flavouring (10% by Sainsbury’s No Added Sugar Double Strength 
Blackcurrant Squash with sucralose) was added to the solutions to mask the 
flavour of the amino acids. The water in drinking bottles was also flavoured to 
match the taste. 
4.2.3. Experimental cages 
In the amino acid supplement preference experiment, custom-made drinking 
tubes were used in the food and drink monitoring cages to present the amino 
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acid solutions. Each drinking tube consisted of a 25 ml Fisherbrand disposable 
polystyrene serological pipette (Fisher, UK) with a widened opening connected 
to a Tecniplast AISI 316 bottle lid with a sipper tube via a 165 mm Tygon 
silicone tube (inside diameter 4.8 mm, outside diameter 7.9 mm; Saint-Gobain 
Performance Plastics, US) and the middle section of a TipOne 1 ml filter tip 
(Starlab, UK). A stopper was fitted at the wide end of the pipette. The silicone 
tube was removed when filling the pipette with an amino acid solution, then 
replaced immediately and flicked gently to remove any bubbles. The filled 
drinking tube was then fixed in a retort stand, and the sipper tube was slotted 
between the bars of a stainless-steel wire cage lid. Two drinking tubes (Ala and 
Arg+Lys) plus a standard drinking bottle with flavoured water were provided for 
each cage. 30 g of RK- or chow pellets were placed directly into the cages. 
There were 6 cages with 2 mice per cage. 
The CLAMS experiments were performed at Queen’s Medical Centre, School of 
Life Sciences, University of Nottingham, with training and assistance from Prof. 
Francis Ebling and Dr. Jo Lewis. The experimental system was obtained from 
Linton Instrumentation, Linton, UK, and manufactured by Columbus 
Instruments, Columbus, OH, US. The CLAMS cages consisted of a centre 
feeder cage on scales to monitor food intake, Oxymax open circuit indirect 
calorimeter, and infrared photocells to detect animal motion. 
The parameters monitored in the CLAMS were total food intake, feeding bout 
frequency and size, oxygen consumption (VO2), carbon dioxide production 
(VCO2), respiratory exchange ratio (RER), heat production and activity levels. 
The data were recorded using Oxymax software (Columbus Instruments, US). 
4.2.4. Imaging 
Ca2+ imaging was performed as described in 2.2.3. The experimental solutions 
used were the same as in 2.2.2. 
4.2.5. Data and statistical analysis 
Ca2+ imaging data analysis was performed as described in 2.2.5. The proportion 
of cells responding was determined using a threshold of ΔF340/F380 ≥ 0.02 
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(based on changes in Ca2+ normally occurring in the baseline) for each cell and 
calculating the number of responsive and unresponsive cells for each animal. 
These numbers were then compared between different dietary conditions using 
Fisher’s exact test. Tanycyte response amplitudes were compared as described 
in 2.2.5. 
The food, water and amino acid intake data from the 2-bottle preference test 
were collected per cage (2 mice) rather than per animal. Amino acid intake in ml 
was then converted to mg calculated using the molarity of each solution. Paired 
Student’s t tests were performed on all data using Graphpad Prism 7; each 
animal was considered a replicate and went through both the RK- and control 
treatments. Mann-Whitney U test was used to compare wild type and Tas1r1-
KO mouse results in this experiment as some of the data had unequal 
variances. 
The data from the CLAMS were divided into 1-hour subsets and averages for 
each hour were calculated for the metabolic data. These averages were then 
used for further analysis of the parameters in the dark and light phases. Total 
food intake, feeding time and feeding bout frequency were calculated in 3-hour 
bins, which were then averaged for the dark and light phases. Fat oxidation 
(Fox), carbohydrate oxidation (CHOx) and energy expenditure (EE) were 
calculated using the following formulae (Frayn 1983): "#$ = (1.67 × ,-.) − (1.67 × ,1-.) 12-$ = (4.55 × ,-.) − (3.2 × ,1-.)	88 = (15.9 × ,-.) + (5.2 × ,1-.) 
The data were plotted and statistical analyses were performed using Graphpad 
Prism 7. Paired statistical analyses (Wilcoxon’s matched pairs test or Student’s 
paired t test) were performed where the same animal was exposed to different 
treatments. 
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4.3. Results 
4.3.1. Short-term fasting increases tanycyte sensitivity to L-alanine 
To determine the effects of fasting on tanycyte responses to amino acids, male 
Sprague-Dawley rats were fasted overnight (15 hours) prior to tissue collection. 
The rats lost on average 9.25% (SEM 1.36%, n = 8) of their initial weight.  
While there was a hint of increased tanycyte Ca2+ responses to Ala after fasting, 
there were no significant differences between the amplitudes of the responses 
to Ala, Arg or Lys in fasted and fed animals (Figure 4.1 A–C). However, the 
variance of the responses to Ala increased in the fasted animals, which may 
mean that cells which would normally not respond to Ala were producing small 
Ca2+ waves, while cells that would be sensitive to Ala under normal feeding 
conditions had increased responses. Alternatively, as the recordings were made 
in slices between approximately Bregma -2.3 mm and Bregma -3.5 mm, the 
changes in the response variance could reflect area-dependent up- and down-
regulation of tanycyte sensitivity to Ala; however, the slices for Ca2+ imaging 
were chosen at random, and this hypothesis could not be tested post hoc. 
Further analysis revealed that fasting increased the proportion of tanycytes 
responding to Ala from 67.3% to 90.3% (Figure 4.1 D). No such changes were 
observed in the responses to Arg or Lys (Figure 4.1 E,F), suggesting that 
fasting induced an upregulation of tanycyte receptors sensitive to Ala (most 
likely mGluR4) or their downstream targets, but not Tas1r1/Tas1r3. 
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Figure 4.1. Fasting increases tanycyte sensitivity to L-alanine. (A, D) An overnight fast 
affected the variance of tanycyte responses to L-alanine (F test for variances) and increased the 
proportion of responsive cells (Fisher’s exact test). Fasting did not affect the responses to L-
lysine (B, E) or L-arginine (C, F). 
4.3.2. Oral L-alanine supplementation does not alter food intake after 
short-term fasting 
If the fasting-induced increase in tanycyte Ala sensitivity was a part of the 
regulatory mechanism for energy homeostasis, this would be reflected in food 
intake or energy expenditure. Thus, another experiment was performed to 
evaluate the potential role of Ala in re-feeding after an overnight fast. 
Rats were single housed and received ad libitum laboratory chow. At 1600 on 
the first day of the experiment, food was removed from half of the cages, and 50 
g of food was returned at 0800 the following morning. The rats were given 
drinking water supplemented with 50 mM Ala or 29 mM Pro. Food intake was 
measured after 4, 8 and 24 hours. Pro was chosen as a control amino acid due 
to its inability to activate tanycytes and no reported effects on food intake. 
Rats lost on average 11.93 ± 0.82% of their bodyweight during the 16-hour fast; 
control animals gained 7.65 ± 0.76% during the same period of time. The weight 
lost during fasting was partially compensated for in the 24 hours of refeeding, 
when fasted rats gained 20.97 ± 1.31% bodyweight, compared to 8.94 ± 0.52% 
in fed rats. Animals that received Ala and Pro in their drinking water gained a 
Ala Lys Arg
Chow Fasted
F 3
40
/F
38
0
0.0
0.2
0.4
0.6
A
Chow Fasted
F 3
40
/F
38
0
0.0
0.1
0.2
0.3
B C
D E F
F 3
40
/F
38
0
Chow Fasted
0.0
0.1
0.2
0.3
P = 0.024
%
 re
sp
on
si
ve
 c
el
ls
Chow Fasted
P < 0.0001
0
20
40
60
80
100
%
 re
sp
on
si
ve
 c
el
ls
Chow Fasted
0
20
40
60
80
100
%
 re
sp
on
si
ve
 c
el
ls
Chow Fasted
0
20
40
60
80
100
Ala Lys Arg
 94 
similar amount of weight in both fed and fasted groups. Total weight change in 
grams is shown in Figure 4.2 A and B. 
The amount of food eaten in the first 4 hours after reintroduction of food was 
unsurprisingly higher in fasted than fed rats, but there was no difference 
between the fasted groups supplemented with Ala and Pro (Figure 4.2 C). The 
results were similar after 8 hours as both time points were in the light phase 
(Figure 4.2 D). 
After 24 hours of refeeding, the fed animals had consumed as much food as the 
fasted groups. Ala supplementation still had no effect on food intake in fasted 
rats, while fed rats ate slightly (yet insignificantly) more with Ala than Pro 
(Figure 4.2 E). 
The amount of Ala or Pro consumed with drinking water could not be measured 
in this experiment, making it likely that the Ala dose was insufficient to have an 
effect on feeding. A direct method of Ala administration (e.g. intragastric or ICV) 
would yield more accurate results. 
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Figure 4.2. L-alanine supplementation in water does not affect food intake after feeding. 
(A) Fasted male rats lost on average 7 grams of weight during the 16 hour fast, while their fed 
littermates gained around 4.5 grams. (B) Ala and Pro supplemented in drinking water did not 
change the amount of weight gained during the 24 hours of refeeding. (C–E) Food intake of fed 
and fasted rats supplemented with Ala or Pro after 4, 8 and 24 hours of refeeding. Both fasted 
groups consumed more food at the start of the refeeding period (after 4 and 8 hours), which 
was in the light phase, but total food intake after 24 hours was not different between any of the 
groups. 
4.3.3. Amino acid-imbalanced diet changes tanycyte sensitivity to amino 
acids 
To investigate if amino acid content in the diet could influence tanycyte 
sensitivity, male Sprague-Dawley rats were given an Arg and Lys deficient diet, 
Ala deficient diet, or kept on normal chow for 22 hours before being culled for 
tissue collection. 
No differences in the response amplitudes to any of the three tested amino 
acids were observed between chow and either of the amino acid-imbalanced 
diets (Figure 4.3 A–C), although tanycytes from rats fed the A- diet exhibited 
higher responses to Arg than those treated with the RK- diet. However, due to 
the high variance in the control responses and the lack of difference between 
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the A- and Chow groups, these results should be interpreted with caution as the 
RK- and A- experiments were run several months apart, so the effects could be 
skewed by external factors such as seasonal changes, possible switch in 
animal suppliers, or subtle differences in the laboratory conditions during brain 
slice incubation and imaging. 
 
Figure 4.3. Diet deficient in L-arginine and L-lysine increases tanycyte sensitivity to L-
alanine. (A, D) 22 hours of the RK- or A- diet increased the proportion of tanycytes responding 
to L-alanine. (B, E) The RK- diet did not affect tanycyte sensitivity to L-lysine, while the A- diet 
slightly reduced the number of cells responding to L-lysine. (C, F) Neither diet affected the 
responses to L-arginine. There were differences between tanycyte responses to L-arginine on 
the RK- and A- diets (Student’s t test), potentially due to a switch in animal suppliers between 
the two sets of experiments. The chow dataset is comprised of animals from both suppliers.. 
Analysis of the proportion of responsive cells under different diets showed that 
similarly to fasting, the RK- diet affected tanycyte sensitivity to Ala, increasing 
the proportion of responsive cells from 85.9% on chow to 97.9% on RK- (Figure 
4.3 D). The proportions of cells responding to Arg and Lys under RK- did not 
change (Figure 4.3 E,F), potentially due to the control responses being so high 
in each tanycyte that the cells could not produce higher or more reliable 
responses when challenged with an imbalanced diet; a change in responses to 
Arg or Lys could still be expected in physiological conditions.  
The A- diet also increased the number of tanycytes sensitive to Ala, although to 
a lesser extent than essential amino acid deficiency – 90.7% of cells responded 
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on A- (Figure 4.3 D). Unexpectedly, the proportion of cells responding to Lys on 
the alanine-deficient diet was slightly decreased – from 97.8% on chow to 
94.0% on A-. 
4.3.4. Essential amino acid-imbalanced diet reduces preference for an L-
alanine enriched drink in wild type mice 
For an evaluation of behavioural changes potentially occurring due to increased 
tanycyte sensitivity to Ala, a variation of a 2-bottle preference test was 
performed. Wild type (C57BL/6J) or Tas1r1-null mice were housed in same-sex 
pairs and given RK- or normal chow for 24 hours in their home cages, then 
placed in modified cages with 30 g of the same diet, 2 serological pipettes with 
amino acid solutions (50 mM Ala in the Ala pipette, 25 mM Arg and 25 mM Lys 
in the Arg+Lys pipette) with blackcurrant flavouring connected to drinking tubes, 
and a drinking bottle with 50 ml water and blackcurrant flavouring, for the next 
24 hours (Figure 4.4 A). Bodyweight, food, Ala, and Arg+Lys intake were 
measured. 
Over the first 24 h in the home cage, female WT mice lost on average 0.106 ± 
0.077 g of bodyweight on the RK- diet, which was not different from 0.089 ± 
0.051 g lost by the chow fed WT mice. The weight loss persisted throughout the 
2-bottle test, but both groups started regaining weight 4 days after the end of 
the test. Male WT mice had slightly reduced growth in both groups after 24 h in 
the monitoring cages but gained weight normally as soon as 2 days after the 
experiment. Overall, there was no marked difference in the weight change 
between WT mice fed chow and RK- during the 2-bottle test (Figure 4.3 B). 
All WT mice ate less RK- than chow (Figure 4.3 C). This may have been due to 
lower palatability of the diet, in accordance with previous studies which have 
shown that an essential amino acid imbalanced diet causes avoidance (Leung 
et al. 1968). Stress related to the novelty of the diet should not have been a 
factor in this experiment as animals were provided with RK- 24 h prior to the 
test. Mean food intake did not differ between male and female mice for either 
diet (data not shown). 
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Figure 4.4. Diet deficient in L-arginine and L-lysine reduces preference for an L-alanine-
enriched drink. (A) Experimental timeline. (B) There were no differences in weight loss 
between mice fed normal chow and the Arg- and Lys-deficient diet. (C) All animals ate less RK- 
food than normal chow. (D) Mice drank a similar amount of water in both dietary conditions. (E) 
Total liquid intake (water, L-alanine-enriched drink, and L-arginine and L-lysine-enriched drink) 
was reduced on the RK- diet. (F) Mouse intake of L-alanine in the form of L-alanine-enriched 
drink was reduced on the RK- diet. (G) The animals showed no changes in preference for the L-
arginine and L-lysine-enriched drink on either diet. (H,I) Amino acid-enriched water intake in 
mice fed chow or RK- did not depend on the amount of food consumed. P values given for 
Student’s paired t test. 
Interestingly, while water consumption was nearly identical on both diets, total 
liquid intake (water, Ala and Arg+Lys solutions combined) was lower under the 
RK- diet (Figure 4.3 D,E). 
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As expected from the results of the tanycyte amino acid sensitivity experiment, 
the RK- diet reduced WT preference for Ala: average Ala intake went from 
14.22 ± 3.01 mg per pair of mice on chow to 7.55 ± 1.67 mg per pair on RK- 
(Figure 4.4 F). The proportion of Ala solution in total liquid consumed was also 
reduced when WT mice were fed RK- (data not shown). There were no 
differences in Arg+Lys intake (Figure 4.3 G). As previous results have shown 
that the RK- diet increases tanycyte sensitivity to Ala, this indicates that the 
changes in tanycyte Ala detection could potentially influence the choice of 
amino acid supplements, i.e. more active tanycyte signalling after the intake of 
the Ala solution would reduce consumption, while unaltered responses to Arg 
and Lys would produce the same behavioural outcome as in animals on the 
normal chow diet. 
No correlation was observed between the amount of food eaten during the 2-
bottle test and amino acid intake (Figure 4.3 H,I). The intake of both amino acid 
drinks did not vary between males and females on either dietary condition (data 
not shown). 
The design of the experiment did not eliminate the possibility that mice would 
consume enough Arg and Lys from the water to compensate for the lack of 
these amino acids in the diet, but the data show that Arg and Lys received from 
the water was on average 4.1 mg per animal per 24 h, while approximate daily 
intakes from standard chow (assuming normal consumption of 5 g/day) are 35 
mg Arg and 37.5 mg Lys. 
4.3.5. Tas1r1-null mice show reduced preference for L-alanine 
independently of essential amino acid intake 
When Tas1r1-null mice were used for the 2-bottle preference experiment, the 
results differed from WT. While their food intake was reduced to the same level 
as WT on RK- (despite supposed inability to taste differences in amino acid 
content; Figure 4.5 B), the Tas1r1-null animals also exhibited significant weight 
loss (Figure 4.5 C). As both WT and Tas1r1-null groups consumed similar 
amounts of food and liquids (Figure 4.5 D), the Tas1r1-null weight loss must be 
attributed to higher metabolic rate or increased activity. 
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Unlike WT, Tas1r1-null mice did not reduce their Ala intake when put on the 
RK- diet; however, their mean Ala consumption compared to WT was 7.9 and 
3.4 times lower in the Chow and RK- groups, respectively (Figure 4.5 E). Arg 
and Lys intake remained unaffected (Figure 4.5 F). Tas1r1-null animals 
compensated for the low Ala solution intake by increasing the amount of water 
they consumed (Figure 4.5 G). 
 
Figure 4.5. Tas1r1-null mice have reduced preference for L-alanine. (A) Experimental 
timeline. (B) When given a diet lacking L-arginine and L-lysine, Tas1r1-null mice consumed less 
food and (C) lost weight. (D) Neither loss of the Tas1r1 receptor subunit nor diet affected total 
liquid intake (consisting of water, alanine solution, and arginine and lysine solution). (E) Tas1r1-
null mice strongly reduced their alanine intake compared to wild type animals in both chow and 
essential amino acid-deprived groups. (F) Arginine and lysine intake was not affected by diet or 
genotype. (G) Tas1r1-null mice consumed more water to compensate for the reduced intake of 
the alanine solution. A, B Student’s paired t test; E, G Mann-Whitney U test. 
There were no differences between male and female Tas1r1-null mice (data not 
shown). Moreover, earlier results showed that Tas1r1-null animals have 
unaltered sensitivity to Ala compared to WT (see Figure 3.3) Therefore, 
tanycyte involvement in the mechanism responsible for Tas1r1-null Ala 
avoidance is unlikely; the behavioural response in potentially mediated by taste 
DC
E
Ar
g+
Ly
s 
in
ta
ke
 (m
g)
0
10
20
30
40
F G
B
Diet/
Control
AAs Home Control/
Diet
AAs Home
Day 1 Day 8A
0
5
10
15
20
To
ta
l l
iq
ui
d 
in
ta
ke
 (m
l)
Fo
od
 e
at
en
 (g
)
5
7
9
11
13
Chow RK- WT
Chow
KO
Chow
WT
RK-
KO
RK-
Chow RK-
-1.0
-0.5
0.0
0.5
1.0
W
ei
gh
t c
ha
ng
e 
(g
)
Al
a 
in
ta
ke
 (m
g)
0
10
20
30
40
0
2
4
6
8
10
W
at
er
 in
ta
ke
 (m
l)
WT
Chow
KO
Chow
WT
RK-
KO
RK-
WT
Chow
KO
Chow
WT
RK-
KO
RK-
WT
Chow
KO
Chow
WT
RK-
KO
RK-
P = 0.0004 P = 0.0032
P = 0.0001 P = 0.0299 P = 0.0014 P = 0.0171
 101 
signalling in the tongue or other amino acid detection mechanisms in the brain 
or gut. 
4.3.6. Amino acid-imbalanced diets only have minor effects on mouse 
metabolism in 24 hours 
To further test the effects of dietary amino acid intake on behaviour and energy 
homeostasis, CLAMS metabolic cages were used. Three types of parameters 
were chosen for analysis: feeding (intake – amount of food eaten in 3 hours; 
frequency – number of meals in 3 hours; duration – total time spent at the food 
hopper in 3 hours), metabolic (all averaged per hour; VCO2 – CO2 expenditure, 
representative of metabolism and activity; Fox – fat oxidation rate; CHOx – 
carbohydrate oxidation rate; RER – respiratory exchange ratio between CO2 
produced an O2 used; and heat production), and activity (number of movements 
per minute around the cage and rearing separately). 
NrCAM+/- mice were monitored in CLAMS for 48 hours at a time, with a change 
of diet occurring in the light cycle after the first 24 hours (Figure 4.6 A). In the 
first experiment, there was a difference in nutrient composition between the IMB 
diets and the HP chow (energy from fat/protein/carbohydrate (%) IMB: 9/16/75 
vs HP: 18/24/58) which affected mouse feeding and metabolism despite similar 
caloric content (Figure 4.6). Firstly, mice consumed HP chow less often than A- 
in the second light phase (the morning after the introduction of the diet; most of 
the initial light phase was required for habituation, whereas all animals were 
considered to experience similar stress levels from the onset of the dark phase, 
hence only the data from the subsequent light phase were used for light phase 
measurements; Figure 4.6 C). Secondly, the HP diet led to weight loss (Figure 
4.6 E) and changes compared to both A- and RK- in most of the metabolic 
parameters measured in this experiment: reduced CO2 expenditure (both dark 
and light phases compared to A-, but only light phase compared to RK-; Figure 
4.6 J,N), increased Fox, and reduced RER (Figure 4.6 K,M,O,Q). Light phase 
activity, including rearing, was increased on chow compared to RK- (Figure 4.6 
R,S). 
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Figure 4.6. Diet composition affects metabolism. (A) Experimental timeline. (B–D, F–H) The 
feeding and (J–Q) metabolic effects of different diets on male NrCAM+/- mice. Dark phase 
feeding duration (H) was the only measured parameter that differed between A- and RK- diets. 
The nutrient composition and fibre contents of the chow led to differences between chow and 
the two experimental diets in food intake and metabolism. (E) Mice lost weight when given 
chow, but gained weight after the introduction of the Ala enhanced diet. (I) Mice gained weight 
on the A- diet, but returned to previous weight when given food rich in Ala. (R,S) Daytime 
activity was increased in mice receiving chow. Activity during the night was unaffected. (T) 
There was slight but insignificant variation in VCO2 on A- and RK- in male mice during both light 
and dark phases. P values given for Student’s t test. 
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Together, the feeding and metabolic data reveal that high protein chow 
promotes fat oxidation and increased activity without increasing respiratory rate, 
while also slightly reducing feeding frequency during the rest period, 
supposedly due to prolonged satiety provided by the protein and fat in the diet. 
As the HP chow was composed of natural materials, while the IMB diets were 
synthetic, the differences in dietary fibre between the diets could also have 
contributed to the observed changes. Therefore, the experiment was repeated 
using an appropriate control diet, referred to here as C2. This time, female mice 
were kept in CLAMS with A-, RK- or C2 for 24 hours before switching to A+. 
While the HP chow was unsuitable as a control, comparisons could still be 
made between the results of the first CLAMS experiments on the amino acid-
deficient diets, RK- and A-. One observable difference between male mice 
deprived of Ala and essential amino acids was a reduction in the duration of 
feeding in the dark phase on RK- (Figure 4.6 H). Moreover, only the A- diet had 
a minor effect on bodyweight: male mice gained weight after 24 hours of low Ala 
diet but returned to their initial weight when given Ala-enhanced food (Figure 
4.6 I). No weight changes were observed in female mice in CLAMS. 
When analysed hourly, the metabolic data of male mice on A- and RK- showed 
a non-significant reduction in VCO2 on RK- in the dark phase, between 0200 
and 0500 hours (Figure 4.6 T). There was also an increase in activity on A- at 
0100 hours (data not shown). None of these differences were reflected in the 
phase averages, except for a higher activity level (not including rearing) on A- 
during the light phase (Figure 4.6 R). 
With the redesigned control diet, the only difference between female mice given 
A- and C2 was feeding duration in the dark: they spent less time at the food 
hopper when the food was low in Ala (Figure 4.7 G). Meal frequency and the 
amount of diet consumed were not affected. All feeding and metabolic 
parameters were similar between RK- and C2, and between RK- and A- (Figure 
4.7). These results confirmed the hypothesis that the extensive differences 
between HP chow and the imbalanced diets were not specific to the amino 
acids that were lacking in RK- and A-, but mostly occurred due to the 
composition of the chow diet. 
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Figure 4.7. Food amino acid content does not affect feeding or metabolism in female 
mice over 24 hours. (A) Experimental timeline. (B–G) Most food intake parameters remained 
similar on control, alanine-deficient, and arginine- and lysine-deficient diets, except for A- 
reducing feeding duration in the dark (Student’s t test). (H–O) Female mouse CO2 production, 
fat oxidation, carbohydrate oxidation and respiratory rate were not dependent on diet. 
4.3.7. An alanine-rich diet affects mouse metabolism 
After the initial 24 hours, all animals were switched to a high Ala diet to 
determine the potential effects of variation in Ala intake. 
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Figure 4.8. Increasing L-alanine content in the diet reduces light phase feeding in male 
and female mice. (A) Experimental timeline. (B–G) Male mice reduced their light phase feeding 
frequency when switched from alanine-deficient to alanine-enhanced diet, but other feeding-
related parameters remained unchanged in both light and dark. (H –J) Female mouse exhibited 
reduced light phase meal frequency and duration when given A+ after both RK- and C2, but 
only consumed less food after C2. (K–M) Female dark phase feeding was unaffected by the diet 
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change. (N) Increasing the amount of alanine in food reduced food intake in female mice 
previously deprived of alanine. (O, P) Switching from A- to A+ did not affect meal frequency or 
duration, but mice switched from C2 to A+ had shorter meals. (Q–S) High alanine did not affect 
dark phase feeding, although mice on C2 exhibited longer meal durations in the initial 24 hours. 
P values shown for Student’s paired t test. 
In the first CLAMS experiment, the switch from the low essential amino acid RK- 
diet to A+ did not have a high effect on male mouse feeding: there were no 
differences in food intake at any time of the day (Figure 4.8 B–G, left). Unlike in 
the 2-bottle experiment, the high Ala content of the A+ diet after exposure to 
RK- did not reduce food intake. The lack of effect of dietary Ala was potentially 
due to the diet no longer being imbalanced in Arg and Lys, which perhaps led to 
increased intake to compensate for the previous lack of essential amino acids. 
Conversely, switching the diet of Ala-deprived male mice from A- to A+ resulted 
in reduced feeding frequency on A+ in the light phase (Figure 4.8 C, right), 
suggesting a higher level of satiety associated with Ala intake.  
In females, increasing the amount of Ala in the diet two-fold by switching from 
C2 to A+ consistently reduced light phase feeding (Figure 4.8 H–J,P, right). The 
effects of the increase were not always the same as when switched from RK- 
(Figure 4.8 H,L) or A- (Figure 4.8 N,P,S). 
Female mice initially deprived of Arg and Lys were more sensitive than males to 
A+: light phase feeding frequency and duration were both reduced when 
switched from RK- to A+; however, these results were also mimicked by mice 
previously given C2, suggesting that the effect did not specifically require 
exposure to RK- (Figure 4.8 I,J). Unlike males, when switched from A- to A+, 
female mice consumed less A+ than A- in the light phase without reducing 
feeding frequency (Figure 4.8 N). 
Essential amino acid deprivation had minor effects on animal activity: male 
activity was increased by A+ compared to RK- in the light phase but slightly 
reduced in the dark phase (Figure 4.9 B,E, left), and female dark phase 
ambulatory activity was decreased under the same conditions (Figure 4.9 F). 
No changes in activity were observed in animals that initially received A- or C2 
(Figure 4.9). 
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Figure 4.9. Dietary alanine has a minor effect on activity. (A) Experimental timeline. (B, E) 
Male mice deprived of essential amino acids increased light phase activity and reduced dark 
phase activity when given an alanine-enhanced diet. (C–D) Increasing alanine content in the 
diet did not affect light phase activity in female mice. (F) Female mice deprived of arginine and 
lysine reduced their dark phase activity after receiving a high alanine diet. (G) No changes in 
activity were observed after giving alanine-enriched food to female mice that previously 
received an alanine-deficient or control diet. P values given for Student’s paired t test. 
The only metabolic change in male mice deprived of Arg and Lys after switching 
from RK- to A+ was an increase in VCO2 in the dark phase (Figure 4.10 F, left). 
In females, the switch from RK- to A+ had different effects from males – 
increased CHOx and heat production in the light (Figure 4.10 L,Q). These 
results also differed to some extent from the effects seen in animals that 
switched from C2 to A+: firstly, in the light phase, A+ only decreased VCO2 in 
mice previously fed C2 but not RK- (Figure 4.10 J); secondly, light phase Fox 
was increased and RER was reduced more consistently when switching from 
C2 rather than RK- to A+ (Figure 4.10 K,M), while light phase heat expenditure 
was increased only in mice previously fed RK- (Figure 4.10 Q). These 
differences suggest that essential amino acid deficiency can reduce the effects 
of high Ala intake. The dependence of the results on previous Arg and Lys 
intake also eliminates the possibility that the metabolic changes observed on A+ 
could be due to mouse habituation to the cages. 
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Figure 4.10. An alanine-rich diet affects metabolism. (A) Experimental timeline. (B–E) 
Switching from alanine-deficient to alanine-enriched diet consistently affected male mouse 
metabolism in the light phase. (F–I) An increase in dietary alanine increased male dark phase 
CO2 production but did not affect any other dark phase metabolic parameters. (J–M) Increasing 
alanine in the diet had stronger light phase effects on female mice previously fed the control diet 
than arginine- and lysine-deficient diet, with the exception of (Q) heat production, which was 
increased by A+ only after essential amino acid deprivation. (N–P) High alanine diet had no 
P = 0.010
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effects on female mice in the dark phase. (R–U) Female mice previously deprived of alanine 
were not affected by high alanine in the light phase. (V–Y) In the dark phase, alanine-rich food 
increased CO2 production in female mice independently of previous alanine intake, while 
reducing fat oxidation and increasing respiratory rate only in the control group. P values shown 
for Student’s paired t test. 
Switching the diet of male mice from A- to A+ also resulted in higher VCO2 in 
the dark phase (Figure 4.10 F, right), while lower VCO2 and RER, and higher 
Fox and CHOx were observed in the light phase (Figure 4.10 B–E, right). 
Interestingly, the same effects were observed in female mice switching from the 
C2 diet to A+ in the light phase in the RK- control group (Figure 4.10 J–M, 
right), but not in female mice switching from A- to A+ or their controls (Figure 
4.10 R–U). 
On the other hand, after having been deprived of Ala for 24 hours, female mice 
also exhibited higher VCO2 in the dark phase when switched to A+, and, in 
addition, showed a trend for lower Fox (P = 0.051 Student’s paired t test; Figure 
4.10 V,W, left). The control animals in this group demonstrated the same 
effects, with the addition of increased RER in the dark (Figure 4.10 V,W,Y, right) 
The inconsistency in the control results may have been caused by a yet 
unidentified flaw in the experimental procedure during the A+ experiment; it 
could also have occurred due to relatively short times that the animals spent on 
each diet, and adjusting the protocol to increase exposure to each diet could 
potentially generate a more reproducible outcome. Nevertheless, the similarities 
of the results of increasing Ala content in males and females suggest a general 
role for Ala in mouse metabolism. 
Taken together, the results of these experiments demonstrate that a diet high in 
Ala can influence feeding and metabolism by increasing VCO2 during the night, 
reducing food intake during the day and increasing fat and carbohydrate 
oxidation while reducing respiratory rate to compensate for that; however, the 
effectiveness of increased Ala consumption depends on prior intake of essential 
amino acids such as Arg and Lys. 
4.4. Discussion 
Amino acid detection in the hypothalamus has long been associated with 
decreased food intake (Panksepp and Booth 1971). The experiments described 
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in this chapter aimed to find potential links between the satiating effect of amino 
acids with subsequent metabolic adjustments and tanycyte amino acid 
signalling. At this stage, the results acquired in the feeding and metabolic 
studies cannot be argued to depend on tanycytes with any certainty, but are 
rather attempts to determine a phenotype that could later be assigned to 
changes in tanycyte signalling. 
The findings of all the diet-related experiments are summarised in Table 2. 
Briefly, modifying the diet or removing food from the cages induced changes in 
tanycyte sensitivity to Ala, food and amino acid supplement intake, bodyweight, 
activity and metabolism. Interestingly, a diet deficient in Arg and Lys had the 
same positive effects on the number of tanycytes responding to Ala as fasting; 
additionally, essential amino acid deficiency lowered food intake in both rats 
and mice, and reduced mouse consumption of Ala-enriched water. The RK- diet 
also had an unexpected impact on decreasing the metabolic effects of high Ala 
intake, otherwise observed in the light phase in mice previously fed a low-Ala or 
control diets: reduced CO2 production and respiratory rate and increased fat 
and carbohydrate oxidation. A low Ala diet, on the other hand, increased 
feeding time in female mice and induced weight gain in male mice. These 
results support the notion that amino acid content in the diet can influence the 
regulation of energy homeostasis in the short term. 
4.4.1. Tanycyte sensitivity to L-alanine is diet-dependent 
The hypothalamus regulates food intake by adjusting to the constant variations 
in the metabolic state of the organism. The results obtained in this study 
demonstrate that hypothalamic tanycytes can alter their signalling to adapt to 
food availability. An overnight fast or 22 hours on a diet deficient in two 
essential amino acids, Arg and Lys, was enough for rat tanycytes to increase 
their sensitivity to Ala, confirming that tanycyte receptor (or downstream target) 
expression is dependent on metabolic state. Based on these findings, at least a 
part of diet-induced hypothalamic plasticity could be attributed to tanycyte 
amino acid signalling.  
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If tanycytes act as a signal of satiety within the hypothalamus to reduce or 
terminate feeding, changes in tanycyte sensitivity to Ala could serve as an 
additional mechanism for the avoidance of essential amino acid imbalanced 
diets in rats (Gietzen et al. 1998). Increased signalling in response to amino 
acids abundant in food such as Ala would make the animal feel satiated before 
it has consumed the amount of food that would otherwise be needed to satisfy 
hunger.  
Reflecting this, in the 2-bottle preference test presented in this work, wild type 
mice consumed less food when given an essential amino acid deficient diet, as 
well as less water supplemented with Ala, while their preferences for plain water 
and water supplemented with the limiting amino acids were unaffected. One 
speculative interpretation of these results could be the occurrence of Ala-
specific satiety, reducing Ala intake while allowing the consumption of essential 
amino acids to remain normal. Interestingly, the Ala satiety seems to be specific 
to essential amino acid deprivation rather than fasting, as fasted rats did not 
alter their food intake during refeeding when supplemented with Ala. In Tas1r1-
null mice, which are less likely to be able to distinguish between different amino 
acids, the putative Ala-specific satiety is lost, possibly to prevent avoidance of 
protein-rich foods. 
So far, changes in hypothalamic gene expression in response to fasting for two 
parts of the tanycyte sweet taste signalling pathway have been described: 
reduced expression of Cx43 (Allard et al. 2014), and increased expression of 
P2Y1 (Seidel et al. 2006). Low blood glucose levels are also associated with the 
reorganization of tanycyte tight junctions, leading to greater blood-
hypothalamus barrier permeability and allowing blood-borne molecules such as 
ghrelin easier access to ARC neurons (Langlet et al. 2013). While both Cx43 
and P2Y1 also have some involvement in tanycyte amino acid sensing, as 
demonstrated in Chapter 2, the changes described above seem to be directly 
related to blood glucose levels, but not overall fasting. 
Obesity and high-fat diet, on the other hand, have been shown to reduce the 
expression of Tas1r3 and G protein subunit α14 in both the hypothalamus and 
brainstem (Chao et al. 2016). This shows that the taste signalling systems in the 
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areas of the brain regulating food intake are highly adaptive to changing 
metabolic states, and the results of the diet-related tanycyte sensitivity 
experiment include tanycyte amino acid sensing in this adaptation mechanism.  
4.4.2. Potential further tanycyte signalling adaptations to dietary changes 
In addition to changes in tanycyte sensitivity, under varying feeding conditions 
tanycyte signals could affect different neuronal populations. Experiments using 
optogenetic tanycyte stimulation have shown that in ad libitum fed mice, the 
activation of tanycytes expressing CaTCh with flashes of blue light activated 
nearby NPY and POMC neurons, but following fasting, the effect on POMC 
neurons was lost (Dr. M. Bolborea, personal communication, September 2017). 
This effect could be explained by a recent study on POMC neuron sensitivity, 
which has shown that fasting reduces the excitability of these cells, along with 
their glucose and leptin sensitivity, due to mitochondrial fission (Santoro et al. 
2017). This is also in line with the observation by Kittner and colleagues that P2 
receptor stimulation with purine analogues enhanced food intake in food 
deprived animals (Kittner et al. 2006). If tanycytes were involved in this 
mechanism, tanycyte purinergic signalling during fasting would only be able to 
activate NPY neurons, therefore having an orexigenic effect.  
Interestingly, in the aforementioned study, ad libitum fed animals exhibited 
increased food intake after specific activation of P2Y1 with adenosine 5′-O-(2-
thiodiphosphate), while non-specific ATP analogue 2-methylthioATP had no 
effect (Kittner et al. 2006). As P2Y1 is associated with tanycyte sweet taste 
signalling (Benford et al. 2017), the results of P2Y1 activation could be specific 
to the regulation of glucose intake, while a broader activation of P2 receptors 
could be involved in the control of total food consumption. 
4.4.3. Changes in tanycyte signalling could be linked to metabolism 
The two experiments using the CLAMS metabolic cages were performed to 
further develop the link between tanycyte amino acid sensing and mouse 
metabolism. Unfortunately, no short-term effects on food intake and metabolism 
were observed after 24 hour exposure to diets lacking L-alanine or L-arginine 
and L-lysine. However, switching the food to an L-alanine-enriched diet 
sufficiently reduced feeding and increased fat and carbohydrate oxidation in 
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both male and female mice. The effects of the high Ala diet were slightly less in 
the mice that had previously been starved of essential amino acids; this 
difference could be related to the previously observed changes in tanycyte Ala 
sensitivity under the Arg and Lys deficient diet. While it is difficult to confirm that 
the changes in mouse food intake and energy expenditure were dependent on 
tanycyte signalling, the ability of tanycytes to detect and distinguish a range of 
amino acids is a likely candidate for a mechanism that would sense subtle 
variations in dietary amino acid content.  
Mice heterozygous for the NrCAM gene were selected for a part of this study 
with hope that the experiment could be repeated on NrCAM-null mice in the 
future. NrCAM-null mice have been shown to have a reduced number of 
tanycytes, although the exact mechanism of tanycyte loss has not been 
explained. Early observations of the NrCAM-null phenotype have revealed that 
these mice exhibit reduced body weight from birth, which persists into their adult 
life (Dr. J. E. Lewis, personal communication, October 2017). If the lean 
phenotype was a direct result of the absence of tanycytes, this would contrast 
the hypothesis that tanycyte signalling is predominantly anorexigenic; however, 
a study using a different line of mice – Gnasxl-null (Gnasxl codes a variant of 
the signalling protein Gαs, termed XLαs) – with a similarly lean, hypermetabolic 
phenotype concluded that their mice lost tanycytes and astrocytes due to 
postnatal undernutrition, which may have led to further compensatory changes 
in the hypothalamic organisation (Holmes et al. 2016). Perhaps the reason why 
there is no direct evidence for tanycyte anorexigenic activity in tanycyte-free 
NrCAM-null mice could be similar. A more direct model of tanycyte deletion, 
preferably one that could be activated postnatally, is required to further explore 
the role that tanycyte signalling plays in the regulation of metabolism.  
A common flaw in research using different diets is an oversimplification of diet 
composition; for example, studies investigating the effects of HFD may use a 
well-defined, purified high-fat diet for the experimental group, while giving the 
control group standard laboratory rodent chow, not taking into account the 
potential effects of dietary fibre, which can lead to misinterpretations of the 
collected data (Dalby et al. 2017). The extent of a similar mistake can be seen 
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in the first CLAMS experiment, where the control chow differed from the 
synthetic purified IMB diets not only in amino acid content, but also in caloric 
density, proportions of energy provided by protein, fat and carbohydrate, 
amount of dietary fibre, smell and, most likely, taste. This oversight was avoided 
in the second experiment by using a 50:50 mix of ground A+ and A- diets to 
achieve a control diet with a balanced level of Ala. In the Ca2+ imaging 
experiments, the differences in the nutrient and fibre composition of chow and 
IMB diets were not relevant as only RK- had an effect on tanycyte sensitivity to 
Ala, while the responses on the nearly identical A- did not differ from those on 
chow. 
This set of experiments is the first link between tanycyte amino acid sensing 
and subsequent behavioural adaptations. While the connection between 
tanycyte Ala sensitivity and mouse dietary choices is at this point highly 
speculative, the subtle changes observed in this study further reinforce the 
need for more detailed research on the role of hypothalamic tanycytes in the 
control of energy homeostasis, not only at the physiological, but also at the 
behavioural level.  
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5. Discussion 
Tanycyte chemosensitivity has received increasing attention in recent years, 
and some tanycyte functions involving the detection of hormones and nutrients 
have been well established. Research into tanycyte nutrient sensing began with 
the discovery of GLUT2 and glucokinase in tanycytes, which led to an 
assumption that tanycytes follow the same glucosensing mechanism as 
pancreatic β cells (García et al. 2003). However, further research revealed that 
local changes in glucose concentration induce Ca2+ and ATP release from 
tanycytes, which was inconsistent with the glucokinase-dependent mechanism 
(Frayling et al. 2011, Orellana et al. 2012). The finding that tanycytes also 
respond to non-metabolisable glucose analogues further strengthened this point 
of view, while also demonstrating that the sweet taste receptor Tas1r2/Tas1r3 
was responsible for the Ca2+ and ATP release (Benford et al. 2017). 
Glucose represents one of the three basic types of macronutrients, and 
therefore the question arises whether these cells also possess the ability to 
detect fatty acids and amino acids. While there is no consensus on the 
existence of a taste receptor for fatty acids, Tas1r1/Tas1r3 is known as a 
broadly-tuned amino acid receptor (Nelson et al. 2002). The similarities 
between the sweet taste receptor and Tas1r1/Tas1r3 prompted the unexpected 
discovery described in this thesis that tanycytes are sensitive to amino acids. 
The significance of tanycyte amino acid sensing might exceed that of 
glucosensing, as amino acids are a central signal of satiety, while glucose has 
not been demonstrated to have such properties (Panksepp and Booth 1971). 
Hypothalamic tanycytes sense L-amino acids in third ventricular CSF using 
Tas1r1/Tas1r3, mGluR4 and potentially another amino acid receptor yet to be 
identified. Both of the receptors known so far are GPCRs, and the response 
pathway indeed follows that of other GPCRs: first, Ca2+ is released from the 
internal stores of the cell; then an ATP signal is sent between the cells via 
pannexin 1, connexin 43 or CalHM1, as well as down the tanycyte processes 
and into the hypothalamic nuclei responsible for food intake and energy 
expenditure. Gustducin, PLC-β2, and IP3, responsible for the opening of Ca2+ 
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channels for ATP release, have been found in tanycytes by different labs 
(Orellana et al. 2012, Chao et al. 2016). The same mechanism is known to be 
used for L-amino acid detection in the tongue. 
The data collected during this project revealed several unexpected results. 
Firstly, there are at least two receptors for L-amino acids. The initial explanation 
for this was that Tas1r1/Tas1r3 was activated by essential amino acids (such as 
Arg, Lys), and mGluR4 detected non-essential amino acids (e.g. Ala, Ser), but 
further experiments with the with the mGluR4 antagonist MAP4 showed some 
agonist overlap: Lys is an agonist for both Tas1r1/Tas1r3 and mGluR4 in mice. 
The conclusion is therefore that multiple amino acid detection mechanisms exist 
in tanycytes due to the physiological importance of amino acids and the signals 
they elicit: the loss of one mechanism would not cause any significant disruption 
to the energy homeostasis of the organism as it could be compensated for by 
the others, as seen in the responses to Arg in male Tas1r1-null mice (Fig. 3.3 
D). Furthermore, the simultaneous activation of several amino acid receptors 
could in theory help evaluate the quality of the food that has been ingested: 
high protein content and a wide range of amino acids represents rich, nutrient 
dense food, which normally leads to a long-lasting satiating effect. 
Secondly, there was sexual dimorphism in mouse responses to some amino 
acids. Notably, male wild type (C57BL/6J) mice were less sensitive to Arg than 
females of the same strain. The difference was reversed in Tas1r1-null mice, 
with the responses in females strongly reduced, and males exhibiting an 
increase. This suggests that male but not female mice have a compensatory 
mechanism for the loss of the Tas1r1 receptor subunit. 
Thirdly, tanycyte responses to Ala, which is not normally considered to be 
involved in the control of feeding but is known to rapidly increase in 
concentration in the hypothalamus after feeding (Choi et al. 1999), were 
dependent on the metabolic state of the animals. Fasting and essential amino 
acid deprivation increased tanycyte sensitivity to Ala, while the alanine 
enhanced diet reduced feeding frequency in the light phase in the CLAMS 
experiments and increased CO2 expenditure during the dark phase. These 
findings support the idea that tanycytes alter their signalling to produce an 
 118 
appropriate response to varying dietary conditions, although definitive evidence 
linking changes in behaviour to tanycytes is currently missing. The changes in 
tanycyte signalling were observed after less than 24 hours of access to any 
diet, or an overnight fast, meaning that the adaptation to dietary challenges is 
rapid; a long-term study would be required to determine whether chronic intake 
of different levels of dietary alanine or other amino acids would alter, for 
example, tanycyte proliferation to further adjust the hypothalamic architecture to 
the specific conditions. 
5.1. Similarities between tanycytes and taste receptor cells 
The recent discoveries of a range of taste receptors in hypothalamic tanycytes 
suggest that tanycytes and taste receptor cells of the tongue might be 
somewhat alike. The similarities between tanycyte and taste receptor cell amino 
acid sensing extend beyond the use of the same umami taste receptors. Firstly, 
in type II taste receptor cells, ATP is used as one of the transmitters to send 
signals about the taste qualities of a substance to nearby sensory nerve fibres, 
which use P2X2 and P2X3 receptors to detect it (Finger et al. 2005). ATP also 
provides positive autocrine feedback onto taste receptor cells by activating P2Y 
receptors to enhance ATP release (Yasumatsu et al. 2012). The current study 
has provided sound evidence that tanycytes respond to amino acids with 
increased intracellular Ca2+ and the release of ATP, the spread of which 
requires several P2X and P2Y receptors. Direct measurements of ATP release 
from tanycytes using microelectrode biosensors have revealed not only that 
tanycytes respond to amino acids by producing a wave of ATP, but also that the 
ATP signal passes into the brain parenchyma. Hypothalamic neurons are 
known to express both P2X and P2Y receptors that could detect tanycyte 
signals (Xiang et al. 1998, Wollmann et al. 2005, Seidel et al. 2006, Colldén et 
al. 2010). Therefore, there is a potential for tanycyte-to-neuron signalling, which 
would allow tanycytes to inform neurons in the arcuate nucleus and possibly the 
rest of the hypothalamus about amino acid availability in the third ventricle. 
Moreover, with responses from different umami taste receptors, the signal could 
code specific information about which individual amino acids are available, as 
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the signalling pathways vary depending on which amino acid is applied to 
tanycytes. 
ATP is released from tanycytes via Panx1 and CalHM1 channels, both of which 
are involved in umami taste signalling in the mouse tongue (Huang et al. 2007, 
Taruno et al. 2013). There has been contradictory evidence for the two 
channels in taste receptor cells, as different groups have shown strong effects 
of disabling either Panx1 or CalHM1 on taste transduction (Dando and Roper 
2009, Taruno et al. 2013, Sclafani et al. 2014). The results of this study 
demonstrate that tanycytes use both Panx1 and CalHM1, and that the two 
channels seem to be downstream of different umami taste receptors: activation 
of Tas1r1/Tas1r3 with Arg opens Panx1, while activation of mGluR4 with Ala 
induces ATP release through CalHM1. 
It is not yet fully known how taste receptor cells that are sensitive to different 
taste modalities but innervated by the same taste nerves keep their signals 
separate. The contrast between tanycyte sweet taste sensing involving Panx1 
and targeting P2Y1 (Benford et al. 2017) and umami taste signalling via Panx1 
and CalHM1 targeting multiple P2 receptors is potentially how tanycytes 
distinguish the information about glucose and amino acid availability. While the 
difference between sweet and umami taste signalling in tanycytes was 
unexpected, the possibility of taste-specific signals suggests that tanycytes are 
more than messengers for food intake and can provide specific information 
about glucose and various amino acid availability to the hypothalamus. 
Considering the parallel between tanycytes and taste receptor cells, it is likely 
that the level of activation of different P2 receptors on taste nerves is also the 
manner in which taste receptor cells keep their signals separate. 
A further shared property of tanycytes and taste receptor cells is that both cell 
types respond to brain-derived neurotrophic factor (BDNF) and proliferate in 
adult mice (Givalois et al. 2004, Meng et al. 2015). BDNF is essential for 
maintaining taste bud innervation and taste cell renewal (Meng et al. 2015).  
The detection of circulating nutrients by tanycytes therefore shows remarkable 
similarity to taste sensing in the taste receptor cells of the tongue, both in the 
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range of receptors involved and the subsequent downstream signalling 
including channel-mediated release of ATP. In light of these findings, tanycytes 
should be regarded as general nutrient sensors in the hypothalamus. 
5.2. Tanycytes as amino acid sensors in the brain 
Amino acids are a key nutrient, and their constant monitoring in both the brain 
and periphery is crucial for survival. Moreover, protein is known for its satiating 
effects (Panksepp and Booth 1971), suggesting that amino acid detection in the 
areas of the brain regulating food intake and energy expenditure, namely the 
hypothalamus and the brainstem, is an integral part of the regulation of energy 
homeostasis. 
The discovery that tanycytes can detect amino acids in the third ventricular CSF 
via at least two receptors is an important advance in understanding the 
underlying mechanism of energy homeostasis as it reveals that, firstly, 
tanycytes are likely a part of the hypothalamic anorexigenic system; and 
secondly, that they might act together with the neural networks in the 
hypothalamus to regulate food intake and energy expenditure. The 
communication could occur via the wave of ATP that is released from tanycyte 
cell bodies and travels down their processes into ARC, as ARC neurons 
express P2 receptors (Kittner et al. 2006, Xu et al. 2016). The ATP released 
from tanycytes could activate the anorexigenic POMC neurons directly, or the 
orexigenic NPY neurons via the inhibitory mTOR pathway as tanycytes have 
been shown to have a close anatomical association with NPY neurons 
(Coppola et al. 2007); mTOR activation would reduce NPY secretion and 
suppress appetite this way. 
It is plausible that tanycytes are capable of signalling to both POMC and NPY 
populations, but the reception of the signals in these neurons is modulated by 
the metabolic state, giving different meanings to the tanycyte signals depending 
on the context. For example, in a starved state even a small increase in CSF 
alanine would allow robust ATP release from tanycytes that would activate NPY 
neurons (but not POMC as their sensitivity is reduced by fasting; see Santoro et 
al., 2017) to promote further feeding. The same tanycyte alanine signal in low 
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essential amino acid conditions would robustly activate POMC neurons, which 
would in turn prevent overconsumption of a diet that is not beneficial for the 
animal. This dual signalling would fit the results from two experiments described 
in this study: in the first one, fasted (therefore the POMC pathway would be 
blocked, although tanycyte alanine sensitivity is increased) rats given extra 
alanine did not reduce food intake during refeeding; in the second one, mice 
deprived of arginine and lysine (POMC active, tanycyte alanine sensitivity 
increased) consumed less food and avoided alanine. 
5.3. A new role for L-alanine in rodent regulation of energy 
homeostasis 
L-alanine is a good indicator of dietary protein intake as it is abundant in most 
protein rich foods and its concentration increases rapidly after a meal in both 
blood plasma and the hypothalamus (Choi et al. 1999, Choi et al. 2000, Choi et 
al. 2001). The results of the food intake and metabolism experiments described 
in this thesis point towards a potential role for L-alanine detection in the control 
of energy metabolism. 
Although the most direct experiment on the effects of L-alanine on food intake, 
where rats were supplemented with Ala after a period of fasting and their food 
consumption was monitored, showed no involvement of Ala in refeeding or 
weight gain, the other parts of the study provided several instances when the 
importance of Ala could be established. Firstly, both fasting and essential amino 
acid starvation increased tanycyte sensitivity to Ala; secondly, mice starved of 
essential amino acids reduced their Ala intake; and lastly, a diet enhanced in 
Ala reduced light phase feeding and increased metabolic rate, but mice that had 
been starved of essential amino acids exhibited these effects to a lesser extent. 
Increased tanycyte sensitivity to Ala could have mediated the latter two effects, 
or, otherwise, all the observed effects may have been influenced by the same 
factor. For example, a global upregulation of mGluR4 would affect both tanycyte 
responses to Ala and oral Ala intake due to perceived stronger taste. Either 
way, combined with the fast rate of post-meal changes in blood and brain Ala 
levels, these results clearly demonstrate that Ala is an important dietary signal 
in rodents. 
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The strong Ala-associated satiety signal is not necessarily a positive one; the 
reduction in Ala intake observed in the above described experiments, as well as 
Tas1r1-null avoidance of Ala-enriched water seen in the second 2-bottle 
preference test, suggest an aversive effect. Indeed, in both rodents and 
humans, extensive satiety eventually leads to leptin resistance (Frederich et al. 
1995). Moreover, leptin receptor and its downstream signalling pathway share a 
lot of similarities with detection mechanisms for some inflammatory markers 
(Anesten et al. 2017). Satiety also reduces motivation and inhibits the reward 
pathway (Hommel et al. 2006), which is not beneficial for animals. While satiety 
induced by high Ala sensitivity most likely does not involve increased leptin 
secretion, it is likely that rodents could associate feeling excessively satiated 
with the negative effects of leptin, and therefore would learn to avoid Ala. 
Although humans and rodents have different dietary needs, feeding patterns 
and amino acid receptor sensitivity profiles, their neuroendocrine systems 
responsible for energy homeostasis are regarded as remarkably similar. 
Interestingly, one human study has shown that L-alanine supplementation 
reduced subsequent food intake in healthy men (Rogers and Blundell 1994). 
These findings have unfortunately not received much attention and therefore 
were never repeated, so the exact role of L-alanine in human energy 
homeostasis is yet to be revealed. 
5.4. Potential role for amino acid sensing in tanycyte neurogenesis 
Hypothalamic tanycytes form one of the three currently known neurogenic 
niches in the adult rodent brain (Lee et al. 2012). Changes in diet have been 
repeatedly reported to influence hypothalamic neurogenesis (Kokoeva et al. 
2005, Li et al. 2014). The newly produced neurons migrate from the wall of 3V 
into the arcuate nucleus where they are integrated in the POMC/CART and 
NPY/AgRP circuits (Pierce and Xu 2010).  
Neural stem cell proliferation can be induced by P2Y receptor signalling (Lin et 
al. 2007). The results acquired in the current project and a previous study in our 
laboratory show that P2Y1 is one of the receptors in tanycytes that is activated 
by ATP release following glucose and amino acid application. Therefore, it 
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could be speculated that chronic tanycyte activation with amino acids or 
glucose over a long time could lead to a higher probability of cell proliferation. 
Receiving a high-fat diet for an extended period of time leads to an increase in 
POMC neuron generation in the male mouse hypothalamus, which may be 
associated with the G-protein-coupled receptor 40 (Nascimento et al. 2016). In 
female mice, the effects of high-fat and low-protein diets on neurogenesis are 
region-specific: tanycyte proliferation is reduced in the arcuate nucleus, while 
the number of new cells is increased in the median eminence (Lee et al. 2014). 
It is not yet clear how a low-protein diet could affect tanycyte proliferation in 
female mice only. However, considering the data presented in this thesis, it 
could be speculated that tanycyte amino acid sensing via umami taste receptors 
could be involved in the maintenance of normal levels of neurogenesis in the 
hypothalamus, and that a reduction in protein content in the diet would alter the 
number of newly generated neurons in order to adapt to such changes.  
Direct tanycyte-to-neuron signalling about amino acid availability together with 
amino acid and ATP-induced tanycyte proliferation into arcuate neurons could 
represent a short-term and a long-term role for tanycytes in the control of 
energy homeostasis.  
5.5. Future work 
The research described here has provided the first details of tanycyte amino 
acid signalling to the metabolic circuits of the hypothalamus. Nevertheless, 
further studies will be needed in order to elaborate the full tanycyte amino acid 
sensing pathway and the impact of tanycyte signalling on food intake and 
energy expenditure. 
First of all, dietary mixtures of L-amino acids at physiological post-meal 
concentrations should be tested on tanycytes to determine whether tanycyte 
signalling occurs in normal conditions, or if the mechanism is only in place for 
situations where amino acid levels in the third ventricle exceed regular levels, 
e.g. inflammation or increased hypothalamic permeability due to high ghrelin. 
The dietary amino acid mixture would be a useful tool to investigate general 
tanycyte signalling, as some amino acids in the solution would taste sweet or 
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bitter and would therefore activate a wider range of receptors than the umami-
tasting amino acids used so far. 
To date, tanycyte responses to amino acids have been tested in chow-fed, 
fasted and L-arginine and L-lysine-deprived animals. It would be interesting to 
see how amino acid detection is affected by high-protein and high-fat diets, as 
well as check for changes in tanycyte signalling in diet-induced and genetic 
obesity, and a rodent model of anorexia nervosa. Foetal metabolic 
programming is another currently popular topic, so investigating the involvement 
of tanycyte amino acid sensing in this complex process would be a worthwhile 
project. 
In vivo Ca2+ imaging is a cutting-edge technique that has proved to be valuable 
in tanycyte signalling research. Initial experiments in our laboratory have shown 
an increase in tanycyte signalling in freely behaving animals around 20 minutes 
after ingestion of a high-protein, high-sucrose chow pellet (T. Sotelo Hitschfeld, 
personal communication, August 2017). More specific tanycyte signals can be 
obtained by using diets that differ in their amino acid contents, as well as 
enriching drinking water with amino acids or other nutrients. 
To test if the effects of knocking out the gene coding the Tas1r1 subunit of the 
umami taste receptor Tas1r1/Tas1r3 are tanycyte-specific, a genetic strategy 
will have to be developed to rescue Tas1r1 expression exclusively in tanycytes. 
These mice will then be used to repeat all the experiments that previously 
included the Tas1r1-null animals, and the results will be compared to both full 
knock-out and wild type mice. If the responses in the newly generated mice are 
similar to wild type, this will suggest that tanycytes are directly responsible for 
the differences observed earlier; however, if the mice expressing Tas1r1 in 
tanycytes exhibit results closer to the Tas1r1-null mice, it will be clear that 
tanycytes only play a partial role in central amino acid detection. 
In terms of the metabolic studies, while the results presented here are showing 
a hint of change in food intake, activity and metabolic rate, longer exposure to 
the amino acid modified diets could yield more reliable results. A study on 
chronic intake of the L-alanine-deficient and L-alanine-enriched diets has been 
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designed and is currently ongoing. The study involves the mice consuming 
either L-alanine-deficient or control diet for a week, then switching to the L-
alanine-enriched food for another week, as they are monitored in the metabolic 
cages at the start and end of each dietary trial. This study will hopefully provide 
more insight into the role of L-alanine in the regulation of mouse metabolism. 
The rat refeeding experiment that aimed to determine the effects of L-alanine 
supplementation on hunger could be repeated using an alanine-enriched diet 
instead of alanine-supplemented water to ensure even consumption of L-
alanine between experimental groups. 
An exciting but presently unlikely study would involve a culture of human 
tanycytes. The possible discovery of human tanycyte sensitivity to nutrients 
would provide the essential link to make the results obtained from rodents in 
this project translatable and further increase the importance of tanycyte 
research in the context of food intake and metabolism.  
  
 126 
6. Conclusions 
This dissertation provides novel insight into the role of hypothalamic tanycytes 
in the regulation of energy homeostasis, exploring in detail tanycyte sensitivity 
to dietary amino acids via different receptors under a range of conditions. More 
precisely, the results of the experiments described here have shown that 
tanycytes respond to a range of non-aromatic L-amino acids in a Ca2+ and ATP 
dependent manner, and Tas1r1/Tas1r3 and mGluR4 are two of the receptors 
involved in the responses. Altering the animal diets has also revealed that 
tanycyte sensitivity to L-alanine is dependent on the metabolic status of the 
subject. And finally, behavioural experiments have drawn a link between 
tanycyte amino acid sensing, metabolism and behaviour.  
The findings that emerged from this work form a new piece of knowledge in the 
complicated subject of hypothalamic control of energy homeostasis. A more 
detailed understanding of how food intake and energy expenditure are 
regulated in the brain may lead to the development of new strategies for 
overcoming the obesity epidemic and other metabolic disorders.  
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Appendix 
Chapter 2 data 
Figure Treatment Trial Med Q1 Q3 Slices Animals 
2.6 C Amino acids 5 mM Arg 0.298 0.219 0.415 6   
    5 mM Lys 0.310 0.193 0.448 6   
    5 mM Ser 0.059 0.045 0.194 4   
    10 mM Ser 0.186 0.089 0.219 5   
    5 mM Ala 0.018 0.015 0.048 4   
    10 mM Ala 0.265 0.103 0.489 12   
    5 mM Pro 0.014 0.001 0.089 3   
    10 mM Pro 0.070 0.037 0.099 10   
2.7 B TTX Arg 0.379 0.262 0.512 7 2 
    Drug + Arg 0.251 0.131 0.414     
    Wash + Arg 0.168 0.144 0.288     
2.8 B MRS2500 Arg 0.456 0.391 0.491 7 2 
    Drug + Arg 0.346 0.280 0.414     
    Wash + Arg 0.286 0.189 0.457     
C PPADS Arg 0.222 0.180 0.442 4 3 
    Drug + Arg 0.139 0.097 0.412     
    Wash + Arg 0.137 0.125 0.153     
  Suramin Arg 0.309 0.138 0.388 6 2 
    Drug + Arg 0.177 0.112 0.290     
    Wash + Arg 0.241 0.165 0.420     
  BBG Arg 0.501 0.339 0.613 5 3 
    Drug + Arg 0.404 0.245 0.488     
    Wash + Arg 0.249 0.164 0.403     
F PPADS/MRS Arg 0.237 0.200 0.324 4 3 
    Drug + Arg 0.104 0.064 0.140     
    Wash + Arg 0.180 0.149 0.291     
  Suramin/MRS Arg 0.320 0.235 0.404 5 3 
    Drug + Arg 0.123 0.095 0.168     
    Wash + Arg 0.177 0.142 0.291     
  BBG/MRS Arg 0.434 0.408 0.526 7 4 
    Drug + Arg 0.217 0.202 0.347     
    Wash + Arg 0.258 0.244 0.294     
2.11 A Gap26 Arg 0.399 0.295 0.427 10 3 
    Gap26 + Arg 0.234 0.095 0.421     
  10panx Arg 0.233 0.220 0.406 11 4 
    
10panx + 
Arg 0.175 0.070 0.271     
  Control Arg 0.289 0.226 0.467 13 7 
    After 30 min 0.319 0.224 0.372     
C RuR Arg 0.371 0.246 0.536 5   
    Drug + Arg 0.313 0.184 0.385     
    Wash + Arg 0.181 0.123 0.242     
D RuR Ala ATP Ala 5.357 4.659 10.830 5   
    Drug + Ala 2.958 2.463 5.543     
    Wash + Ala 3.110 2.818 6.720     
2.11 E RuR Ala Ala 0.247 0.203 0.490 5   
    Drug + Ala 0.156 0.045 0.187     
    Wash + Ala 0.225 0.095 0.325     
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Chapter 3 data 
Figure Treatment Trial Med Q1 Q3 Slices Animals 
3.1 C IMP Arg 0.097 0.048 0.111 14 4 
    Drug + Arg 0.110 0.094 0.201     
    Wash + Arg 0.074 0.04 0.158     
E IMP Lys 0.044 0.033 0.062 5 3 
    Drug + Lys 0.056 0.043 0.099     
    Ala 0.053 0.043 0.114 5 2 
    Drug + Ala 0.063 0.049 0.109     
    Ser 0.078 0.029 0.082 5 1 
    Drug + Ser 0.038 0.031 0.063     
3.3 A Tas1r1-null WT Ala 0.045 0.023 0.054   23 
    KO Ala 0.043 0.032 0.073   20 
    WT Lys 0.111 0.073 0.153   24 
    KO Lys 0.067 0.044 0.116   23 
    WT Arg 0.153 0.081 0.205   23 
    KO Lys 0.140 0.062 0.224   21 
C Female KO WT Ala 0.051 0.023 0.082   9 
    KO Ala 0.038 0.036 0.054   7 
    WT Lys 0.108 0.053 0.131   8 
    KO Lys 0.050 0.030 0.067   11 
    WT Arg 0.229 0.180 0.307   8 
    KO Arg 0.054 0.047 0.127   8 
D Male KO WT Ala 0.045 0.023 0.054   15 
    KO Ala 0.048 0.027 0.078   13 
    WT Lys 0.114 0.080 0.179   16 
    KO Lys 0.088 0.051 0.123   12 
    WT Arg 0.107 0.064 0.172   15 
    KO Arg 0.190 0.125 0.253   13 
3.4 A 4-CPG Ala 0.052 0.044 0.082 7 4 
    Drug + Ala 0.021 0.011 0.030     
    Wash + Ala 0.019 0.010 0.062     
    Lys 0.122 0.073 0.264 5 3 
    Drug + Lys 0.074 0.058 0.142     
    Wash + Lys 0.061 0.050 0.127     
    Arg 0.125 0.089 0.182 5 4 
    Drug + Arg 0.062 0.032 0.215     
    Wash + Arg 0.056 0.051 0.127     
D MAP4 Ala 0.041 0.023 0.067 9 6 
    Drug + Ala 0.015 0.01 0.025     
    Wash + Ala 0.025 0.016 0.036     
    Lys 0.157 0.108 0.236 8 7 
    Drug + Lys 0.081 0.051 0.124     
    Wash + Lys 0.105 0.079 0.147     
    Arg 0.162 0.118 0.261 6 5 
    Drug + Arg 0.091 0.074 0.151     
    Wash + Arg 0.072 0.059 0.111     
E MAP4 + KO Ala 0.042 0.029 0.072 6 6 
    Drug + Ala 0.017 0.008 0.019     
    Wash + Ala 0.018 0.012 0.032     
    Lys 0.081 0.057 0.126 6 6 
    Drug + Lys 0.069 0.041 0.084     
    Wash + Lys 0.060 0.043 0.101     
    Arg 0.179 0.109 0.244 6 6 
    Drug + Arg 0.142 0.073 0.178     
    Wash + Arg 0.146 0.052 0.164     
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Chapter 4 data 
Figure Treatment Trial Mean SEM N 
4.1 A Fasting Chow Ala 0.073 0.007 6 
    Fasted Ala 0.102 0.018 8 
B Fasting Chow Lys 0.160 0.126 6 
    Fasted Lys 0.036 0.028 8 
C Fasting Chow Arg 0.307 0.049 6 
    Fasted Arg 0.268 0.063 8 
D Fasting (%) Chow Ala 67.31 
 
566 
    Fasted Ala 90.33 
 
455 
E Fasting (%) Chow Lys 85.91 
 
369 
    Fasted Lys 87.10 
 
465 
F Fasting (%) Chow Arg 97.35 
 
378 
    Fasted Arg 96.40 
 
445 
4.2 A Fasting weight Fed 4.458 0.554 12 
    Fasted -7.008 0.588 12 
B Refeeding weight Fed + Pro 5.483 0.526 6 
    Fed + Ala 5.400 0.402 6 
    Fasted + Pro 10.880 1.214 6 
    Fasted + Ala 10.750 1.272 6 
C Food intake 4h Fed + Pro 1.15 0.35 6 
    Fed + Ala 0.98 0.26 6 
    Fasted + Pro 4.08 0.32 6 
    Fasted + Ala 4.25 0.50 6 
D Food intake 8h Fed + Pro 1.85 0.39 6 
    Fed + Ala 2.10 0.25 6 
    Fasted + Pro 5.82 0.23 6 
    Fasted + Ala 5.65 0.72 6 
E Food intake 24 h Fed + Pro 14.20 2.24 6 
    Fed + Ala 17.60 2.75 6 
    Fasted + Pro 15.40 1.24 6 
    Fasted + Ala 15.10 1.70 6 
4.3 A RK-/A- diet Chow Ala 0.088 0.020 8 
    RK- Ala 0.110 0.012 8 
    A- Ala 0.101 0.015 8 
B RK-/A- diet Chow Lys 0.180 0.016 8 
    RK- Lys 0.147 0.018 8 
    A- Lys 0.161 0.020 8 
C RK-/A- diet Chow Arg 0.229 0.034 8 
    RK- Arg 0.211 0.026 8 
    A- Arg 0.289 0.020 8 
D RK-/A- diet (%) Chow Ala 85.86 
 
601 
    RK- Ala 97.91 
 
575 
    A- Ala 90.69 
 
612 
E RK-/A- diet (%) Chow Lys 97.84 
 
556 
    RK- Lys 97.66 
 
555 
    A- Lys 93.99 
 
632 
F RK-/A- diet (%) Chow Arg 99.15 
 
585 
    RK- Arg 99.64 
 
561 
    A- Arg 98.80 
 
585 
4.4 B RK- + AA solutions Chow -0.047 0.068 36 
  bodyweight RK- -0.147 0.089 36 
C RK- + AA solutions Chow 8.58 0.221 18* 
  food intake RK- 6.87 0.152 18* 
D RK- + AA solutions Chow 3.090 0.438 18* 
  water consumption RK- 3.240 0.468 18* 
E RK- + AA solutions Chow 7.444 0.601 18* 
  total liquid intake RK- 5.606 0.354 18* 
F RK- + AA solutions Chow 14.220 3.008 18* 
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  Ala intake RK- 7.547 1.669 18* 
G RK- + AA solutions Chow 8.604 1.916 18* 
  Arg+Lys intake RK- 8.189 2.016 18* 
4.5 B KO RK- + AA solutions Chow 9.50 0.472 12* 
  food intake RK- 7.10 0.258 12* 
C KO RK- + AA solutions Chow 0.088 0.072 12* 
  bodyweight RK- -0.308 0.071 12* 
D KO RK- + AA solutions WT Chow 7.444 0.601 18* 
  total liquid intake KO Chow 7.283 0.568 12* 
    WT RK- 5.606 0.354 18* 
    KO RK- 6.617 0.720 12* 
E KO RK- + AA solutions WT Chow 14.220 3.008 18* 
  Ala intake KO Chow 1.847 0.605 12* 
    WT RK- 7.547 1.669 18* 
    KO RK- 2.210 0.789 12* 
F KO RK- + AA solutions WT Chow 8.604 1.916 18* 
  Arg+Lys intake KO Chow 7.539 3.676 11* 
    WT RK- 8.189 2.016 18* 
    KO RK- 5.609 2.340 11* 
G KO RK- + AA solutions WT Chow 3.090 0.438 18* 
  Water consumption KO Chow 5.717 0.567 12* 
    WT RK- 3.240 0.468 18* 
    KO RK- 5.183 0.632 12* 
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CLAMS data 
Figure Treatment Parameter Diet Mean SEM N 
4.6 B A-/RK- Food intake L Chow 0.235 0.031 16 
    males   A- 0.302 0.038 8 
        RK- 0.313 0.028 6 
  C   Meal frequency L Chow 4.69 0.588 16 
        A- 6.94 0.933 8 
        RK- 6.13 0.498 8 
  D   Meal duration L Chow 247.1 28.82 16 
        A- 296.4 34.63 8 
        RK- 241.7 26.09 8 
  E   Bodyweight A- Before 29.49 0.780 8 
        A- 29.88 0.767 8 
        A+ 29.64 0.704 8 
  F   Food intake D Chow 0.586 0.042 16 
        A- 0.574 0.029 8 
        RK- 0.648 0.068 8 
  G   Meal frequency D Chow 11.16 0.639 16 
        A- 11.22 0.640 8 
        RK- 12.66 0.822 8 
  H   Meal duration D Chow 594.2 42.17 16 
        A- 552.1 21.48 8 
        RK- 437.9 18.34 8 
  I   Bodyweight Chow Before 29.86 0.537 16 
        Chow 28.98 0.479 16 
        A+ 29.63 0.529 16 
  J   VCO2 L Chow 3479 97.5 15 
        A- 4254 205.6 8 
        RK- 3897 141.4 8 
  K   Fox L Chow 0.008 0.002 15 
        A- -0.003 0.005 8 
        RK- -0.001 0.002 8 
  L   CHOx L Chow 0.100 0.005 15 
        A- 0.088 0.010 8 
        RK- 0.085 0.007 8 
  M   RER L Chow 0.921 0.014 15 
        A- 1.027 0.040 8 
        RK- 1.017 0.021 8 
  N   VCO2 D Chow 4613 110.0 15 
        A- 5061 115.6 8 
        RK- 4940 117.8 8 
  O   Fox D Chow 0.005 0.003 15 
        A- -0.006 0.004 8 
        RK- -0.007 0.004 8 
  P   CHOx D Chow 0.117 0.008 15 
        A- 0.098 0.010 8 
        RK- 0.093 0.010 8 
  Q   RER D Chow 0.968 0.022 15 
        A- 1.048 0.030 8 
        RK- 1.057 0.029 8 
  R   Activity L Chow 39.31 2.944 15 
        A- 59.91 18.110 8 
        RK- 28.26 2.731 8 
  S   Rearing L Chow 16.15 2.578 15 
        A- 18.56 4.810 8 
        RK- 7.41 1.629 7 
4.7  B A-/RK- Food intake L C2 0.238 0.021 15 
    females   A- 0.236 0.025 7 
        RK- 0.253 0.027 8 
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   C   Meal frequency L C2 5.40 0.406 15 
        A- 5.50 0.707 7 
        RK- 5.88 0.350 8 
   D   Meal duration L C2 382.5 30.69 15 
        A- 306.6 48.20 7 
        RK- 360.8 39.99 8 
   E   Food intake D C2 0.534 0.028 16 
        A- 0.493 0.047 7 
        RK- 0.537 0.059 8 
   F   Meal frequency D C2 10.80 0.455 16 
        A- 9.64 0.822 7 
        RK- 10.38 0.990 8 
   G   Meal duration D C2 715.9 36.80 16 
        A- 537.3 29.56 7 
        RK- 600.2 67.97 8 
   H   VCO2 L C2 4660 179.0 16 
        A- 4770 260.5 7 
        RK- 4566 191.8 8 
   I   Fox L C2 0.010 0.001 16 
        A- 0.011 0.002 7 
        RK- 0.012 0.001 8 
  J   CHOx L C2 0.133 0.004 16 
        A- 0.138 0.007 7 
        RK- 0.135 0.005 8 
   K   RER L C2 0.922 0.010 16 
        A- 0.918 0.017 7 
        RK- 0.912 0.006 8 
   L   VCO2 D C2 5829 218.9 16 
        A- 6015 336.2 7 
        RK- 5818 321.6 8 
   M   Fox D C2 0.003 0.002 16 
        A- 0.004 0.005 7 
        RK- 0.005 0.003 8 
   N   CHOx D C2 0.139 0.005 16 
        A- 0.147 0.013 7 
        RK- 0.145 0.003 8 
   O   RER D C2 0.979 0.015 16 
        A- 0.976 0.030 7 
        RK- 0.964 0.021 8 
4.8  B Switch to A+ M food intake L RK- 0.313 0.028 8 
    food intake   A+ 0.304 0.041 8 
        A- 0.302 0.038 8 
        A+ 0.221 0.034 8 
   C   M frequency L RK- 6.13 0.498 8 
        A+ 5.56 0.637 8 
        A- 6.94 0.933 8 
        A+ 4.50 0.433 8 
   D   M duration L RK- 241.7 26.09 8 
        A+ 197.4 20.15 8 
        A- 296.4 34.63 8 
        A+ 219.7 39.16 8 
   E   M food intake D RK- 0.648 0.068 8 
        A+ 0.683 0.061 8 
        A- 0.574 0.029 8 
        A+ 0.665 0.033 8 
   F   M frequency D RK- 12.66 0.822 8 
        A+ 12.19 1.049 8 
        A- 11.22 0.640 8 
        A+ 12.16 0.671 8 
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   G   M duration D RK- 437.9 18.34 8 
        A+ 486.9 38.95 8 
        A- 552.1 21.48 8 
        A+ 546.7 32.83 8 
   H   F RK- intake L RK- 0.253 0.027 8 
        A+ 0.194 0.012 8 
        C2 0.231 0.030 8 
        A+ 0.124 0.022 8 
   I   F RK- frequency L RK- 5.88 0.350 8 
        A+ 4.19 0.365 8 
        C2 5.31 0.590 8 
        A+ 2.94 0.438 8 
   J   F RK- duration L RK- 360.8 39.99 8 
        A+ 235.4 24.18 8 
        C2 344.9 31.07 8 
        A+ 163.1 27.60 8 
   K   F RK- intake D RK- 0.537 0.059 8 
        A+ 0.595 0.030 8 
        C2 0.583 0.031 8 
        A+ 0.553 0.019 8 
   L   F RK- frequency D RK- 10.38 0.990 8 
        A+ 12.34 0.537 8 
        C2 11.72 0.605 8 
        A+ 11.09 0.398 8 
   M   F RK- duration D RK- 600.2 67.97 8 
        A+ 679.9 72.20 8 
        C2 724.7 55.61 8 
        A+ 575.6 50.22 8 
   N   F A- intake L A- 0.493 0.047 7 
        A+ 0.516 0.031 7 
        C2 0.484 0.042 8 
        A+ 0.515 0.041 8 
   O   F A- frequency L A- 5.50 0.707 7 
        A+ 4.21 0.770 7 
        C2 5.50 0.598 8 
        A+ 4.29 0.635 8 
   P   F A- duration L A- 306.6 48.20 7 
        A+ 220.1 69.46 7 
        C2 425.4 53.33 8 
        A+ 285.4 33.88 8 
   Q   F A- intake D A- 0.236 0.025 7 
        A+ 0.144 0.028 7 
        C2 0.247 0.030 8 
        A+ 0.191 0.030 8 
   R   F A- frequency D A- 9.64 0.822 7 
        A+ 11.43 0.582 7 
        C2 9.88 0.526 8 
        A+ 9.88 0.502 8 
   S   F A- duration D A- 537.3 29.56 7 
        A+ 522.8 49.97 7 
        C2 707.1 51.87 8 
        A+ 626.6 42.82 8 
4.9  B Switch to A+ M activity L RK- 26.9 2.71 7 
    activity   A+ 32.7 2.56 7 
        A- 43.3 8.31 7 
        A+ 42.7 3.60 7 
   C   F RK- activity L RK- 60.1 5.95 8 
        A+ 62.5 12.38 8 
        C2 69.4 12.88 8 
        A+ 49.0 10.88 8 
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   D   F A- activity L A- 52.3 6.27 8 
        A+ 70.2 24.91 8 
        C2 58.8 6.50 8 
        A+ 48.3 5.98 8 
   E   M activity D RK- 184 17.14 8 
        A+ 137.9 18.05 8 
        A- 165.3 22.68 8 
        A+ 127.4 12.33 8 
   F   F RK- activity D RK- 257.9 43.12 7 
        A+ 176 43.83 7 
        C2 253.2 36.11 8 
        A+ 204.9 34.87 8 
   G   F A- activity D A- 228.1 29.45 7 
        A+ 159.7 30.52 7 
        C2 242.5 28.07 8 
        A+ 189.2 20.33 8 
4.1  B Switch to A+ M VCO2 L RK- 3897 141.4 8 
    metabolism   A+ 4067 146.2 8 
        A- 4254 205.6 8 
        A+ 3902 149 8 
   C   M Fox L RK- -0.001 0.002 8 
        A+ -0.003 0.003 8 
        A- -0.003 0.005 8 
        A+ 0.005 0.005 8 
   D   M CHOx L RK- 0.085 0.007 8 
        A+ 0.083 0.007 8 
        A- 0.088 0.010 8 
        A+ 0.101 0.012 8 
   E   M RER L RK- 1.017 0.021 8 
        A+ 1.031 0.025 8 
        A- 1.027 0.040 8 
        A+ 0.960 0.045 8 
   F   M VCO2 D RK- 4940 117.8 8 
        A+ 5185 152.2 8 
        A- 5061 115.6 8 
        A+ 5381 173.4 8 
   G   M Fox D RK- -0.007 0.004 8 
        A+ -0.011 0.002 8 
        A- -0.006 0.004 8 
        A+ -0.011 0.006 8 
   H   M CHOx D RK- 0.093 0.010 8 
        A+ 0.854 0.008 8 
        A- 0.098 0.010 8 
        A+ 0.092 0.014 8 
   I   M RER D RK- 1.057 0.029 8 
        A+ 1.092 0.022 8 
        A- 1.048 0.030 8 
        A+ 1.083 0.044 8 
   J   F RK- VCO2 L RK- 4566 191.8 8 
        A+ 4627 112.4 8 
        C2 4627 201.8 8 
        A+ 4143 164.1 8 
   K   F RK- Fox L RK- 0.012 0.001 8 
        A+ 0.017 0.003 8 
        C2 0.011 0.002 8 
        A+ 0.023 0.002 8 
   L   F RK- CHOx L RK- 0.135 0.005 8 
        A+ 0.147 0.009 8 
        C2 0.135 0.004 8 
        A+ 0.155 0.006 8 
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   M   F RK- RER L RK- 0.913 0.006 8 
        A+ 0.882 0.021 8 
        C2 0.915 0.015 8 
        A+ 0.824 0.013 8 
   N   F RK- VCO2 D RK- 5818 321.6 8 
        A+ 5943 258.1 8 
        C2 5965 237.2 8 
        A+ 5939 250.00 8 
   O   F RK- Fox D RK- 0.005 0.003 8 
        A+ 0.000 0.002 8 
        C2 0.000 0.002 8 
        A+ 0.002 0.001 8 
   P   F RK- CHOx D RK- 0.145 0.003 8 
        A+ 0.134 0.009 8 
        C2 0.135 0.007 8 
        A+ 0.139 0.006 8 
   Q   F RK- Heat L RK- 0.624 0.018 8 
        A+ 0.650 0.015 8 
        C2 0.628 0.015 8 
        A+ 0.609 0.012 8 
   R   F A- VCO2 L A- 4770 260.5 7 
        A+ 4897 271.1 7 
        C2 4693 310.2 8 
        A+ 4750 234.4 8 
   S   F A- Fox L A- 0.011 0.002 7 
        A+ 0.004 0.003 7 
        C2 0.009 0.002 8 
        A+ 0.005 0.003 8 
   T   F A- CHOx L A- 0.138 0.007 7 
        A+ 0.122 0.006 7 
        C2 0.131 0.007 8 
        A+ 0.119 0.006 8 
   U   F A- RER L A- 0.918 0.017 7 
        A+ 0.963 0.025 7 
        C2 0.930 0.015 8 
        A+ 0.963 0.020 8 
   V   F A- VCO2 D A- 6015 336.2 7 
        A+ 6418 327.1 7 
        C2 5693 379.2 8 
        A+ 6338 272.2 8 
  W   F A- Fox D A- 0.004 0.005 7 
        A+ -0.010 0.004 7 
        C2 0.006 0.004 8 
        A+ -0.007 0.003 8 
   X   F A- CHOx D A- 0.147 0.013 7 
        A+ 0.116 0.006 7 
        C2 0.143 0.007 8 
        A+ 0.123 0.008 8 
   Y   F A- RER D A- 0.976 0.030 7 
        A+ 1.058 0.022 7 
        C2 0.961 0.025 8 
        A+ 1.042 0.019 8 
 
 
